A (2010-2017)

STUDIES ON CONDITIONS and RELATED ARTICLES 2010-2017

*Articles/Studies in Pre-2000 List
+Articles/Studies in 2000-2009 List

ACHALASIA (Esophageal sphincter doesn’t relax, preventing food from entering the intestines)
ACHILLES TENDINOSIS
ACIDEMIA (See ORGANIC ACIDEMIA)
ACNE +
ACUPUNCTURE/ELECTROACUPUNCTURE +
ADD/ADHD*+
ADDICTION/CRAVING/PROBLEMATIC USE*+
ADOLESCENTS/YOUNG ADULTS +
ADRENOLEUKODYSTROPHY (Inherited condition that affects the white matter of the nervous system and adrenal cortex)
AGE-RELATED DIFFERENCES
AGING + (See Also OLDER ADULT CANNABIS USERS, MENOPAUSE)
AIDS (See HIV)
ALCOHOLISM/ALCOHOL*+
ALLERGIES AND CANNABIS*+
ALLERGIES TO CANNABIS*+
ALS/AMYOTROPHIC LATERAL SCLEROSIS +
ALZHEIMER’S DISEASE/DEMENTIA*+
AMOTIVATIONAL SYNDROME*+
ANGELMAN’S SYNDROME (See Also News Section)
ANGIOEDEMA (Similar to Hives, but Swelling is Under the Skin, May be Due to Allergies)
ANGIOGENESIS + (Formation of New Blood Vessels)
ANOREXIA/ANOREXIA NERVOSA + (See Also APPETITE)
ANTI-BACTERIAL PROPERTIES*+ (See Also MRSA)
ANTI-FUNGAL PROPERTIES +
ANTIOXIDANT PROPERTIES +
ANTI-PARASITIC PROPERTIES
ANTI-PROTOZOAL PROPERTIES*+
ANXIETY/ANXIOLYTIC EFFECTS*+ (Anxiety Reducing)
APPETITE*+ (See Also OBESITY, TASTE)
ARTHRITIS +
ARACHIDONYL-2′-CHLOROETHYLAMIDE (See ACEA in the SYNTHETICS Section)
2-ARACHIDONOYLGLYCEROL (See 2-AG in the ENDOCANNABINOID SYSTEM Section)
ASTHMA*+ (See Also LUNG FUNCTION)
ATAXIA*+ (Lack of Muscle Coordination During Movements Like Walking, Sometimes Hereditary, See Also SPINOCEREBELLAR ATAXIA and PHARC)
ATHEROSCLEROSIS*+
AUTISM + (See Also FRAGILE X SYNDROME)
top


ACHALASIA
Self-medication of achalasia with cannabis, complicated by a cannabis use disorder (full–2015) http://www.wjgnet.com/1007-9327/full/v21/i20/6381.htm


ACHILLES TENDINOSIS
Increased Expression of Cannabinoid CB(1) Receptors in Achilles Tendinosis (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3169627/?tool=pubmed


ACNE
Endocannabinoid signaling and epidermal differentiation (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21628127
Cannabidiol exerts sebostatic and antiinflammatory effects on human sebocytes (full–2014) http://www.jci.org/articles/view/64628
The safety and efficacy of 3% Cannabis seeds extract cream for reduction of human cheek skin sebum and erythema content (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26142529
Dermatological Aspects of Synthetic Cannabinoid Addiction (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27028361 Differential effectiveness of selected non-psychotropic phytocannabinoids on human sebocyte functions implicates their introduction in dry/seborrheic skin and acne treatment (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27094344 Targeting Cutaneous Cannabinoid Signaling in Inflammation – A “High”-way to Heal? (full–2017) http://www.ebiomedicine.com/article/S2352-3964(17)30003-8/fulltext


ACUPUNCTURE/ELECTROACUPUNCTURE
Involvement of ERK 1/2 activation in electroacupuncture pretreatment via cannabinoid CB1 receptor in rats (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20654595
Electroacupuncture increases CB2 receptor expression on keratinocytes and infiltrating inflammatory cells in inflamed skin tissues of rats (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20627823
Cannabinoid CB2 Receptors Contribute to Upregulation of β-endorphin in Inflamed Skin Tissues by Electroacupuncture (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3281798/
Activation of epsilon protein kinase C-mediated anti-apoptosis is involved in rapid tolerance induced by electroacupuncture pretreatment through cannabinoid receptor type 1 (full–2011) http://stroke.ahajournals.org/content/42/2/389.long
Electroacupuncture reduces the expression of proinflammatory cytokines in inflamed skin tissues through activation of cannabinoid CB2 receptors (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22337285
top
Effects of repeated electroacupuncture on gene expression of cannabinoid receptor-1 and dopamine 1 receptor in nucleus accumbens-caudate nucleus region in inflammatory-pain rats (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21585053
Electroacupuncture inhibits CB1 upregulation induced by ethanol withdrawal in mice (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22613131
Multimodal stepped care approach with acupuncture and PPAR-α agonist palmitoylethanolamide in the treatment of a patient with multiple sclerosis and central neuropathic pain (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22301508
Electroacupuncture reduces the expression of proinflammatory cytokines in inflamed skin tissues through activation of cannabinoid CB2 receptors (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22337285
Electroacupuncture inhibition of hyperalgesia in rats with adjuvant arthritis: involvement of cannabinoid receptor 1 and dopamine receptor subtypes in striatum (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3677619/
On the g-protein-coupled receptor heteromers and their allosteric receptor-receptor interactions in the central nervous system: focus on their role in pain modulation (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3730365/
CB1 and CB2 contribute to antinociceptive and anti-inflammatory effects of electroacupuncture on experimental arthritis of the rat temporomandibular joint (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23181276
Activation of STAT3 is involved in neuroprotection by electroacupuncture pretreatment via cannabinoid CB1 receptors in rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23880371
Acupuncture therapy for stroke patients (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/24215922
Care and Feeding of the Endocannabinoid System: A Systematic Review of Potential Clinical Interventions that Upregulate the Endocannabinoid System (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3951193/
Mn-SOD Upregulation by Electroacupuncture Attenuates Ischemic Oxidative Damage via CB1R-Mediated STAT3 Phosphorylation (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25432886
Glycogen synthase kinase-3β is involved in electroacupuncture pretreatment via the cannabinoid CB1 receptor in ischemic stroke (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/23943518
Involvement of GluR2 up-regulation in neuroprotection by electroacupuncture pretreatment via cannabinoid CB1 receptor in mice (full–2015) http://www.nature.com/srep/2015/150330/srep09490/full/srep09490.html
What do we understand from clinical and mechanistic studies on acupuncture treatment for hypertension? (full–2015) http://www.cmjournal.org/content/10/1/36
Cannabis-therapy for the future? (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26375695
Mn-SOD Upregulation by Electroacupuncture Attenuates Ischemic Oxidative Damage via CB1R-Mediated STAT3 Phosphorylation (abst–2016) http://link.springer.com/article/10.1007/s12035-014-8971-7
top
Glycogen synthase kinase-3β is involved in electroacupuncture pretreatment via the cannabinoid CB1 receptor in ischemic stroke. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/23943518
Involvement of GluR2 up-regulation in neuroprotection by electroacupuncture pretreatment via cannabinoid CB1 receptor in mice. (full – 2015) http://www.nature.com/srep/2015/150330/srep09490/full/srep09490.html
What do we understand from clinical and mechanistic studies on acupuncture treatment for hypertension? (full–2015) http://www.cmjournal.org/content/10/1/36
Acupuncture Mechanisms: Anesthesia, Analgesia and Protection on Organ Functions (link to PDF–2015) http://citeseerx.ist.psu.edu/viewdoc/summary? doi=10.1.1.732.8262&rank=2&q=cannabinoid&osm=&ossid
Cannabis – therapy for the future? (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26375695
Mn-SOD Upregulation by Electroacupuncture Attenuates Ischemic Oxidative Damage via CB1R-Mediated STAT3 Phosphorylation (abst–2016) http://link.springer.com/article/10.1007/s12035-014-8971-7
Ischemic Stroke, Excitatory Amino Acids Toxicity and the Adjustment of Acupuncture Intervention (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27323449 Endocannabinoid mechanism for orofacial antinociception induced by electroacupuncture in acupoint St36 in rats (abst–2016) http://www.sciencedirect.com/science/article/pii/S1734114016300913
Antagonism of cannabinoid receptor 1 attenuates the anti-inflammatory effects of electroacupuncture in a rodent model of migraine (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27834685


ADD/ADHD
Oral Delta 9-tetrahydrocannabinol improved refractory Gilles de la Tourette syndrome in an adolescent by increasing intracortical inhibition: a case report (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20520294
Panic Attack after Spice Abuse in a Patient with ADHD (abst–2010) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0029-1243252
Loss of striatal cannabinoid CB1 receptor function in attention-deficit/hyperactivity disorder mice with point-mutation of the dopamine transporter (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22034972
Why Omega-3s Affect Your Mood (news–2011) http://voices.yahoo.com/why-omega-3s-affect-mood-8180941.html?cat=5
Effects of amphetamine on dopamine release in the rat nucleus accumbens shell region depend on cannabinoid CB1 receptor activation (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22426202
Cannabidiol and clozapine reverse MK-801-induced deficits in social interaction and hyperactivity in Sprague-Dawley rats (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22495620
Impact of ADHD and cannabis use on executive functioning in young adults (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23992650
Subtypes of Attention Deficit-Hyperactivity Disorder (ADHD) and Cannabis Use (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24093525
An exploratory study of the combined effects of orally administered methylphenidate and delta-9-tetrahydrocannabinol (THC) on cardiovascular function, subjective effects, and performance in healthy adults (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25175495
Childhood and current ADHD symptom dimensions are associated with more severe cannabis outcomes in college students (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24332802
Medical marijuana: review of the science and implications for developmental-behavioral pediatric practice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25650954
Neuropsychological sex differences associated with age of initiated use among young adult cannabis users (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25832823
Use of paracetamol during pregnancy and child neurological development (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25851072
Adult attention-deficit/hyperactivity disorder and its association with substance use and substance use disorders in young men (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25989844
From badness to illness: Medical cannabis and self-diagnosed attention deficit hyperactivity disorder (abst–2015) http://informahealthcare.com/doi/abs/10.3109/16066359.2014.954556
ADHD and cannabis use in young adults examined using fMRI of a Go/NoGo task (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26489976
top
Adult attention deficit hyperactivity disorder symptom profiles and concurrent problems with alcohol and cannabis: sex differences in a representative, population survey (full–2016) http://bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-016-0746-4
ADHD Is Highly Prevalent in Patients Seeking Treatment for Cannabis Use Disorders (full–2016) http://journals.sagepub.com/doi/full/10.1177/1087054716640109
Attention deficit hyperactivity disorder and drug addiction rehabilitation patients (full – 2016) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004- 282X2016001201003&lng=en&nrm=iso&tlng=en
Gender Differences in Associations Between Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/26903256
Is attention deficit/hyperactivity disorder among men associated with initiation or escalation of substance use at 15-month follow up? A longitudinal study involving young Swiss men (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27061514
Heterologous Regulation of the Cannabinoid Type 1 Receptor by Angiotensin II in Astrocytes of Spontaneously Hypertensive Rats (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27529509
Targeting the Endocannabinoid System in Psychiatric Illness (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27811555
Distinct effects of childhood ADHD and cannabis use on brain functional architecture in young adults (full–2017) http://www.sciencedirect.com/science/article/pii/S221315821630170X


ADDICTION/CRAVING/PROBLEMATIC USE
Indian hemp and the dope fiends of Old England (article-undated) http://www.idmu.co.uk/indian.htm Addictive Properties of Popular Drugs (article–undated) http://www.drugwarfacts.org/cms/Addictive_Properties#sthash.6yenIhQ8.dpbs
Medical marijuana users in substance abuse treatment (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2848643/?tool=pubmed
More aroused, less fatigued: fatty acid amide hydrolase gene polymorphisms influence acute response to amphetamine (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2945903/
Aerobic Exercise Training Reduces Cannabis Craving and Use in Non-Treatment Seeking Cannabis-Dependent Adults (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3050879/?tool=pmcentrez
Dronabinol for the treatment of cannabis dependence: a randomized, double-blind, placebo-controlled trial (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3154755/
Characterizing smoking topography of cannabis in heavy users (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3641906/
The Endocannabinoid System as Pharmacological Target Derived from Its CNS Role in Energy Homeostasis and Reward. Applications in Eating Disorders and Addiction (link to PDF-2011) http://www.mdpi.com/1424-8247/4/8/1101
Abuse potential and psychoactive effects of δ-9-tetrahydrocannabinol and cannabidiol oromucosal spray (Sativex), a new cannabinoid medicine (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21542664
A Double-Blind Randomized Controlled Trial of N-Acetylcysteine in CannabisDependent Adolescents (full–2012) http://ajp.psychiatryonline.org/article.aspx?articleID=1184217&resultClick=1
The Interplay between Parental Monitoring and the Dopamine D4 Receptor Gene in Adolescent Cannabis Use (full–2012) http://www.plosone.org/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0049432&representation=PDF
Involvement of the endocannabinoid system in reward processing in the human brain (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3266503/
Medical marijuana laws in 50 states: Investigating the relationship between state legalization of medical marijuana and marijuana use, abuse and dependence (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3251168/
Associations of Alcohol, Nicotine, Cannabis, and Drug Use/Dependence with Educational Attainment: Evidence from Cotwin-Control Analyses (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3412907/
A genetic perspective on the proposed inclusion of cannabis withdrawal in DSM-5 (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3733446/
Cannabis as a substitute for alcohol and other drugs: A dispensary-based survey of substitution effect in Canadian medical cannabis patients (full–2012) https://philippelucasvictoria.files.wordpress.com/2012/12/rx-mj-as-a-substitute-for-aod-addiction-researchand-theory-2012-in-press.pdf
top
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities (full–2012)
http://rstb.royalsocietypublishing.org/content/367/1607/3353.full?sid=1569c370-cd5c-4358-89ff-857201f5e069
The genetic basis of the endocannabinoid system and drug addiction in humans (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/21937688
Reduction of dependence to cannabinoids by GLT-1 activating property of the betalactam antibiotic (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23253111
Human abuse potential and cognitive effects of taranabant, a cannabinoid 1 receptor inverse agonist: a randomized, double-blind, placebo- and active-controlled, crossover study in recreational polydrug users (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22722508
Anandamide and 2-arachidonoylglycerol: Pharmacological Properties, Functional Features, and Emerging Specificities of the Two Major Endocannabinoids (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22801993
Implicit Associations and Explicit Expectancies toward Cannabis in Heavy Cannabis Users and Controls (full–2013) http://www.frontiersin.org/Addictive_Disorders_and_Behavioral_Dyscontrol/10.3389/fpsyt.2013.00059/full
The Global Epidemiology and Contribution of Cannabis Use and Dependence to the Global Burden of Disease: Results from the GBD 2010 Study (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0076635
THC reduces the anticipatory nucleus accumbens response to reward in subjects with a nicotine addiction (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590996/
Further evidence for association of polymorphisms in the CNR1 gene with cocaine addiction: confirmation in an independent sample and meta-analysis (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3223560/
Inhibition of FAAH and activation of PPAR: New approaches to the treatment of cognitive dysfunction and drug addiction (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662489/
Probability and predictors of transition from abuse to dependence on alcohol, cannabis and cocaine: results from the national epidemiologic survey on alcohol and related conditions (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3755735/
Therapeutic potential of cannabinoid medicines (full–2013) http://onlinelibrary.wiley.com/doi/10.1002/dta.1529/full
Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835353/
Impulsivity, Variation in the Cannabinoid Receptor (CNR1) and Fatty Acid Amide Hydrolase (FAAH) Genes, and Marijuana-Related Problems (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817049/
top
Cannabis Cue Reactivity and Craving Among Never, Infrequent and Heavy Cannabis Users (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3957117/
Low frequency stimulation evokes serotonin release in the nucleus accumbens and induces long-term depression via production of endocannabinoid (full–2013) http://jn.physiology.org/content/111/5/1046.long
Cannabinoid and opioid interactions: implications for opiate dependence and withdrawal (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3742578/
Role of CB2 Cannabinoid Receptor in the Rewarding, Reinforcing and Physical Effects of Nicotine (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3799072/
Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835353/
Biphasic effects of Δ9-tetrahydrocannabinol on brain stimulation reward and motor activity (full–2013) http://ijnp.oxfordjournals.org/content/16/10/2273
Taking Note of Over-the-Counter Remedies for Adolescents With Cannabis Dependence (editorial–2013) http://ajp.psychiatryonline.org/doi/full/10.1176/appi.ajp.2012.12050615
Legalization of marijuana: unraveling quandaries for the addiction professional (article–2013) http://journal.frontiersin.org/article/10.3389/fpsyt.2013.00050/full
Cannabis and Cigarettes (abst–2013) http://jama.jamanetwork.com/article.aspx?articleid=1681388&resultClick=3
Endocannabinoid system and drug addiction: new insights from mutant mice approaches (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23490550
Lipids and addiction: how sex steroids, prostaglandins, and cannabinoids interact with drugs of abuse (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23510307
Role of intra-accumbal cannabinoid CB1 receptors in the potentiation, acquisition and expression of morphine-induced conditioned place preference (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23523958
Dysregulation of Cannabinoid CB1 Receptor and Associated Signaling Networks in Brains of Cocaine Addicts and Cocaine-Treated Rodents (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23727505
Male and Female Rats Differ in Brain Cannabinoid CB1 Receptor Density and Function and in Behavioural Traits Predisposing To Drug Addiction: Effect of Ovarian Hormones (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23829370
Palmitoylethanolamide: From endogenous cannabimimetic substance to innovative medicine for the treatment of cannabis dependence (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23896215
top
Neural responses to subliminally presented cannabis and other emotionally evocative cues in cannabis-dependent individuals (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24186078
Endocannabinoids underlie reconsolidation of hedonic memories in Wistar rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24247477
Cannabis withdrawal syndrome: An important diagnostic consideration in adolescents presenting with disordered eating (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24281745
Relationship between working-memory network function and substance use: a 3-year longitudinal fMRI study in heavy cannabis users and controls (abst–2013) http://onlinelibrary.wiley.com/doi/10.1111/adb.12111/abstract
The effects of cannabis use expectancies on self-initiated cannabis cessation (abst–2013) http://onlinelibrary.wiley.com/doi/10.1111/add.12233/abstract
Cross-sectional and prospective relation of cannabis potency, dosing and smoking behaviour with cannabis dependence: an ecological study (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/add.12508/full
Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/epi.12631/full
Prolonged monoacylglycerol lipase blockade causes equivalent CB1-receptor mediated adaptations in FAAH wild type and knockout mice (full–2014) http://jpet.aspetjournals.org/content/early/2014/05/21/jpet.114.212753.long
Pregnenolone can protect the brain from cannabis intoxication (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057431/
Potential Role of N-Acetylcysteine in the Management of Substance Use Disorders (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4009342/
Systematic review of N-acetylcysteine in the treatment of addictions (full–2014) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462014005031244&lng=en&nrm=iso&tlng=en
Endocannabinoid-dependent modulation of phasic dopamine signaling encodes external and internal reward-predictive cues (full–2014) http://journal.frontiersin.org/Journal/10.3389/fpsyt.2014.00118/full
Dependence Potential of the Synthetic Cannabinoids JWH-073, JWH-081, and JWH-210: In Vivo and In Vitro Approaches (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4131522/
top
Delta-9 tetrahydrocannabinol (THC) and endocannabinoid degradative enzyme inhibitors attenuate intracranial self-stimulation (ICSS) in mice (full–2014) http://jpet.aspetjournals.org/content/early/2014/11/14/jpet.114.218677.long
Evaluation of WIN 55,212-2 self-administration in rats as a potential cannabinoid abuse liability model (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930061/
Prevalence and correlates of alcohol and cannabis use disorders in the United States: Results from the national longitudinal study of adolescent health (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3963405/
Nabiximols as an Agonist Replacement Therapy During Cannabis Withdrawal: A Randomized Clinical Trial (full–2014) http://archpsyc.jamanetwork.com/article.aspx?articleid=1812720
Evaluation of sex differences in cannabinoid dependence (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3971653/
Mutation of Putative GRK Phosphorylation Sites in the Cannabinoid Receptor 1 (CB1R) Confers Resistance to Cannabinoid Tolerance and Hypersensitivity to Cannabinoids in Mice (full–2014) http://www.jneurosci.org/content/34/15/5152.long
Cannabis withdrawal in chronic, frequent cannabis smokers during sustained abstinence within a closed residential environment (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3986824/
Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/epi.12631/full
Enhanced Endocannabinoid-Mediated Modulation of Rostromedial Tegmental Nucleus Drive onto Dopamine Neurons in Sardinian Alcohol-Preferring Rats (full–2014) http://www.jneurosci.org/content/34/38/12716.long
Chronic stimulation of the tone of endogenous anandamide reduces cue – and stress induced relapse in rats (full–2014) http://ijnp.oxfordjournals.org/content/18/1/pyu025.long
Cannabis Withdrawal in Patients With and Without Opioid Dependence (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4127106/
The CB1 Receptor as an Important Mediator of Hedonic Reward Processing (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4138748/
Sex differences in antinociceptive tolerance to delta-9-tetrahydrocannabinol in the rat (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161674/
Investigation of sex-dependent effects of cannabis in daily cannabis smokers (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4518446/
Frequent marijuana use is associated with greater nicotine addiction in adolescent smokers (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4097075/
Expression and localization of cannabinoid receptor 1 in rats’ brain treated with acute and repeated morphine (link to PDF–2014) http://www.ncbi.nlm.nih.gov/pubmed/25231848
Imaging dopamine transmission parameters in cannabis dependence (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24513022
top
Strain differences in the expression of endocannabinoid genes and in cannabinoid receptor binding in the brain of Lewis and Fischer 344 rats (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24607771
Changes in cigarette and alcohol use during cannabis abstinence (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24613633
The FAAH inhibitor PF-04457845 has THC-like rewarding and reinstatement effects in squirrel monkeys and increases dopamine levels in the nucleus accumbens shell in rats (abst–2014) http://www.fasebj.org/content/28/1_Supplement/838.6.abstract?sid=db987fd0-3ef0-4796-aff6-4103f0c84daf
Endocannabinoid signaling and food addiction (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25173635
Association study of CNR1, GAD1 and BDNF polymorphisms with male heroin dependence in the Dai population in Yunnan (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25252306
Cannabinoid modulation of drug reward and the implications of marijuana legalization (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25463025
Neuroinflammation as a possible link between cannabinoids and addiction (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25455257
Hippocampal Cannabinoid Transmission Modulates Dopamine Neuron Activity: Impact on Rewarding Memory Formation and Social Interaction (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25510937
Potential use of Magnolia officinalis bark polyphenols in the treatment of cannabis dependence (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25459131
The endocannabinoid system regulates synaptic transmission in nucleus accumbens by increasing DAGL-α expression following short-term morphine withdrawal (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25296881
Etno-territorial prevalence of hashishism in some Siberian areas (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25403303
Cocaine-induced endocannabinoid release modulates behavioral and neurochemical sensitization in mice (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/adb.12080/full
Interactions of the opioid and cannabinoid systems in reward: Insights from knockout studies. (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4318341/
Trends in the co-occurrence of tobacco and cannabis use in 15-year-olds from 2002 to 2010 in 28 countries of Europe and North America (full–2015) http://eurpub.oxfordjournals.org/content/25/suppl_2/73.long
Use of Prescription Pain Medications Among Medical Cannabis Patients: Comparisons of Pain Levels, Functioning, and Patterns of Alcohol and Other Drug Use (full–2015) http://ssw.umich.edu/sites/default/files/documents/news/use-of-prescription-pain-medications-amongmedical-cannabis-patients.pdf
Heritability, SNP- and Gene-Based Analyses of Cannabis Use Initiation and Age at Onset (full–2015) http://link.springer.com/article/10.1007/s10519-015-9723-9/fulltext.html
top
Role of the endogenous cannabinoid system in nicotine addiction: novel insights (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373509/
Enhancing Brain Pregnenolone May Protect Cannabis Intoxication but Should Not Be Considered as an Anti-addiction Therapeutic: Hypothesizing Dopaminergic Blockade and Promoting Anti-Reward (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545660/
Ventral tegmental area dopamine and GABA neurons: Physiological properties and expression of mRNA for endocannabinoid biosynthetic elements (full–2015) http://www.nature.com/articles/srep16176
Cannabidiol as an Intervention for Addictive Behaviors: A Systematic Review of the Evidence (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4444130/
Craving is associated with amygdala volumes in adolescent marijuana users during abstinence (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4568004/
Cocaine-Induced Endocannabinoid Mobilization in the Ventral Tegmental Area (full–2015) http://www.cell.com/cell-reports/fulltext/S2211-1247%2815%2900926-2
Cellular Mechanisms of Action of Drug Abuse on Olfactory Neurons (full–2015) http://www.mdpi.com/1660-4601/13/1/5/htm
Cannabis conundrum: Evidence of harm?: Opposition to marijuana use is often rooted in arguments about the drug’s harm to children and adults, but the scientific evidence is seldom clear-cut (article–2015) http://onlinelibrary.wiley.com/doi/10.1002/cncy.21516/full
Marijuana, Reconsidered: Dr Lester Grinspoon On 45 Years Of Cannabis Science (interview–2015) http://www.mintpressnews.com/MyMPN/marijuana-reconsidered-an-interview-with-doctor-lestergrinspoon/
Cannabis problem experiences among users of the tobacco-cannabis combination known as blunts (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25746234
Effect of oral THC pretreatment on marijuana cue-induced responses in cannabis dependent volunteers (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25725933
A review of co-morbid tobacco and cannabis use disorders: Possible mechanisms to explain high rates of co-use (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25662704
Individual differences and vulnerability to drug addiction: a focus on the endocannabinoid system (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25714966
Further human evidence for striatal dopamine release induced by administration of ∆9-tetrahydrocannabinol (THC): selectivity to limbic striatum (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25801289
Smoke Your Troubles Away: Exploring the Effects of Death Cognitions on Cannabis Craving and Consumption (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25950588
The hippocampal NMDA receptors may be involved in acquisition, but not expression of ACPA-induced place preference (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26072736
The influence of cannabinoids on learning and memory processes of the dorsal striatum (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26092091
Do Medical Marijuana Laws Reduce Addictions and Deaths Related to Pain Killers? (abst–2015) http://www.nber.org/papers/w21345
top
Morphine-induced locomotor sensitization produces structural plasticity in the mesocorticolimbic system dependent on CB1-R activity (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26179931
Cross-tolerance to cannabinoids in morphine-tolerant rhesus monkeys (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26202613
Sex differences in associations between cannabis craving and neural responses to cannabis cues: Implications for treatment (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26237321
Separate and combined effects of gabapentin and [delta]9-tetrahydrocananbinol in humans discriminating [delta]9-tetrahydrocananbinol (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26313650
Early Phase in the Development of Cannabidiol as a Treatment for Addiction: Opioid Relapse Takes Initial Center Stage (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26269227
Buspirone treatment of cannabis dependence: A randomized, placebo-controlled trial (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26386827
Effects of daily delta-9-tetrahydrocannabinol treatment on heroin self-administration in rhesus monkeys (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26397756
Evaluation of the abuse potential of AM281, a new synthetic cannabinoid CB1 receptor antagonist (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26450088
Substituting cannabis for prescription drugs, alcohol and other substances among medical cannabis patients: The impact of contextual factors (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26364922
CB1 receptor antagonism blocks stress-potentiated reinstatement of cocaine seeking in rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26455361
Addressing the stimulant treatment gap: A call to investigate the therapeutic benefits potential of cannabinoids for crack-cocaine use (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26500166
Ghrelin and endocannabinoids participation in morphine-induced effects in the rat nucleus accumbens (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26507196
Monoacylglycerol lipase (MGLL) polymorphism rs604300 interacts with childhood adversity to predict cannabis dependence symptoms and amygdala habituation: Evidence from an endocannabinoid system-level analysis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26595473
Social anxiety and cannabis cravings: The influences of parent injunctive norms and tension reduction expectancies (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26586926
Cannabinoid Transmission in the Hippocampus Activates Nucleus Accumbens Neurons and Modulates Reward and Aversion-Related Emotional Salience (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26681496
top
Endocannabinoid Signaling in Motivation, Reward, and Addiction: Influences on Mesocorticolimbic Dopamine Function (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26638769
Acute and Chronic Ethanol Exposure Differentially Regulate CB1 Receptor Function at Glutamatergic Synapses in the Rat Basolateral Amygdala (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26707595
Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26708108
KAT2B polymorphism identified for drug abuse in African Americans with regulatory links to drug abuse pathways in human prefrontal cortex (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26202629
Relationship between the 1359 G/A polymorphism of the Central Cannabinoid Receptor 1 (CNR1) gene and susceptibility to cannabis addiction in a Turkish population (abst–2015) http://www.ingentaconnect.com/search/article?option1=tka&value1=cannabinoid&sortDescending=true&sortField=prism_publicationDate&pageSize=10&index=69
Natural outcome of cannabis use disorder: a 3-year longitudinal follow-up (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26212076
Mediating processes between stress and problematic marijuana use (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25661989
Combined Treatment with Morphine and Δ9-Tetrahydrocannibinol (THC) in Rhesus Monkeys: Antinociceptive Tolerance and Withdrawal (abst–2015) http://www.fasebj.org/content/29/1_Supplement/616.9.abstract?sid=edf921ac-0690-4aa6-ac81-0546314dd384
Are genetic variants for tobacco smoking associated with cannabis involvement? (abst–2015) http://www.drugandalcoholdependence.com/article/S0376-8716%2815%2900113-1/abstract
Cannabinoid Ligands and Alcohol Addiction: A Promising Therapeutic Tool or a Humbug? (full–2016) http://link.springer.com/article/10.1007/s12640-015-9555-7/fulltext.html
Interactions between the endocannabinoid and nicotinic cholinergic s ystems: preclinical evidence and therapeutic perspectives (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26728894
The Relationships of Cigarette and Alcohol Use With the Initiation, Reinitiation, and Persistence of Cannabis Use (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26751361
Longitudinal predictors of cannabis use and dependence in offspring from families at ultra high risk for alcohol dependence and in control families (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26756393
Genetic Versus Pharmacological Assessment of the Role of Cannabinoid Type 2 Receptors in Alcohol Reward-Related Behaviors (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26756798
Brain reactivity to alcohol and cannabis marketing during sobriety and intoxication (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26769333
top
CB1 receptor antagonism blocks stress-potentiated reinstatement of cocaine seeking in rats (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26455361
The effect of O-1602, an atypical cannabinoid, on morphine-induced conditioned place preference and physical dependence (abst–2016) http://www.sciencedirect.com/science/article/pii/S1734114016000037
Rapid Changes in Cannabinoid 1 Receptor Availability in Cannabis-Dependent Male Subjects After Abstinence From Cannabis (abst–2016) http://www.sciencedirect.com/science/article/pii/S2451902215000099
Self-administration of the anandamide transport inhibitor AM404 by squirrel monkeys (abst–2016) http://link.springer.com/article/10.1007/s00213-016-4211-3
Opposite regulation of cannabinoid CB1 and CB2 receptors in the prefrontal cortex of rats treated with cocaine during adolescence (abst–2016) http://www.sciencedirect.com/science/article/pii/S0304394016300192
Attempts to Stop or Reduce Daily Cannabis Use: An Intensive Natural History Study (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4877269/
Enkephalin levels and the number of neuropeptide Y-containing interneurons in the hippocampus are decreased in female cannabinoid-receptor 1 knock-out mice (full–2016) http://www.sciencedirect.com/science/article/pii/S0304394016301689
Interactions between cannabinoid receptor agonists and mu opioid receptor agonists in rhesus monkeys discriminating fentanyl (full–2016) http://www.sciencedirect.com/science/article/pii/S0014299916303235
Estradiol impacts the endocannabinoid system in female rats to influence behavioral and structural responses to cocaine (full–2016) http://www.sciencedirect.com/science/article/pii/S0028390816302428
Pharmacological characterization of repeated administration of the first generation abused synthetic cannabinoid CP47,497 (full–2016) http://www.degruyter.com/view/j/jbcpp.2016.27.issue-3/jbcpp-2015-0118/jbcpp-2015-0118.xml
Cognitive behavioral therapy program for cannabis use cessation in first-episode psychosis patients: study protocol for a randomized controlled trial (full–2016) http://trialsjournal.biomedcentral.com/articles/10.1186/s13063-016-1507-x
Orexins contribute to restraint stress-induced cocaine relapse by endocannabinoidmediated disinhibition of dopaminergic neurons (full–2016) http://www.nature.com/ncomms/2016/160722/ncomms12199/full/ncomms12199.html
Ecological Momentary Assessment and Smartphone Application Intervention in Adolescents with Substance Use and Comorbid Severe Psychiatric Disorders: Study Protocol (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028912/
Black–White Disparities in Criminal Justice Referrals to Drug Treatment: Addressing Treatment Need or Expanding the Diagnostic Net? (full – 2016) http://www.mdpi.com/2076-328X/6/4/21/htm Involvement of Endocannabinoids in Alcohol “Binge” Drinking: Studies of Mice with Human Fatty Acid Amide Hydrolase Genetic Variation and After CB1 Receptor Antagonists (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4962692/
Are adolescents more vulnerable to the harmful effects of cannabis than adults? A placebo-controlled study in human males (full–2016) http://www.nature.com/tp/journal/v6/n11/full/tp2016225a.html
Presynaptic G Protein-Coupled Receptors: Gatekeepers of Addiction? (full–2016) http://journal.frontiersin.org/article/10.3389/fncel.2016.00264/full
Regional Influence of Cannabinoid CB1 Receptors in the Regulation of Ethanol SelfAdministration by Wistar Rats (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5152943/ Attenuation of Cocaine-Induced Conditioned Place Preference and Motor Activity via Cannabinoid CB2 Receptor Agonism and CB1 Receptor Antagonism in Rats (full–2016) http://ijnp.oxfordjournals.org/content/early/2016/12/19/ijnp.pyw102.long
ADHD Is Highly Prevalent in Patients Seeking Treatment for Cannabis Use Disorders (full–2016) http://journals.sagepub.com/doi/full/10.1177/1087054716640109
Cannabis craving in response to laboratory-induced social stress among racially diverse cannabis users: The impact of social anxiety disorder (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5147424/
fMRI study of neural sensitization to hedonic stimuli in long-term, daily cannabis users. (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012952/
Effects of an acute cannabidiol treatment on cocaine self-administration and cue-induced cocaine seeking in male rats (full–2016) http://journals.sagepub.com/doi/full/10.1177/0269881116667706
Attention deficit hyperactivity disorder and drug addiction rehabilitation patients (full–2016) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004- 282X2016001201003&lng=en&nrm=iso&tlng=en
Dissecting the signaling pathways involved in the crosstalk between mGlu5 and CB1 receptors (link to PDF–2016) http://molpharm.aspetjournals.org/content/early/2016/06/23/mol.116.104372.long Opioids Out, Cannabis In (1st page–2016) http://jamanetwork.com/journals/jama/article-abstract/2576617 Lipids in psychiatric disorders and preventive medicine (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763415303353
Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26728894
The Relationships of Cigarette and Alcohol Use With the Initiation, Reinitiation, and Persistence of Cannabis Use (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26751361 Longitudinal predictors of cannabis use and dependence in offspring from families at ultra high risk for alcohol dependence and in control families (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26756393
Brain reactivity to alcohol and cannabis marketing during sobriety and intoxication (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26769333
Self-administration of the anandamide transport inhibitor AM404 by squirrel monkeys (abst–2016) http://link.springer.com/article/10.1007/s00213-016-4211-3
The Changing Drug Culture: Medical and Recreational Marijuana (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26881768
Blockade of Nicotine and Cannabinoid Reinforcement and Relapse by a Cannabinoid CB1-Receptor Neutral Antagonist AM4113 and Inverse Agonist Rimonabant in Squirrel Monkeys (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26888056
Combined treatment with morphine and Δ9-tetrahydrocannibinol (THC) in rhesus monkeys: antinociceptive tolerance and withdrawal (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26937020
Effects of fixed or self-titrated dosages of Sativex on cannabis withdrawal and cravings (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26925704
Alcohol and cannabis use among college students: Substitutes or complements? (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26894560
Low Pretreatment Impulsivity and High Medication Adherence Increase the Odds of Abstinence in a Trial of N-Acetylcysteine in Adolescents with Cannabis Use Disorder (abst -2016) http://www.journalofsubstanceabusetreatment.com/article/S0740-5472%2815%2900313-X/abstract
Cannabis policy and the uptake of treatment for cannabis-related problems. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27004985 Beyond the CB1 Receptor: Is Cannabidiol the Answer for Disorders of Motivation? (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27023732 Preclinical studies on the reinforcing effects of cannabinoids. A tribute to the scientific research of Dr. Steve Goldberg. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27026633 Dermatological Aspects of Synthetic Cannabinoid Addiction (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27028361
Functional effects of cannabinoids during dopaminergic specification of human neural precursors derived from induced pluripotent stem cells (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27027565
The association of specific traumatic experiences with cannabis initiation and transition to problem use: Differences between African-American and European-American women (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27012434
Keep off the grass? Cannabis, cognition and addiction (abst–2016) http://www.nature.com/nrn/journal/v17/n5/full/nrn.2016.28.html
COMT Val158Met genotype and cannabis use in people with an At Risk Mental State for psychosis: Exploring Gene x Environment interactions (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27052366
Gender differences in cannabis use disorder treatment: Change readiness and taking steps predict worse cannabis outcomes for women (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27156221
Comorbid Cannabis and Tobacco Use in Adolescents and Adults (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27175326
Social Anxiety and Cannabis-Related Impairment: The Synergistic Influences of Peer and Parent Descriptive and Injunctive Normative Perceptions (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27144526
A Functional 3’UTR Polymorphism (rs2235749) of Prodynorphin Alters microRNA-365 Binding in Ventral Striatonigral Neurons to Influence Novelty Seeking and Positive Reward Traits. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27074815
Dual Cannabis and Alcohol Use Disorders in Young Adults: Problems Magnified. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27070725
Is attention deficit/hyperactivity disorder among men associated with initiation or escalation of substance use at 15-month follow up? A longitudinal study involving young Swiss men (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27061514
Declining Prevalence of Marijuana Use Disorders Among Adolescents in the United States, 2002 to 2013 (abst–2016) http://www.jaacap.com/article/S0890-8567%2816%2930101-0/abstract
Sativex Associated With Behavioral-Relapse Prevention Strategy as Treatment for Cannabis Dependence: A Case Series (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27261670
Craving Cannabis: A Meta-analysis of Self-Report and Psychophysiological CueReactivity Studies (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27239052
Co-occurrent cannabis and tobacco uses: Clinical knowledge and therapeutic prospects (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27235655
Exercise as an adjunctive treatment for cannabis use disorder (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27314543
Assessing the risk of marijuana use disorder among adolescents and adults who use marijuana (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27292878
Cannabidiol disrupts the reconsolidation of contextual drug-associated memories in Wistar rats (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26833888
Problematic Use of Prescription Opioids and Medicinal Cannabis Among Patients Suffering from Chronic Pain (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27346885 Older-adult marijuana users and ex-users: Comparisons of sociodemographic characteristics and mental and substance use disorders (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27282425
Consequences of adolescent use of alcohol and other drugs: Studies using rodent models (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763416304304
Blockade of Cannabinoid CB1 receptor attenuates the acquisition of morphine-induced conditioned place preference along with a downregulation of ERK, CREB phosphorylation, and BDNF expression in the nucleus accumbens and hippocampus (abst–2016) http://www.sciencedirect.com/science/article/pii/S0304394016305419
A preliminary evaluation of synthetic cannabinoid use among adolescent cannabis users: Characteristics and treatment outcomes (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27454353 Synthetic cannabinoids to avoid urine drug screens: Implications for contingency management and other treatments for drug dependence (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27424166 Magnitude and duration of cue-induced craving for marijuana in volunteers with cannabis use disorder (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27436749 Limitations to the Dutch cannabis toleration policy: Assumptions underlying the reclassification of cannabis above 15% THC (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27471078 Genetic variation in FAAH is associated with cannabis use disorders in a young adult sample of Mexican Americans (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27394933
Cue-elicited increases in incentive salience for marijuana: Craving, demand, and attentional bias (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27515723
Contribution of health motive to cannabis use among high-school students (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27543835
Effects of Adolescent Cannabinoid Self-Administration in Rats on Addiction-Related Behaviors and Working Memory. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27582345

Sex differences in alcohol consumption and alterations in nucleus accumbens endocannabinoid mRNA in alcohol-dependent rats (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27578612
Does marijuana “blunt” smoking contribute to nicotine exposure?: Preliminary product testing of nicotine content in wrappers of cigars commonly used for blunt smoking (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27639129
Genetic and Environmental Factors Associated with Cannabis Involvement (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27642547
Marijuana and tobacco co-administration in blunts, spliffs, and mulled cigarettes: A systematic literature review (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27654966
Drug-Induced Alterations of Endocannabinoid-Mediated Plasticity in Brain Reward Regions (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27707960
CB1 Cannabinoid Receptors Mediate Cognitive Deficits and Structural Plasticity Changes During Nicotine Withdrawal (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27737762
Child maltreatment and cannabis use in young adulthood: A birth cohort study (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27741369
Anxiety Sensitivity and Distress Intolerance as Predictors of Cannabis Dependence Symptoms, Problems, and Craving: The Mediating Role of Coping Motives (abst–2016) http://www.jsad.com/doi/10.15288/jsad.2016.77.889
The endocannabinoid hydrolysis inhibitor SA-57: Intrinsic antinociceptive effects, augmented morphine-induced antinociception, and attenuated heroin seeking behavior in mice (abst–2016) http://www.sciencedirect.com/science/article/pii/S0028390816305123
A novel inhibitor of endocannabinoid catabolic enzymes sheds light on behind the scene interplay between chronic pain, analgesic tolerance, and heroin dependence (abst–2016) http://www.sciencedirect.com/science/article/pii/S0028390816305226
The anabolic steroid nandrolone alters cannabinoid self-administration and brain CB1 receptor density and function (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816306685
Behavioral Determinants of Cannabinoid Self-Administration in Old-World Monkeys. (abst – 2016) https://www.ncbi.nlm.nih.gov/pubmed/28059083
Synthetic cannabinoids: A new addiction matrix (abst – 2016) https://www.ncbi.nlm.nih.gov/pubmed/28063756
Differential effects of cannabis dependence on cortical inhibition in patients with schizophrenia and non-psychiatric controls. (abst – 2016) https://www.ncbi.nlm.nih.gov/pubmed/27964871
Identifying HIV care enrollees at-risk for cannabis use disorder. (abst – 2016) https://www.ncbi.nlm.nih.gov/pubmed/28006972
Persistent cannabis dependence and alcohol dependence represent risks for midlife economic and social problems: A longitudinal cohort study. (abst – 2016) https://www.ncbi.nlm.nih.gov/pubmed/28008372
Marijuana Could Help Treat Drug Addiction and Mental Health Problems (news & abst–2016) http://neurosciencenews.com/addiction-mental-health-marijuana-5536/ Multidimensional Family Therapy Reduces Self-Reported Criminality Among Adolescents With a Cannabis Use Disorder (full–2017) http://journals.sagepub.com/doi/full/10.1177/0306624X16687536
Brain cannabinoid receptor 2: expression, function and modulation (abst-2017) https://www.ncbi.nlm.nih.gov/pubmed/28065934
Do recreational cannabis users, unlicensed and licensed medical cannabis users form distinct groups? (abst – 2017) https://www.ncbi.nlm.nih.gov/pubmed/28107687
Whole genome sequence study of cannabis dependence in two independent cohorts (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28111843
Cannabis Use and Disorder From Childhood to Adulthood in a Longitudinal Community Sample With American Indians (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28117058


ADOLESCENTS/YOUNG ADULTS
Uni-Morbid and Co-Occurring Marijuana and Tobacco Use: Examination of Concurrent Associations with Negative Mood States (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2861285/?tool=pubmed
Learning and memory performances in adolescent users of alcohol and marijuana: interactive effects (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2965487/
Influence of cannabis use trajectories, grade repetition and family background on the school-dropout rate at the age of 17 years in France (full-2010) http://eurpub.oxfordjournals.org/content/20/2/157.long
PTSD contributes to teen and young adult cannabis use disorders (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2784238/?tool=pubmed
Adolescent cannabis use increases risk for cocaine-induced paranoia (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2821949/pdf/nihms156770.pdf
Cannabis withdrawal severity and short-term course among cannabis-dependent adolescent and young adult inpatients (abst-2010) http://www.unboundmedicine.com/medline/ebm/record/19783382/abstract/Cannabis_withdrawal_severity_and_short_term_course_among_cannabis_dependent_adolescent_and_young_adult_inpatients_
Cannabis Use and Obesity and Young Adults (abst-2010) http://informahealthcare.com/doi/abs/10.3109/00952990.2010.500438
A Life-course Perspective on the “Gateway Hypothesis” (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20943588
The Effects of Cannabis on Heart Rate Variability and Well-Being in Young Men (abst–2010) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0030-1248314
Patterns of Youth Participation in Cannabis Cultivation (abst–2010) http://jod.sagepub.com/content/40/2/263.abstract
top
History of cannabis use is not associated with alterations in striatal dopamine D2/D3 receptor availability (full–2011) http://jop.sagepub.com/content/26/1/144.long
The social contagion effect of marijuana use among adolescents (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018468/?tool=pubmed
Racial differences in trajectories of heavy drinking and regular marijuana use from ages 13 to 24 among African-American and White males (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3258364/
CNR2 functional variant (Q63R) influences childhood immune thrombocytopenic purpura (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232275/
Intelligence across childhood in relation to illegal drug use in adulthood: 1970 British Cohort Study (full–2011) (must register) http://www.academia.edu/1090026/Intelligence_across_childhood_in_relation_to_illegal_drug_use_in_adulthood_1970_British_Cohort_Study
Rural Adolescent Alcohol, Tobacco and Illicit Drug Use: A Comparison of Students in Victoria, Australia and Washington State, United States (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3186916/
Myocardial Infarction Associated With Use of the Synthetic Cannabinoid K2 (full–2011) http://pediatrics.aappublications.org/content/128/6/e1622.long
The association between early conduct problems and early marijuana use in college students (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3163297/
Gender differences in adolescent marijuana use and associated psychosocial characteristics (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3359836/
Synthetic cannabinoid use: a case series of adolescents (full–2011) http://www.jahonline.org/article/S1054-139X%2811%2900277-1/fulltext
Some features of teenage beer alcoholism combined with hashish addiction (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21322145
Pediatric cannabinoid hyperemesis: two cases (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21131803
Prospective Study of Cannabis Use in Adolescents at Clinical High-Risk for Psychosis: Impact on Conversion to Psychosis and Functional Outcome (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3459073/
Acute Intoxication Caused by a Synthetic Cannabinoid in Two Adolescents (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3470439/
Does the “gateway” sequence increase prediction of cannabis use disorder development beyond deviant socialization? Implications for prevention practice and policy (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3387340/
Intelligence quotient in childhood and the risk of illegal drug use in middle-age: the 1958 National Child Development Survey (full-2012) http://www.annalsofepidemiology.org/article/S1047-2797%2812%2900170-6/fulltext
top
Cannabinoid receptor type 2 functional variant influences liver damage in children with non-alcoholic Fatty liver disease (full–2012) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0042259
Adolescent Exposure of JWH-018 “Spice” Produces Subtle Effects on Learning and Memory Performance in Adulthood (full–2012) http://file.scirp.org/Html/2-3900080_19505.htm
Prevalence and co-use of marijuana among young adult cigarette smokers: An anonymous online national survey (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3507655/
The Interplay between Parental Monitoring and the Dopamine D4 Receptor Gene in Adolescent Cannabis Use (full–2012) http://www.plosone.org/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0049432&representation=PDF
A Double-Blind Randomized Controlled Trial of N-Acetylcysteine in CannabisDependent Adolescents (full–2012) http://ajp.psychiatryonline.org/article.aspx?articleID=1184217&resultClick=1
Medical Marijuana Laws and Teen Marijuana Use (full–2012) http://ftp.iza.org/dp6592.pdf
Acute intoxication caused by a synthetic cannabinoid in two adolescents (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3470439/
Sensation-seeking genes and physical activity in youth (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581711/
Do medical marijuana laws increase marijuana use? Replication study and extension (full–2012) http://www.annalsofepidemiology.org/article/S1047-2797%2811%2900372-3/fulltext
Alcohol as a Gateway Drug: A Study of US 12th Graders (abst–2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1746-1561.2012.00712.x/abstract
The combined effects of parental divorce and parental history of depression on cannabis use in young adults in France (abst–2012)  http://www.ncbi.nlm.nih.gov/pubmed/22682099
Adolescent Synthetic Cannabinoid Exposures Reported to Texas Poison Centers (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23023462
‘It’s just a social thing’: Drug use, friendship and borderwork among marginalized young people (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23352335
The changing demographic of blunt smokers across birth cohorts (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23201173
Sex and grade level differences in marijuana use among youth (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23705514
Water pipe smoking and psychoactive substances (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23421061
top
Cannabis extract treatment for terminal acute lymphoblastic leukemia with a Philadelphia chromosome mutation (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3901602/
Identity Formation, Marijuana and “The Self”: A Study of Cannabis Normalization among University Students (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847659/
Correlations between cannabis use and IQ change in the Dunedin cohort are consistent with confounding from socioeconomic status (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600466/
Effects of State Medical Marijuana Laws on Adolescent Marijuana Use (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4007871/
Legalization of medical marijuana and marijuana use among youths (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3638722/
Weeding out the information: an ethnographic approach to exploring how young people sense of the evidence on cannabis (full–2013) http://www.harmreductionjournal.com/content/10/1/34
Fascination and Social Togetherness-Discussions about Spice Smoking on a Swedish Internet Forum (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3855086/
Impact of ADHD and cannabis use on executive functioning in young adults (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820098/
Computer and therapist based brief interventions among cannabis-using adolescents presenting to primary care: One year outcomes (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3770780/
Do societal wealth, family affluence and gender account for trends in adolescent cannabis use? A 30 country cross-national study (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3947129/
Motivations to quit cannabis use in an adult non-treatment sample: Are they related to relapse? (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681844/
From “Social Supply” to “Real Dealing”: Drift, Friendship, and Trust in Drug-Dealing Careers (full–2013) http://jod.sagepub.com/content/43/4/392.full.pdf+html
THE IMPORTANCE OF FAMILY RELATIONS FOR CANNABIS USERS: THE CASE OF SERBIAN ADOLESCENTS (full–2013) http://www.sid.ir/en/VEWSSID/J_pdf/86320130302.pdf
Statistics on cannabis users skew perceptions of cannabis use (full–2013) http://journal.frontiersin.org/article/10.3389/fpsyt.2013.00138/full
Higher rates of adolescent substance use in child welfare versus community populations in the United States (link to PDF-2013) http://www.jsad.com/jsad/article/Higher_Rates_of_Adolescent_Substance_Use_in_Child_Welfare_Versus_Community_/4863.html
Taking Note of Over-the-Counter Remedies for Adolescents With Cannabis Dependence (editorial–2013) http://ajp.psychiatryonline.org/doi/full/10.1176/appi.ajp.2012.12050615
Identity formation, marijuana and “the self”: a study of cannabis normalization among university students (article–2013) http://journal.frontiersin.org/article/10.3389/fpsyt.2013.00160/full
National-level drug policy and young people’s illicit drug use: A multilevel analysis of the European Union (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23298650
top
To What Extent Does Adding Tobacco to Cannabis Expose Young Users to Nicotine? (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23674840
Cannabis withdrawal syndrome: An important diagnostic consideration in adolescents presenting with disordered eating (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/24281745
Testing bidirectional effects between cannabis use and depressive symptoms: moderation by the serotonin transporter gene (abst–2013)  http://onlinelibrary.wiley.com/doi/10.1111/j.1369-1600.2011.00380.x/abstract
Cannabis use among a sample of 16 to 18 year-old students in Switzerland (full–2014) http://www.hdbp.org/psychiatria_danubina/pdf/dnb_vol26_no1/dnb_vol26_no1_56.pdf
Cigarette smoking during an N-acetylcysteine-assisted cannabis cessation trial in adolescents (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4118750/
Pediatric exposure to drugs of abuse by hair testing: monitoring 15 years of evolution in Spain (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4143861/
An Examination of Opinions Toward Marijuana Policies Among High School Seniors in the United States (full–2014) http://www.tandfonline.com/doi/full/10.1080/02791072.2014.962716#tabModule
The Impact of State Medical Marijuana Legislation on Adolescent Marijuana Use (full–2014) http://www.jahonline.org/article/S1054-139X%2814%2900107-4/pdf
An exploratory study of the combined effects of orally administered methylphenidate and delta-9-tetrahydrocannabinol (THC) on cardiovascular function, subjective effects, and performance in healthy adults (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4250392/
Childhood and current ADHD symptom dimensions are associated with more severe cannabis outcomes in college students (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3904106/
Prevalence and correlates of alcohol and cannabis use disorders in the United States: Results from the national longitudinal study of adolescent health (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3963405/
Correlates of intentions to use cannabis among US high school seniors in the case of cannabis legalization (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4071130/
Neurocognition in college-aged daily marijuana users (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4074777/
Cannabinoid findings in children hair – what do they really tell us? An assessment in the light of three different analytical methods with focus on interpretation of Δ9-tetrahydrocannabinolic acid A concentrations (full–2014) http://onlinelibrary.wiley.com/doi/10.1002/dta.1692/full
Adverse psychosocial outcomes associated with drug use among US high school seniors: a comparison of alcohol and marijuana (full–2014) http://informahealthcare.com/doi/pdf/10.3109/00952990.2014.943371
Early onset of cannabis use: Does personality modify the relation with changes in perceived parental involvement? (full–2014) http://www.drugandalcoholdependence.com/article/S0376-8716%2814%2901893-6/fulltext
top
What are young adults smoking in their hookahs? A latent class analysis of substances smoked (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4091668/
Frequent marijuana use is associated with greater nicotine addiction in adolescent smokers (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4097075/
Synthetic cannabinoid use among patients in residential substance use disorder treatment: Prevalence, motives, and correlates (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161625/
The Impact of a Motivational Statement and Age of Cannabis Use Onset on Neuro-psychological Test Performance (full–2014) https://www.researchgate.net/publication/268577210_The_impact_of_a_motivational_statement_and_age_of_cannabis_use_onset_on_neuropsychological_test_performance
EFFICACY AND SAFETY OF EPIDIOLEX (CANNABIDIOL) IN CHILDREN AND YOUNG ADULTS WITH TREATMENT-RESISTANT EPILEPSY: INITIAL DATA FROM AN EXPANDED ACCESS PROGRAM (abst–2014) https://www.aesnet.org/meetings_events/annual_meeting_abstracts/view/1868751#sthash.pbnOqzNG.dpuf
The co-use of tobacco and cannabis among adolescents over a 30-year period (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24443776
Interpersonal Guilt and Substance Use in College Students (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24579980
Role of CNR1 polymorphisms in moderating the effects of psychosocial adversity on impulsivity in adolescents (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24980155
Prevalence of Cannabis Lifetime Use in Iranian High School and College Students: A Systematic Review, Meta-Analyses, and Meta-Regression (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25147097
Synthetic Cannabinoids: Use and predictors in a Community Sample of Young Adults (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25222129
Cannabis use and suicidal ideations in high-school students (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25123343
Socialization Instances Linked to Cannabis Experimentation Among French Teenagers (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25099311
Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25409697
Frequent electronic media communication with friends is associated with higher adolescent substance use (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25471077
Medical marijuana and children (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25647865
THE EFFECT OF EPIDIOLEX (CANNABIDIOL) ON SERUM LEVELS OF CONCOMITANT ANTI-EPILEPTIC DRUGS IN CHILDREN AND YOUNG ADULTS WITH TREATMENT-RESISTANT EPILEPSY IN AN EXPANDED ACCESS PROGRAM (abst–2014) https://www.aesnet.org/meetings_events/annual_meeting_abstracts/view/1868391#sthash.uxbwgudh.dpuf
top
Status Report: Marijuana Legalization in Colorado After One Year of Retail Sales and Two Years of Decriminalization (full–2015) http://www.drugpolicy.org/sites/default/files/Colorado_Marijuana_Legalization_One_Year_Status_Report.pdf
The Impact of Marijuana Policies on Youth: Clinical, Research, and Legal Update (full–2015) http://pediatrics.aappublications.org/content/early/2015/01/20/peds.2014-4147.long
Trends in the co-occurrence of tobacco and cannabis use in 15-year-olds from 2002 to 2010 in 28 countries of Europe and North America (full–2015) http://eurpub.oxfordjournals.org/content/25/suppl_2/73.long
PTSD Growth and Substance Abuse Among a College Student Community: Coping Strategies after 2009 L’aquila Earthquake (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397827/
Sex-dependent vulnerability to Cannabis abuse in adolescence (full-2015) http://journal.frontiersin.org/article/10.3389/fpsyt.2015.00056/full
Changes in cannabinoid receptors, aquaporin 4 and vimentin expression after traumatic brain injury in adolescent male mice. Association with edema and neurological deficit (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0128782
Heritability, SNP- and Gene-Based Analyses of Cannabis Use Initiation and Age at Onset (full–2015) http://link.springer.com/article/10.1007/s10519-015-9723-9/fulltext.html
Impact of Cannabis Use on the Development of Psychotic Disorders (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4352721/
Cannabis Withdrawal Among Detained Adolescents: Exploring the Impact of Nicotine and Race (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4331066/
Medical marijuana laws and adolescent marijuana use in the USA from 1991 to 2014: results from annual, repeated cross-sectional surveys (full–2015) http://press.thelancet.com/AdolescentMarijuana.pdf
Daily marijuana use is not associated with brain morphometric measures in adolescents or adults (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25632127
The Cannabinoid Receptor 2 Q63R Variant Modulates the Relationship between Childhood Obesity and Age at Menarche (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0140142
Evaluating the impact of cannabis use on thalamic connectivity in youth at clinical high risk of psychosis (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640353/
State Estimates of Adolescent Marijuana Use and Perceptions of Risk of Harm From Marijuana Use: 2013 and 2014 (full–2015)  http://www.samhsa.gov/data/sites/default/files/report_2121/ShortReport-2121.html
High School Students’ Use of Electronic Cigarettes to Vaporize Cannabis (full–2015) http://pediatrics.aappublications.org/content/136/4/611.long
Chronic Adolescent Marijuana Use as a Risk Factor for Physical and Mental Health Problems in Young Adult Men (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26237286
Prevalence and correlates of hashish use in a national sample of high school seniors in the United States (full–2015) http://www.tandfonline.com/doi/full/10.3109/00952990.2015.1011745
top
Medical marijuana’s public health lessons-implications for retail marijuana in Colorado (full–2015) http://www.nejm.org/doi/full/10.1056/NEJMp1500043
Craving is associated with amygdala volumes in adolescent marijuana users during abstinence (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4568004/
E-Cigarettes: A Review of New Trends in Cannabis Use (full–2015) http://www.mdpi.com/1660-4601/12/8/9988
Adolescent cannabis exposure interacts with mutant DISC1 to produce impaired adult emotional memory (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640936/
The role of the Cannabinoid Receptor 1 in adolescents’ processing of facial expressions (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/ejn.13118/full
Developmental regulation of fear learning and anxiety behavior by endocannabinoids (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/gbb.12253/full
Medical marijuana: review of the science and implications for developmental-behavioral pediatric practice (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4318349/
Associations between cigarette smoking and cannabis dependence: A longitudinal study of young cannabis users in the United Kingdom (link to PDF–2015) http://www.drugandalcoholdependence.com/article/S0376-8716%2815%2900010-1/abstract
Marijuana use and risk of prediabetes and diabetes by middle adulthood: the Coronary Artery Risk Development in Young Adults (CARDIA) study (link to PDF-2015) http://link.springer.com/article/10.1007/s00125-015-3740-3
Cannabis conundrum: Evidence of harm?: Opposition to marijuana use is often rooted in arguments about the drug’s harm to children and adults, but the scientific evidence is seldom clear-cut (article–2015) http://onlinelibrary.wiley.com/doi/10.1002/cncy.21516/full
More people think cannabis should be legal than tobacco (poll results–2015) http://www.studentmoneysaver.co.uk/article/more-people-think-cannabis-should-be-legal-than-tobacco/
Alcohol confounds relationship between cannabis misuse and psychosis conversion in a high-risk sample (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25572323
The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25586398
Young adult cannabis users report greater propensity for risk-taking only in nonmonetary domains (abst–2015) http://www.sciencedirect.com/science/article/pii/S0376871614020006
Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial (abst–2015) http://www.thelancet.com/journals/laneur/article/PIIS1474-4422%2815%2900379-8/abstract
top
13-Year-Old Girl With Recurrent, Episodic, Persistent Vomiting: Out of the Pot and Into the Fire (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25733759
Synthetic cannabinoid use in a nationally representative sample of US high school seniors (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25736618
Urinary early kidney injury molecules in children with beta-thalassemia major (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25656833
Synthetic cannabinoid use in a nationally representative sample of US high school seniors (abst–2015) http://www.drugandalcoholdependence.com/article/S0376-8716%2815%2900079-4/abstract
Longitudinal Effects of School Drug Policies on Student Marijuana Use in Washington State and Victoria, Australia (abst–2015) http://ajph.aphapublications.org/doi/10.2105/AJPH.2014.302421
Perceived risk of regular cannabis use in the United States from 2002 to 2012: Differences by sex, age, and race/ethnicity (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25735467
Cognitive performance in a placebo-controlled pharmacotherapy trial for youth with marijuana dependence (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25661990
Neuropsychological sex differences associated with age of initiated use among young adult cannabis users (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25832823
Parental reporting of response to oral cannabis extracts for treatment of refractory epilepsy (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25845492
Neighborhood-level and individual-level correlates of cannabis use among young persons living with HIV/AIDS (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25858786
Long-term consequences of perinatal and adolescent cannabinoid exposure on neural and psychological processes (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25960036
Adult attention-deficit/hyperactivity disorder and its association with substance use and substance use disorders in young men (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25989844
K2 and Spice use among a cohort of college students in southeast region of the USA (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26030768
Cigarette smoking may modify the association between cannabis use and adiposity in males (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26026899
Myocardial Ischemia Secondary to Synthetic Cannabinoid (K2) Use in Pediatric Patients (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26165442
The effect of alcohol availability on marijuana use: Evidence from the minimum legal drinking age (abst–2015) http://www.sciencedirect.com/science/article/pii/S0167629611001718
Reasons for recent marijuana use in relation to use of other illicit drugs among high school seniors in the United States (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26115351
top
Retrospective Analysis of Tetrahydrocannabinol Based on 31 Neurologically Critically Ill Children (abst–2015) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0035-1550707
Chronic Adolescent Marijuana Use as a Risk Factor for Physical and Mental Health Problems in Young Adult Men (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26237286
K2 and Spice use among a cohort of college students in southeast region of the USA (abst–2015) http://informahealthcare.com/doi/abs/10.3109/00952990.2015.1043438
Association between cannabinoid receptor type 2 Q63R variant and oligo/polyarticular juvenile idiopathic arthritis (abst–2015) http://informahealthcare.com/doi/abs/10.3109/03009742.2015.1020863
From badness to illness: Medical cannabis and self-diagnosed attention deficit hyperactivity disorder (abst–2015) http://informahealthcare.com/doi/abs/10.3109/16066359.2014.954556
Teenage Cardiac Arrest Following Abuse of Synthetic Cannabis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26256565
Synthetic Cannabinoid Abuse in Adolescents: A Case Series (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26293411
Past 15-year trends in adolescent marijuana use: Differences by race/ethnicity and sex (abst–2015) http://www.drugandalcoholdependence.com/article/S0376-8716%2815%2901618-X/abstract
Enhanced Functional Activity of the Cannabinoid Type-1 Receptor Mediates Adolescent Behavior (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26468198
ADHD and cannabis use in young adults examined using fMRI of a Go/NoGo task (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26489976
Self-reported use of novel psychoactive substances in a US nationally representative survey: Prevalence, correlates, and a call for new survey methods to prevent underreporting (abst–2015) http://www.drugandalcoholdependence.com/article/S0376-8716%2815%2901622-1/abstract
Social anxiety and cannabis cravings: The influences of parent injunctive norms and tension reduction expectancies (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26586926
Novel psychoactive substance use by US adolescents: Characteristics associated with use of synthetic cannabinoids and synthetic cathinones (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26711540
CANNABIS: ALTERNATIVE REALITIES (CRA) (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26650405
The Association of Low Parental Monitoring With Early Substance Use in European American and African American Adolescent Girls (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26562593
Prevalence of Marijuana and Other Substance Use Before and After Washington State’s Change from Legal Medical Marijuana to Legal Medical and Non-Medical Marijuana: Cohort Comparisons in a Sample of Adolescents (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26252354
top
Who receives cannabis use offers: A general population study of adolescents (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26433564
Shared Predisposition in the Association Between Cannabis Use and Subcortical Brain Structure (abst–2015) http://archpsyc.jamanetwork.com/article.aspx?articleid=2429550
The Effect of Medical Marijuana Laws on Body Weight (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26602324
Predicting Alcohol, Cigarette, and Marijuana Use From Preferential Music Consumption (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26400900
Past 15-year trends in adolescent marijuana use: Differences by race/ethnicity and sex (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26361714
Natural outcome of cannabis use disorder: a 3-year longitudinal follow-up (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26212076
Enhanced Functional Activity of the Cannabinoid Type-1 Receptor Mediates Adolescent Behavior (abst–2015) http://www.jneurosci.org/content/35/41/13975.abstract?sid=a8be93ef-f299-4c98-a01c-50f266b84e3e
Prevalence of Marijuana-Related Traffic on Twitter, 2012-2013: A Content Analysis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26075917
Investigating cannabis use normalization by distinguishing between experimental and regular use: a multilevel study in 31 countries (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25785792
IQ and educational outcomes in teenagers related to their cannabis use? A prospective cohort study (full–2016)  http://jop.sagepub.com/content/early/2016/01/06/0269881115622241.full
Prioritizing Alcohol Prevention: Establishing Alcohol as the Gateway Drug and Linking Age of First Drink With Illicit Drug Use (full–2016) http://onlinelibrary.wiley.com/doi/10.1111/josh.12351/full
Longitudinal predictors of cannabis use and dependence in offspring from families at ultra high risk for alcohol dependence and in control families (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26756393
Cannabidiol limits Tcell-mediated chronic autoimmune myocarditis: implications to autoimmune disorders and organ transplantation (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26772776
CBD-enriched medical cannabis for intractable pediatric epilepsy: The current Israeli experience (abst–2016) http://www.sciencedirect.com/science/article/pii/S1059131116000054
Cannabis and Psychosis: a Critical Overview of the Relationship (abst–2016) http://link.springer.com/article/10.1007/s11920-015-0657-y
Opposite regulation of cannabinoid CB1 and CB2 receptors in the prefrontal cortex of rats treated with cocaine during adolescence (abst–2016) http://www.sciencedirect.com/science/article/pii/S0304394016300192
Cannabinoid CB1 receptor inhibition blunts adolescent-typical increased binge alcohol and sucrose consumption in male C57BL/6J mice (abst–2016) http://www.sciencedirect.com/science/article/pii/S0091305716300089
Chest pain, troponin rise, and ST-elevation in an adolescent boy following the use of the synthetic cannabis product K2. (full – 2016) http://www.annalspc.com/article.asp?issn=0974- 2069;year=2016;volume=9;issue=1;spage=79;epage=81;aulast=Zaleta
Medicinal Use of Marijuana: What School Nurses Need to Know. (full – 2016) http://nas.sagepub.com/content/31/3/170.long
URB597 inhibits oxidative stress induced by alcohol binging in the prefrontal cortex of adolescent rats (full–2016) http://www.sciencedirect.com/science/article/pii/S0304394016302907
Dissociating the role of endocannabinoids in the pleasurable and motivational properties of social play behaviour in rats (full–2016) http://www.sciencedirect.com/science/article/pii/S1043661816303917
Case Series of Synthetic Cannabinoid Intoxication from One Toxicology Center (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4899060/
Associations Between Cannabis Use and Physical Health Problems in Early Midlife (full–2016) http://archpsyc.jamanetwork.com/article.aspx?articleid=2526003
Prevalence of marijuana use does not differentially increase among youth after states pass medical marijuana laws: Commentary on and reanalysis of US National Survey on Drug Use in Households data 2002-2011 (full–2016) http://www.ijdp.org/article/S0955-3959(16)00038-4/fulltext
First-Episode of Synthetic Cannabinoid-Induced Psychosis in a Young Adult, Successfully Managed with Hospitalization and Risperidone (full–2016) http://www.hindawi.com/journals/crips/2016/7257489/
National Estimates of Marijuana Use and Related Indicators — National Survey on Drug Use and Health, United States, 2002–2014 (full–2016) http://www.cdc.gov/mmwr/volumes/65/ss/ss6511a1.htm?s_cid=ss6511a1_e
Current Therapeutic Cannabis Controversies and Clinical Trial Design Issues (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00309/full
Ecological Momentary Assessment and Smartphone Application Intervention in Adolescents with Substance Use and Comorbid Severe Psychiatric Disorders: Study Protocol (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028912/
Synthetic Cannabis Overdose and Withdrawal in a Young Adult: A Case Report, Commentary on Regulation, and Review of the Literature (full–2016) https://www.hindawi.com/journals/crips/2016/3640549/
Adverse Social Experiences in Adolescent Rats Result in Enduring Effects on Social Competence, Pain Sensitivity and Endocannabinoid Signaling (full–2016) http://journal.frontiersin.org/article/10.3389/fnbeh.2016.00203/full
Are adolescents more vulnerable to the harmful effects of cannabis than adults? A placebo-controlled study in human males (full–2016) http://www.nature.com/tp/journal/v6/n11/full/tp2016225a.html
Acute Eosinophilic Pneumonia with Respiratory Failure Induced by Synthetic Cannabinoid Inhalation (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5156457/ Individual differences in frontolimbic circuitry and anxiety emerge with adolescent changes in endocannabinoid signaling across species (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4843434/
Cannabinoids reverse the effects of early stress on neurocognitive performance in adulthood (full–2016) http://learnmem.cshlp.org/content/23/7/349.long
Impact of adolescent marijuana use on intelligence: Results from two longitudinal twin studies (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747759/
Effects of Adolescent Intermittent Alcohol Exposure on the Expression of Endocannabinoid Signaling-Related Proteins in the Spleen of Young Adult Rats (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5035052/
Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5032490/ Interacting Cannabinoid and Opioid Receptors in the Nucleus Accumbens Core Control Adolescent Social Play (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5110529/
Ontogeny of sensorimotor gating and short-term memory processing throughout the adolescent period in rats. (full – 2016) http://www.sciencedirect.com/science/article/pii/S1878929316300639
Assessment of rates of recanting and hair testing as a biological measure of drug use in a general population sample of young people (full – 2016) http://onlinelibrary.wiley.com/doi/10.1111/add.13645/full
Cannabis Withdrawal, Posttreatment Abstinence, and Days to First Cannabis Use Among Emerging Adults in Substance Use Treatment: A Prospective Study. (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4748964/
The relationship between cannabis use and measures of anxiety and depression in a sample of college campus cannabis users and non-users post state legalization in Colorado. (full – 2016) https://peerj.com/articles/2782/
Attention deficit hyperactivity disorder and drug addiction rehabilitation patients (full – 2016) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004- 282X2016001201003&lng=en&nrm=iso&tlng=en Psychometric properties of the Spanish version of the Cannabis Use Problems Identification Test among Chilean university students: A validation study. (click ELSEVIER for link to PDF–2016) https://www.ncbi.nlm.nih.gov/pubmed/27866060
Use of marijuana for medical purposes. (click “full Text Links” for download–2016) http://www.ncbi.nlm.nih.gov/pubmed/27660881 Cannabinoid receptor 2 as anti-obesity target: inflammation, fat storage and browning modulation. (link to PDF-2016) http://www.nature.com/tp/journal/v6/n11/full/tp2016225a.html http://press.endocrine.org/doi/10.1210/jc.2015-4381?url_ver=Z39.88-2003&rfr_id=ori%3Arid %3Acrossref.org&rfr_dat=cr_pub%3Dpubmed&
Cannabidiol limits Tcell-mediated chronic autoimmune myocarditis: implications to autoimmune disorders and organ transplantation (click “Molecular Medicine” for PDF– 2016) http://www.ncbi.nlm.nih.gov/pubmed/26772776
Anti-N-methyl-D-aspartate receptor encephalitis and drug abuse – the probable role of molecular mimicry or the overstimulation of CB receptors in a 17-year-old adolescent – case report (link to download–2016) http://www.mppt.hu/folyoirat/1/abstract/? vol=18&issue=3&elsooldal=162
Dose of Reality: The Effect of State Marijuana Legalizations (report–2016) http://www.cato.org/publications/policy-analysis/dose-reality-effect-state-marijuana-legalizations#full
Letter to the editor re Sredni et al.: spontaneous involution of pediatric low-grade gliomas: high expression of cannabinoid receptor 1 (CNR1) at the time of diagnosis may indicate involvement of the endocannabinoid system (2016) (letter–2016) http://link.springer.com/article/10.1007%2Fs00381-016-3333-6
Can your heart handle the spice: A case of acute myocardial infarction and left ventricular apical thrombus (1st page–2016) http://www.internationaljournalofcardiology.com/article/S0167-5273%2816%2930735-5/abstract
Longitudinal predictors of cannabis use and dependence in offspring from families at ultra high risk for alcohol dependence and in control families (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26756393
Cannabis and Psychosis: a Critical Overview of the Relationship (abst–2016) http://link.springer.com/article/10.1007/s11920-015-0657-y
Sex and age specific effects of delta-9-tetrahydrocannabinol during the periadolescent period in the rat: The unique susceptibility of the prepubescent animal (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26898326
Experience with Gambling in Late Childhood and Early Adolescence: Implications for Substance Experimentation Behavior (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/26836642
Cannabis – Position Paper of the German Respiratory Society (DGP) (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26935046
Lack of hippocampal CB1 receptor desensitization by Δ9-tetrahydrocannabinol in aged mice and by low doses of JZL 184. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/26984820
Weeding Out the Truth: Adolescents and Cannabis (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/26985645
Alcohol and cannabis use among college students: Substitutes or complements? (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26894560
Mitigation of Marijuana-Related Legal Harms to Youth in California (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26891110
Age of Sexual Debut and Cannabis Use in the United States (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26881806
Cannabis use and symptoms of anxiety in adolescence and the moderating effect of the serotonin transporter gene (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26860734
Low Pretreatment Impulsivity and High Medication Adherence Increase the Odds of Abstinence in a Trial of N-Acetylcysteine in Adolescents with Cannabis Use Disorder (abst–2016) http://www.journalofsubstanceabusetreatment.com/article/S0740-5472%2815%2900313-X/abstract
Bidirectional Associations Between Cannabis Use and Depressive Symptoms From Adolescence Through Early Adulthood Among At-Risk Young Men (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26997187
Cognitive Function in Individuals With Psychosis: Moderation by Adolescent Cannabis Use (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27033329
The association of specific traumatic experiences with cannabis initiation and transition to problem use: Differences between African-American and European-American women (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27012434
Because difficulty is not the same for everyone: the impact of complexity in working memory is associated with cannabinoid 1 receptor genetic variation in young adults (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27108777
Adolescent social rejection alters pain processing in a CB1 receptor dependent manner. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27157075
Comorbid Cannabis and Tobacco Use in Adolescents and Adults. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27175326
Prevalence and Correlates of Any and Frequent Synthetic Cannabinoid Use in a Representative Sample of High School Students. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27191966
Childhood Maltreatment in the Migraine Patient. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27194425
Associations of Posttraumatic Stress Disorder Symptoms With Marijuana and Synthetic Cannabis Use Among Young Adult U.S. Veterans: A Pilot Investigation (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27172584
Association between schizotypal and borderline personality disorder traits, and cannabis use in young adults. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27149691
Social Anxiety and Cannabis-Related Impairment: The Synergistic Influences of Peer and Parent Descriptive and Injunctive Normative Perceptions (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27144526
Influence of legal status on the uptake of cannabis in young people. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27096170
Racial Differences and the Role of Neighborhood in the Sequencing of Marijuana and Tobacco Initiation Among Urban Youth. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27092865
Decision-Making Does not Moderate the Association between Cannabis Use and Body Mass Index among Adolescent Cannabis Users. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27079834
Dual Cannabis and Alcohol Use Disorders in Young Adults: Problems Magnified. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27070725
Neural mechanisms of sensitivity to peer information in young adult cannabis users. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27068178
Is attention deficit/hyperactivity disorder among men associated with initiation or escalation of substance use at 15-month follow up? A longitudinal study involving young Swiss men (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27061514
Declining Prevalence of Marijuana Use Disorders Among Adolescents in the United States, 2002 to 2013 (abst–2016) http://www.jaacap.com/article/S0890-8567%2816%2930101-0/abstract
Synthetic Cannabinoid Use and Descriptive Norms among Collegiate Student-Athletes. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27224428
Marijuana-Related Posts on Instagram (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27262456
Traffic accidentability and risky driving behavior in young people in New Caledonia. Results of study (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27259836
Substitution and Complementarity of Alcohol and Cannabis: A Review of the Literature. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27249324
Self-reported use of novel psychoactive substances among attendees of electronic dance music venues. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27315522
Secondary Effects of an Alcohol Prevention Program Targeting Students and/or Parents (abst–2016) http://www.journalofsubstanceabusetreatment.com/article/S0740-5472(16)30152-0/abstract
Assessing the risk of marijuana use disorder among adolescents and adults who use marijuana (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27292878
Marijuana Misadventures in Children: Exploration of a Dose-Response Relationship and Summary of Clinical Effects and Outcomes. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27050740
Pediatric oncology providers and use of medical marijuana in children with cancer (abst–2016) http://meetinglibrary.asco.org/content/170798-176
Peripubertal treatment with cannabidiol prevents the emergence of psychosis in an animal model of schizophrenia (abst–2016) http://www.schres-journal.com/article/S0920-9964(16)30060-3/abstract
New Zealand Health Survey 2012/13: characteristics of medicinal cannabis users (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27349158
Childhood weight status and timing of first substance use in an ethnically diverse sample (abst–2016) http://www.drugandalcoholdependence.com/article/S0376-8716(16)30111-9/abstract
Consequences of adolescent use of alcohol and other drugs: Studies using rodent models (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763416304304
A preliminary evaluation of synthetic cannabinoid use among adolescent cannabis users: Characteristics and treatment outcomes (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27454353
Deficient adolescent social behavior following early-life inflammation is ameliorated by augmentation of anandamide signaling (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27453335
Correlates of new psychoactive substance use among a self-selected sample of nightclub attendees in the United States (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27419383
Cross-section and panel estimates of peer effects in early adolescent cannabis use: With a little help from my ‘friends once removed’ (abst–2016) http://www.sciencedirect.com/science/article/pii/S0277953616303021
Alveolar haemorrhage following a cannabis water pipe (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27421143
Anxiety, depression and risk of cannabis use: Examining the internalising pathway to use among Chilean adolescents (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27427415
Genetic variation in FAAH is associated with cannabis use disorders in a young adult sample of Mexican Americans (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27394933
Understanding resilience: New approaches for preventing and treating PTSD (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27417856
Age, period, and cohort effects in synthetic cannabinoid use among US adolescents, 2011-2015 (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27491817
Adolescent cannabis use: What is the evidence for functional brain alteration? (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27514709
Alcohol use during a trial of N-acetylcysteine for adolescent marijuana cessation (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27521979
Consuming energy drinks at the age of 14 predicted legal and illegal substance use at 16 (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27513298
Cannabinoids and Psychosis (3) (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27568729
Cannabis and Pediatric Inflammatory Bowel Disease: Change Blossoms A Mile High. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27579692
Contribution of health motive to cannabis use among high-school students. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27543835
Effects of Adolescent Cannabinoid Self-Administration in Rats on Addiction-Related Behaviors and Working Memory. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27582345 Disturbances of sleep and circadian rhythms: novel risk factors for obesity. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27584008
Cannabis for Cognitive Enhancement as a New Coping Strategy? Results From a Survey of Students at Four Universities in Germany. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27607062
Buying drugs on a Darknet market: A better deal? Studying the online illicit drug market through the analysis of digital, physical and chemical data. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27611957
Spontaneous involution of pediatric low-grade gliomas: high expression of cannabinoid receptor 1 (CNR1) at the time of diagnosis may indicate involvement of the endocannabinoid system (abst–2016) http://link.springer.com/article/10.1007%2Fs00381-016-3243-7 Abnormal white matter integrity in synthetic cannabinoid users (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27617779
Prevalence and Correlates of Vaping Cannabis in a Sample of Young Adults (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27631612
Risky substance use and peer pressure in Swiss young men: Test of moderation effects. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27632359
The Synthetic Cannabinoids Phenomenon. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27655416
The hazards of bad sleep-Sleep duration and quality as predictors of adolescent alcohol and cannabis use. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27659736
UPPS-P model impulsivity and marijuana use behaviors in adolescents: A meta-analysis (abst–2016) http://www.drugandalcoholdependence.com/article/S0376-8716(16)30923-1/abstract
Child maltreatment and cannabis use in young adulthood: A birth cohort study (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27741369
“Just one bad high:” considering synthetic cannabinoid outcome expectancies in adolescents. (abst – 2016) https://www.ncbi.nlm.nih.gov/pubmed/27749024
Changing perspectives on marijuana use during early adolescence and young adulthood: Evidence from a panel of cross-sectional surveys. (abst – 2016) https://www.ncbi.nlm.nih.gov/pubmed/27750184
Effects of Marijuana on ictal and interictal EEG activity in idiopathic generalized epilepsy. (abst – 2016) https://www.ncbi.nlm.nih.gov/pubmed/27763968
The neurobiology of social play and its rewarding value in rats (abst – 2016) http://www.sciencedirect.com/science/article/pii/S0149763416303724
Prevalence and correlates of “Vaping” as a route of cannabis administration in medical cannabis patients (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27770657
A social network analysis of substance use among immigrant adolescents in six European cities (abst-2016) http://www.sciencedirect.com/science/article/pii/S027795361630538X
Pseudo-Underage Assessment of Compliance With Identification Regulations at Retail Marijuana Outlets in Colorado (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27797687
The Normalization of Cannabis Use Among Bangladeshi and Pakistani Youth: A New Frontier for the Normalization Thesis? (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27849430
Alcohol, tobacco and cannabis use: Do students with mild-intellectual disability mimic students in the general population? (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27793551
Cannabinoid Receptor 2 Functional Variant Contributes to the Risk for Pediatric Inflammatory Bowel Disease (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27875353
From niche to stigma-Headshops to prison: Exploring the rise and fall of synthetic cannabinoid use among young adults (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27894904
From adolescent to elder rats: Motivation for palatable food and cannabinoids receptors (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27935269
The consequences of chronic cannabis smoking in vulnerable adolescents (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27986504
The role of mifamurtide in chemotherapy-induced osteoporosis of children with osteosarcoma (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27993113
Is the Legalization of Marijuana Associated With Its Use by Adolescents? (abst–2016) http://www.tandfonline.com/doi/full/10.1080/10826084.2016.1223139?src=recsys Independent Versus Co-occurring Substance Use in Relation to Gambling Outcomes in Older Adolescents and Young Adults (abst – 2016) https://www.ncbi.nlm.nih.gov/pubmed/28011065
Distinct effects of childhood ADHD and cannabis use on brain functional architecture in young adults (full–2017) http://www.sciencedirect.com/science/article/pii/S221315821630170X
Multidimensional Family Therapy Reduces Self-Reported Criminality Among Adolescents With a Cannabis Use Disorder. (full – 2017) http://journals.sagepub.com/doi/full/10.1177/0306624X16687536
Association Between Use of Cannabis in Adolescence and Weight Change into Midlife (link to download–2017) http://journals.plos.org/plosone/article? id=10.1371/journal.pone.0168897
Rocky Mountain High: Preventing Cannabis-Related Injuries (1st page–2017) http://www.jenonline.org/article/S0099-1767(16)30339-7/abstract
Peer Network Counseling as Brief Treatment for Urban Adolescent Heavy Cannabis Users. (abst – 2017) https://www.ncbi.nlm.nih.gov/pubmed/27936376
Support for Marijuana Legalization and Predictors of Intentions to Use Marijuana More Often in Response to Legalization Among U.S. Young Adults (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/27976988
Developmental Patterns of Adolescent Marijuana and Alcohol Use and Their Joint Association with Sexual Risk Behavior and Outcomes in Young Adulthood (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28083726
Self-reported Driving Under the Influence of Alcohol and Cannabis Among Ontario Students: Associations with Graduated Licensing, Risk Taking and Substance Abuse (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28095034
Cannabis Use and Disorder From Childhood to Adulthood in a Longitudinal Community Sample With American Indians (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28117058
Cannabis use, COMT, BDNF and age at first-episode psychosis (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28142064
top


ADRENOLEUKODYSTROPHY
Synthetic cannabinoids revealing adrenoleukodystrophy (abst–2016) http://www.sciencedirect.com/science/article/pii/S0967586815004567


AGE-RELATED DIFFERENCES
Are adolescents more vulnerable to the harmful effects of cannabis than adults? A placebo-controlled study in human males (full–2016) http://www.nature.com/tp/journal/v6/n11/full/tp2016225a.html


AGING 
The Management of Chronic Pruritus in the Elderly (full–2010) http://www.skintherapyletter.com/2010/15.8/2.html
N-acylethanolamine signalling mediates the effect of diet on lifespan in Caenorhabditis elegans (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3093655/
Deficiency of CB2 cannabinoid receptor in mice improves insulin sensitivity but increases food intake and obesity with age (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20936991
The effects of Cannabis sativa L. seed (hempseed) in the ovariectomized rat model of menopause (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/21069097
The type 2 cannabinoid receptor protects against age-related bone loss and ovariectomy induced bone loss by stimulating bone formation (abst–2010) http://www.thebonejournal.com/article/S8756-3282%2810%2900619-8/abstract
Role of CB1 cannabinoid receptors on GABAergic neurons in brain aging (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3131310/?tool=pubmed
Comparison of Cannabinoid CB1 Receptor Binding in Adolescent and Adult Rats: A Positron Emission Tomography Study Using [18F]MK-9470 (full–2011) http://www.hindawi.com/journals/ijmi/2011/548123/
Early onset of aging-like changes is restricted to cognitive abilities and skin structure in Cnr1(-/-) mice (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/20724033
Gender-dependent increases with healthy aging of the human cerebral cannabinoid-type 1 receptor binding using [(18)F]MK-9470 PET (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/18077184
Endocannabinoid type 1 receptor gene (CNR1) polymorphisms (rs806381, rs10485170, rs6454674, rs2023239) and cardiovascular risk factors in postmenopausal women (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21480765
Are endocannabinoid type 1 receptor gene (CNR1) polymorphisms associated with obesity and metabolic syndrome in postmenopausal Polish women? (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/20838400
Loss of CB1 receptors leads to differential age-related changes in reward-driven learning and memory (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3514639/
top
Role of CB1 cannabinoid receptors on GABAergic neurons in brain aging (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3131310/?tool=pubmed
Can the benefits of cannabinoid receptor stimulation on neuroinflammation, neurogenesis and memory during normal aging be useful in AD prevention? (full–2012) http://www.jneuroinflammation.com/content/9/1/10
The endocannabinoid, anandamide, augments Notch-1 signaling in cultured cortical neurons exposed to amyloid-beta and in the cortex of aged rats (full–2012) http://www.jbc.org/content/early/2012/08/13/jbc.M112.350678.long
Review article: The endocannabinoid system in normal and pathological brain ageing (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3326.full?sid=161e7b36-5055-448b-962e-697c782e901d
Cannabinoid Type 1 Receptor Gene Polymorphism and Macronutrient Intake (full–2012) http://www.karger.com/Article/FullText/343563
Age-related changes of anandamide metabolism in CB1 cannabinoid receptor knockout mice: correlation with behaviour (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/11982628
Combined deficiency of the CB1 and CB2 receptors enhances peak bone mass by inhibiting osteoclast differentiation but increases age-related bone loss by promoting adipocyte differentiation and reducing osteoblast differentiation (abst–2012) http://www.thebonejournal.com/article/S8756-3282%2812%2900153-6/abstract
The cannabinoid receptor type 1 is essential for mesenchymal stem cell survival and differentiation: implications for bone health (full–2013)
http://www.hindawi.com/journals/sci/2013/796715/
Aging modifies the enzymatic activities involved in 2-arachidonoylglycerol metabolism (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23281018
Anandamide deficiency and heightened neuropathic pain in aged mice (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23597506
Loss of CB1 receptors leads to decreased cathepsin D levels and accelerated lipofuscin accumulation in the hippocampus (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23954857
GPR55 Deletion in Mice Leads to Age-Related Ventricular Dysfunction and Impaired Adrenoceptor-Mediated Inotropic Responses (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25275556
Differential effects of delayed aging on phenotype and striatal pathology in a murine model of huntington disease (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4236397/
Endocannabinoid signalling and the deteriorating brain (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471876/
Diacylglycerol lipase regulates lifespan and oxidative stress response by inversely modulating TOR signaling in Drosophila and C. elegans (full–2014) http://www.ncbi.nlm.nih.gov/pubmed/?term=24889782
Plasma-Free Fatty Acids, Fatty Acid-Binding Protein 4 and Mortality in Older Adults (from the Cardiovascular Health Study) (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25073566
top
The endocannabinoid system and appetite: relevance for food reward (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24933167
Normal aging in rats and pathological aging in human Alzheimer disease decrease FAAH activity: Modulation by cannabinoid agonists (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25456842
Enhanced microglial activity in FAAH-/- animals (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25534441
Cannabinoid receptor-dependent metabolism of 2-arachidonoylglycerol during aging (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24768821
Endocannabinoid signalling and the deteriorating brain (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25524120
Potential Therapeutical Contributions of the Endocannabinoid System towards Aging and Alzheimer’s Disease (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567222/
CB1 receptor blockade counters age-induced insulin resistance and metabolic dysfunction (full–2016) http://onlinelibrary.wiley.com/doi/10.1111/acel.12438/full
Age-related changes in the endocannabinoid system in the mouse hippocampus (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26278494
Pro-inflammatory obesity in aged cannabinoid-2 receptor deficient mice (abst–2015)
http://www.ncbi.nlm.nih.gov/pubmed/26303348
The Effect of Medical Marijuana Laws on Body Weight (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26602324
Age-specific influences of chronic administration of the fatty acid amide hydrolase inhibitor URB597 on cardiovascular parameters and organ hypertrophy in DOCA-salt hypertensive rats (abst–2016) http://www.sciencedirect.com/science/article/pii/S1734114015003412
Metabolomic-Driven Elucidation of Serum Disturbances Associated with Alzheimer’s Disease and Mild Cognitive Impairment (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26825096
Lack of hippocampal CB1 receptor desensitization by Δ9-tetrahydrocannabinol in aged mice and by low doses of JZL 184 (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26984820
Circulating levels of endocannabinoids and oxylipins altered by dietary lipids in older women are likely associated with previously identified gene targets (abst–2016) http://www.sciencedirect.com/science/article/pii/S1388198116302013
Delineating the Efficacy of a Cannabis-Based Medicine at Advanced Stages of Dementia in a Murine Model (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27567873
Selective modulator of cannabinoid receptor type 2 reduces memory impairment and infarct size during cerebral hypoperfusion and vascular dementia (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27586843
Selective modulator of cannabinoid receptor type 2 (CB2) against biochemical alterations and brain damage in chronic cerebral hypoperfusion induced vascular dementia (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27599483
β-Caryophyllene promotes osteoblastic mineralization, and suppresses osteoclastogenesis and adipogenesis in mouse bone marrow cultures in vitro. (abst – 2016) https://www.ncbi.nlm.nih.gov/pubmed/28105093


ALCOHOLISM/ALCOHOL
The use of Cannnabidiol (CBD) to Reduce Insomnia and the Urge To Use Alcohol in a Geriatric person in on going Behavior Therapy. (case report – undated) http://cannabisclinicians.org/view-all-case-reports/entry/420/?pagenum=2
The use of Cannnabidiol (CBD) and Meditation to reduce Binge Drinking, Anxiety and to improve Emotional Regulation in Long Term Behavior Therapy (case report – undated) http://cannabisclinicians.org/view-all-case-reports/entry/437/?pagenum=2
Harm Reduction: Alcohol Use Disorder, Cannabis-induced Psychotic Disorder and a tale of two Hemp Oils, in a Patient diagnosed with a Cluster A & B Personality Disorders in Long Term Behavior Therapy. (case report – undated) http://cannabisclinicians.org/view-all-case-reports/entry/601/?pagenum=2
Plasma anandamide and other N-acylethanolamines are correlated with their corresponding free fatty acid levels under both fasting and non-fasting conditions in women (full–2010) http://www.nutritionandmetabolism.com/content/7/1/49
Converging action of alcohol consumption and cannabinoid receptor activation on adult hippocampal neurogenesis (full–2010) http://ijnp.oxfordjournals.org/content/13/2/191.long
top
Learning and memory performances in adolescent users of alcohol and marijuana: interactive effects (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2965487/
The Endocannabinoid System Tonically Regulates Inhibitory Transmission and Depresses the Effect of Ethanol in Central Amygdala (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2904853/
Selective alterations of the CB1 receptors and the fatty acid amide hydrolase in the ventral striatum of alcoholics and suicides (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2878847/
Influence of ethanol on cannabinoid pharmacokinetic parameters in chronic users (abst-2010) http://www.ncbi.nlm.nih.gov/pubmed/21116612
11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid ethyl ester (THC-COOEt): unsuccessful search for a marker of combined cannabis and alcohol consumption (abst–2010) http://www.unboundmedicine.com/medline/ebm/record/20074877/abstract/11_nor_Delta9_tetrahydrocannabinol_9_carboxylic_acid_ethyl_ester__THC_COOEt_:_unsuccessful_search_for_a_marker_of_combined_cannabis_and_alcohol_consumption_
Role of the endocannabinoid system in alcoholic liver disease (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/21525760
The effects of cannabis and alcohol on simulated arterial driving: Influences of driving experience and task demand (abst–2010) http://www.unboundmedicine.com/medline/ebm/record/20380913/abstract/The_effects_of_cannabis_and_alcohol_on_simulated_arterial_driving:_Influences_of_driving_experience_and_task_demand_
Cannabinoid receptor type 1 expression modulates alcohol-induced liver fibrosis: Role of Acetaldehyde (abst–2010) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0029-1246364
Tolerance and cross-tolerance to neurocognitive effects of THC and alcohol in heavy cannabis users (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3045517/
Pharmacological activation/inhibition of the cannabinoid system affects alcohol withdrawal-induced neuronal hypersensitivity to excitotoxic insults (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3158793/
Effect of an Acute Consumption of a Moderate Amount of Ethanol on Plasma Endocannabinoid Levels in Humans (full–2011) http://alcalc.oxfordjournals.org/content/47/3/226.full
HIV-1 infection and alcohol abuse: neurocognitive impairment, mechanisms of neurodegeneration and therapeutic interventions (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3098312/
Combined effects of acute, very-low-dose ethanol and delta(9)-tetrahydrocannabinol in healthy human volunteers (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018238/
top
Cannabinoid CB2 receptors protect against alcoholic liver disease by regulating kupffer cell polarization in mice (full–2011) http://onlinelibrary.wiley.com/doi/10.1002/hep.24524/full
Racial differences in trajectories of heavy drinking and regular marijuana use from ages 13 to 24 among African-American and White males (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3258364/
Rural Adolescent Alcohol, Tobacco and Illicit Drug Use: A Comparison of Students in Victoria, Australia and Washington State, United States (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3186916/
Popular intoxicants: what lessons can be learned from the last 40 years of alcohol and cannabis regulation? (full–2011) http://www.lufg.com.au/files/media/Popular_intoxicants_what_lessons_can_be_learned.pdf
Gender-dependent increases with healthy aging of the human cerebral cannabinoid-type 1 receptor binding using [(18)F]MK-9470 PET (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/18077184
The role of the cannabinoid system in the pathogenesis and treatment of alcohol dependence (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21934185
Some features of teenage beer alcoholism combined with hashish addiction (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21322145
Upregulation of cannabinoid type 1 receptors in dopamine D2 receptor knockout mice is reversed by chronic forced ethanol consumption (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3004984/?tool=pubmed
Associations of Alcohol, Nicotine, Cannabis, and Drug Use/Dependence with Educational Attainment: Evidence from Cotwin-Control Analyses (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3412907/
Alcohol and cannabis use and mortality in people with schizophrenia and related psychotic disorders (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3392453/
Reduced alcohol intake and reward associated with impaired endocannabinoid signaling in mice with a deletion of the glutamate transporter GLAST (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3372600/
Tolerance to cannabinoid-induced behaviors in mice treated chronically with ethanol (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249519/
Borderline personality traits and substance use: genetic factors underlie the association with smoking and ever use of cannabis, but not with high alcohol consumption (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3744119/
Involvement of the Endocannabinoid System in Ethanol-Induced Corticostriatal Synaptic Depression (full–2012) https://www.jstage.jst.go.jp/article/jphs/120/1/120_12118FP/_pdf
Effects of ethanol, Δ(9)-tetrahydrocannabinol, or their combination on object recognition memory and object preference in adolescent and adult male rats (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3477605/
Positron Emission Tomography Shows Elevated Cannabinoid CB 1 Receptor Binding in Men with Alcohol Dependence (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3418442/
top
Cannabis as a substitute for alcohol and other drugs: A dispensary-based survey of substitution effect in Canadian medical cannabis patients (full–2012) https://philippelucasvictoria.files.wordpress.com/2012/12/rx-mj-as-a-substitute-for-aod-addiction-researchand-theory-2012-in-press.pdf
Alcohol as a Gateway Drug: A Study of US 12th Graders (abst–2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1746-1561.2012.00712.x/abstract
Detecting impairment associated with cannabis with and without alcohol on the Standardized Field Sobriety Tests (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22763669
Concomitant consumption of marijuana, alcohol and tobacco in oral squamous cell carcinoma development and progression: Recent advances and challenges (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22727410
Electroacupuncture inhibits CB1 upregulation induced by ethanol withdrawal in mice (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22613131
Acetaldehyde as a drug of abuse: insight into AM281 administration on operant-conflict paradigm in rats (full–2013) http://www.frontiersin.org/Behavioral_Neuroscience/10.3389/fnbeh.2013.00064/full
Reduced expression of brain cannabinoid receptor 1 (Cnr1) is coupled with an increased complementary micro-RNA (miR-26b) in a mouse model of fetal alcohol spectrum disorders (full–2013) http://www.clinicalepigeneticsjournal.com/content/5/1/14
Perception of tobacco, cannabis, and alcohol use of others is associated with one’s own use (full–2013) http://www.ascpjournal.org/content/8/1/15
Influence of Ethanol on the Pharmacokinetic Properties of Δ9-Tetrahydrocannabinol in Oral Fluid (full–2013) http://jat.oxfordjournals.org/content/37/3/152.full
Hepatic Cannabinoid Receptor Type 1 Mediates Alcohol-Induced Regulation of Bile Acid Enzyme Genes Expression Via CREBH (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0068845
The effects of caffeine, nicotine, ethanol, and tetrahydrocannabinol on exercise performance (full–2013) http://www.nutritionandmetabolism.com/content/10/1/71
Medical Marijuana Laws, Traffic Fatalities, and Alcohol Consumption (full–2013)
http://gatton.uky.edu/faculty/sandford/391_f13/marijuana.pdf
Probability and predictors of transition from abuse to dependence on alcohol, cannabis, and cocaine: results from the national epidemiologic survey on alcohol and related conditions (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3755735/
Role of cannabinoid CB2 receptor in the reinforcing actions of ethanol (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/adb.12076/full
Differential expression and functional role of cannabinoid genes in alcohol users (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3818789/
top
Transdermal delivery of cannabidiol attenuates binge alcohol-induced neurodegeneration in a rodent model of an alcohol use disorder (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4096899/
Effect of Diet on Tissue Levels of Palmitoylethanolamide (link to PDF–2013) http://www.eurekaselect.com/107972/article
Endocannabinoid/GABA interactions in the entopeduncular nucleus modulates alcohol intake in rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23291357
Lipids and addiction: how sex steroids, prostaglandins, and cannabinoids interact with drugs of abuse (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23510307
Lifetime prevalence of alcohol and substance use in egypt: a community survey (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23577901
A spontaneous deletion of α-Synuclein is associated with an increase in CB1 mRNA transcript and receptor expression in the hippocampus and amygdala: Effects on alcohol consumption (abst–2013) http://onlinelibrary.wiley.com/doi/10.1002/syn.21639/abstract
Transient changes in the endocannabinoid system after acute and chronic ethanol exposure and abstinence in the rat: a combined PET and microdialysis study (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23740372
Endogenous cannabinoids in amygdala and hippocampus in post-mortem brains of Cloninger type 1 and 2 alcoholics (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23747173
Angiotensin II-induced activation of central AT1 receptors exerts endocannabinoid mediated gastroprotective effect in rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24145131
Prevalence of alcohol and other drugs and the concentrations in blood of drivers killed in road traffic crashes in Sweden (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24265165
Chronic ethanol alters network activity and endocannabinoid signaling in the prefrontal cortex (full–2014) http://journal.frontiersin.org/Journal/10.3389/fnint.2014.00058/full
Cannabinoid receptor 2 agonist attenuates pain related behavior in rats with chronic alcohol / high fat diet induced pancreatitis (full–2014) http://www.molecularpain.com/content/10/1/66
Reduced expression of brain cannabinoid receptor 1 (Cnr1) is coupled with an increased complementary micro-RNA (miR-26b) in a mouse model of fetal alcohol spectrum disorders (full–2014) http://www.clinicalepigeneticsjournal.com/content/5/1/14
Enhanced Endocannabinoid-Mediated Modulation of Rostromedial Tegmental Nucleus Drive onto Dopamine Neurons in Sardinian Alcohol-Preferring Rats (full–2014) http://www.jneurosci.org/content/34/38/12716.long
Adverse psychosocial outcomes associated with drug use among US high school seniors: a comparison of alcohol and marijuana (full–2014) http://informahealthcare.com/doi/pdf/10.3109/00952990.2014.943371
top
Acute alcohol use temporally increases the odds of male perpetrated dating violence: A diary analysis (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3858531/
Can Cannabis be Considered a Substitute Medication for Alcohol? (full–2014) http://alcalc.oxfordjournals.org/content/early/2014/01/07/alcalc.agt182.full
Cannabidiol protects liver from binge alcohol-induced steatosis by mechanisms including inhibition of oxidative stress and increase in autophagy  full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4112960/
Changes in Cerebral CB1 Receptor Availability after Acute and Chronic Alcohol Abuse and Monitored Abstinence (full–2014) http://www.jneurosci.org/content/34/8/2822.long
Prevalence and correlates of alcohol and cannabis use disorders in the United States: Results from the national longitudinal study of adolescent health (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3963405/
Effects of Δ9-tetrahydrocannabinol in individuals with a familial vulnerability to alcoholism (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24424782
Relationship between working-memory network function and substance use: a 3-year longitudinal fMRI study in heavy cannabis users and controls (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24589297
Changes in cigarette and alcohol use during cannabis abstinence (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24613633
The Effect of Medical Marijuana Laws on Marijuana, Alcohol, and Hard Drug Use (abst–2014) http://www.nber.org/papers/w20085#fromrss
Recreational drug use and binge drinking: Stimulant but not cannabis intoxication is associated with excessive alcohol consumption (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24975774
The cannabinoid receptor 2 agonist, β-Caryophyllene, reduced voluntary alcohol intake and attenuated ethanol-induced place preference and sensitivity in mice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24999220
The endocannabinoid system is altered in the post-mortem prefrontal cortex of alcoholic subjects (abst–2014) http://onlinelibrary.wiley.com/doi/10.1111/adb.12160/abstract
Patterns of medical marijuana use among individuals sampled from medical marijuana dispensaries in los angeles (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25188696
Gene-Specific Disruption of Endocannabinoid Receptor 1 (cnr1a) by Ethanol Probably Leads to the Development of Fetal Alcohol Spectrum Disorder (FASD) Phenotypes in Japanese Rice Fish (Oryzias latipes) Embryogenesis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25251458
top
Drug and Alcohol Crash Risk (full–2015) http://kimabim.s3.amazonaws.com/812117-Drug_and_Alcohol_Crash_Risk.pdf
Comparative risk assessment of alcohol, tobacco, cannabis and other illicit drugs using the margin of exposure approach (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4311234/
Drugs of Abuse in HIV infection and neurotoxicity (full–2015) http://journal.frontiersin.org/article/10.3389/fmicb.2015.00217/full
PTSD Growth and Substance Abuse Among a College Student Community: Coping Strategies after 2009 L’aquila Earthquake (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397827/
Effects of mood inductions by meal ambiance and moderate alcohol consumption on endocannabinoids and N-acylethanolamines in humans: a randomized crossover trial (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0126421
Drug and Alcohol Crash Risk (full–2015) http://kimabim.s3.amazonaws.com/812117-Drug_and_Alcohol_Crash_Risk.pdf
Comparative risk assessment of alcohol, tobacco, cannabis and other illicit drugs using the margin of exposure approach (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4311234/
Drugs of Abuse in HIV infection and neurotoxicity (full–2015) http://journal.frontiersin.org/article/10.3389/fmicb.2015.00217/full
PTSD Growth and Substance Abuse Among a College Student Community: Coping Strategies after 2009 L’aquila Earthquake (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397827/
Effects of mood inductions by meal ambiance and moderate alcohol consumption on endocannabinoids and N-acylethanolamines in humans: a randomized crossover trial (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0126421
Use of Prescription Pain Medications Among Medical Cannabis Patients: Comparisons of Pain Levels, Functioning, and Patterns of Alcohol and Other Drug Use (full–2015) http://ssw.umich.edu/sites/default/files/documents/news/use-of-prescription-pain-medications-amongmedical-cannabis-patients.pdf
Controlled Cannabis Vaporizer Administration: Blood and Plasma Cannabinoids with and without Alcohol (full–2015) http://www.clinchem.org/content/61/6/850.long
Alcohol confounds relationship between cannabis misuse and psychosis conversion in a high-risk sample (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25572323
Daily marijuana use is not associated with brain morphometric measures in adolescents or adults (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25632127
Profiles of medicinal cannabis patients attending compassion centers in rhode island (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25715068
Interaction of cannabinoid receptor 2 and social environment modulates chronic alcohol consumption (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25827923
Postnatal ethanol exposure alters levels of 2-arachidonylglycerol-metabolizing enzymes and pharmacological inhibition of monoacylglycerol (MAGL) does not cause neuro-degeneration in neonatal mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25857698
top
European rating of drug harms (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25922421
Chronic ethanol exposure decreases CB1 receptor function at GABAergic synapses in the rat central amygdala (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25940135
Microstructural analysis of rat ethanol and water drinking patterns using a modified operant self-administration model (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26037631
Roles for the endocannabinoid system in ethanol-motivated behavior (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26123153
The effect of alcohol availability on marijuana use: Evidence from the minimum legal drinking age (abst–2015) http://www.sciencedirect.com/science/article/pii/S0167629611001718
Altered CB1 receptor coupling to G-proteins in the post-mortem caudate nucleus and cerebellum of alcoholic subjects (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26253623
Controlled vaporized cannabis, with and without alcohol: subjective effects and oral fluid-blood cannabinoid relationships (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26257143
top
Drug and Alcohol Crash Risk (full–2015) http://kimabim.s3.amazonaws.com/812117-Drug_and_Alcohol_Crash_Risk.pdf
Comparative risk assessment of alcohol, tobacco, cannabis and other illicit drugs using the margin of exposure approach (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4311234/
Drugs of Abuse in HIV infection and neurotoxicity (full–2015) http://journal.frontiersin.org/article/10.3389/fmicb.2015.00217/full
PTSD Growth and Substance Abuse Among a College Student Community: Coping Strategies after 2009 L’aquila Earthquake (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397827/
Effects of mood inductions by meal ambiance and moderate alcohol consumption on endocannabinoids and N-acylethanolamines in humans: a randomized crossover trial (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0126421
Use of Prescription Pain Medications Among Medical Cannabis Patients: Comparisons of Pain Levels, Functioning, and Patterns of Alcohol and Other Drug Use (full–2015)  http://ssw.umich.edu/sites/default/files/documents/news/use-of-prescription-pain-medications-amongmedical-cannabis-patients.pdf
Controlled Cannabis Vaporizer Administration: Blood and Plasma Cannabinoids with and without Alcohol (full–2015) http://www.clinchem.org/content/61/6/850.long
Daily marijuana use is not associated with brain morphometric measures in adolescents or adults (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4308597/
Alcohol Versus Cannabinoids: A Review of Their Opposite Neuro-Immunomodulatory Effects and Future Therapeutic Potentials (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4607066/
top
Pharmacological activation of CB2 receptors counteracts the deleterious effect of ethanol on cell proliferation in the main neurogenic zones of the adult rat brain (full–2015) http://journal.frontiersin.org/article/10.3389/fncel.2015.00379/full
Alcohol and Cannabinoids Differentially Affect HIV Infection and Function of Human Monocyte-Derived Dendritic Cells (MDDC) (full–2015) http://journal.frontiersin.org/article/10.3389/fmicb.2015.01452/full
Interactions between ethanol and the endocannabinoid system at GABAergic synapses on basolateral amygdala principal neurons (full–2015) http://www.alcoholjournal.org/article/S0741-8329%2815%2930019-7/fulltext
Prenatal exposure to recreational drugs affects global motion perception in preschool children (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652269/
Alcohol confounds relationship between cannabis misuse and psychosis conversion in a high-risk sample (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25572323
Profiles of medicinal cannabis patients attending compassion centers in rhode island (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25715068
Interaction of cannabinoid receptor 2 and social environment modulates chronic alcohol consumption (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25827923
Postnatal ethanol exposure alters levels of 2-arachidonylglycerol-metabolizing enzymes and pharmacological inhibition of monoacylglycerol (MAGL) does not cause neurodegeneration in neonatal mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25857698
European rating of drug harms (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25922421
Chronic ethanol exposure decreases CB1 receptor function at GABAergic synapses in the rat central amygdala (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25940135
Microstructural analysis of rat ethanol and water drinking patterns using a modified operant self-administration model (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26037631
Roles for the endocannabinoid system in ethanol-motivated behavior (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26123153
The effect of alcohol availability on marijuana use: Evidence from the minimum legal drinking age (abst–2015) http://www.sciencedirect.com/science/article/pii/S0167629611001718
Altered CB1 receptor coupling to G-proteins in the post-mortem caudate nucleus and cerebellum of alcoholic subjects (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26253623
Controlled vaporized cannabis, with and without alcohol: subjective effects and oral fluid-blood cannabinoid relationships (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26257143
Effects of Chronic Alcohol Exposure on the Modulation of Ischemia-Induced Glutamate Release via Cannabinoid Receptors in the Dorsal Hippocampus (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26343919
top
Orphan nuclear receptor oestrogen-related receptor γ (ERRγ) plays a key role in hepatic cannabinoid receptor type 1-mediated induction of CYP7A1 gene expression (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26348907
Tetrahydrocannabinol pharmacokinetics; new synthetic cannabinoids; road safety and cannabis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26427296
Substituting cannabis for prescription drugs, alcohol and other substances among medical cannabis patients: The impact of contextual factors (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26364922
Chronic ethanol exposure increases voluntary home cage intake in adult male, but not female, Long-Evans rats (abst–2015) http://www.sciencedirect.com/science/article/pii/S0091305715300885
Maternal separation and early stress cause long-lasting effects on dopaminergic and endocannabinergic systems and alters dendritic morphology in the nucleus accumbens and frontal cortex in rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26539755
Acute and Chronic Ethanol Exposure Differentially Regulate CB1 Receptor Function at Glutamatergic Synapses in the Rat Basolateral Amygdala (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26707595
Prevalence of Marijuana and Other Substance Use Before and After Washington State’s Change from Legal Medical Marijuana to Legal Medical and Non-Medical Marijuana: Cohort Comparisons in a Sample of Adolescents (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26252354
In the weeds: a baseline view of cannabis use among legalizing states and their neighbours (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26687431
Protective effect of Xingnaojia formulation on rats with brain and liver damage caused by chronic alcoholism (abst–2015) http://www.ingentaconnect.com/search/article?option1=tka&value1=cannabinoid&sortDescending=true&sortField=prism_publicationDate&pageSize=10&index=106
The Effect of Medical Marijuana Laws on Body Weight (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26602324
Substituting cannabis for prescription drugs, alcohol and other substances among medical cannabis patients: The impact of contextual factors (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26364922
Predicting Alcohol, Cigarette, and Marijuana Use From Preferential Music Consumption (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26400900
Effect of Cannabis sativa extract on gastric acid secretion, oxidative stress and gastric mucosal integrity in rats (abst–2015) http://link.springer.com/article/10.1007/s00580-015-2090-3
Behavioral, Metabolic and Immune Consequences of Chronic Alcohol or Cannabinoids on HIV/AIDs: Studies in the Non-Human Primate SIV Model (abst–2015)  http://link.springer.com/article/10.1007/s11481-015-9599-8
top
Cannabinoid Ligands and Alcohol Addiction: A Promising Therapeutic Tool or a Humbug? (full–2016) http://link.springer.com/article/10.1007/s12640-015-9555-7/fulltext.html
Prioritizing Alcohol Prevention: Establishing Alcohol as the Gateway Drug and Linking Age of First Drink With Illicit Drug Use (full–2016) http://onlinelibrary.wiley.com/doi/10.1111/josh.12351/full
Impacts of Changing Marijuana Policies on Alcohol Use in the United States (full–2016) http://onlinelibrary.wiley.com/doi/10.1111/acer.12942/full
The Relationships of Cigarette and Alcohol Use With the Initiation, Reinitiation, and Persistence of Cannabis Use (abst-2016) http://www.ncbi.nlm.nih.gov/pubmed/26751361
Longitudinal predictors of cannabis use and dependence in offspring from families at ultra high risk for alcohol dependence and in control families (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26756393
Genetic Versus Pharmacological Assessment of the Role of Cannabinoid Type 2 Receptors in Alcohol Reward-Related Behaviors (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26756798
Ketamine and MAG Lipase Inhibitor-Dependent Reversal of Evolving Depressive Behavior during Forced Abstinence from Alcohol Drinking (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26751284
Brain reactivity to alcohol and cannabis marketing during sobriety and intoxication (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26769333
Chronic alcohol exposure disrupts CB1 regulation of GABAergic transmission in the rat basolateral amygdala (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26786379
Cannabinoid CB1 receptor inhibition blunts adolescent-typical increased binge alcohol and sucrose consumption in male C57BL/6J mice (abst–2016) http://www.sciencedirect.com/science/article/pii/S0091305716300089
Effect of Blood Collection Time on Measured Δ9-Tetrahydrocannabinol Concentrations:
Implications for Driving Interpretation and Drug Policy (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26823611
A common public health-oriented policy framework for cannabis, alcohol and tobacco in Canada? (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/26986906
Gender Differences in Associations Between Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/26903256 Alcohol and cannabis use among college students: Substitutes or complements? (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26894560
Cannabis effects on driving longitudinal control with and without alcohol (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26889769
ALCOHOL DEPENDENCE–NEUROBIOLOGY AND TREATMENT. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27008795
Alcohol, Methamphetamine, and Marijuana Exposure Have Distinct Effects on the Human Placenta. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27038593
Dual Cannabis and Alcohol Use Disorders in Young Adults: Problems Magnified (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27070725
Is attention deficit/hyperactivity disorder among men associated with initiation or escalation of substance use at 15-month follow up? A longitudinal study involving young Swiss men. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27061514
Ethanol downregulates N-acyl phosphatidylethanolamine-phospholipase D expression in BV2 microglial cells via epigenetic mechanisms. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27266665
Older-adult marijuana users and ex-users: Comparisons of sociodemographic characteristics and mental and substance use disorders. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27282425
Cannabis and Alcohol Use, Affect, and Impulsivity in Psychiatric Outpatients’ Daily Lives. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27270874
Comparing adults who use cannabis medically with those who use recreationally: Results from a national sample. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27262964
Traffic accidentability and risky driving behavior in young people in New Caledonia. of study (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27259836
Substitution and Complementarity of Alcohol and Cannabis: A Review of the Literature. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27249324
Drugs of abuse and alcohol consumption among different groups of population on the Greek Island of Lesvos through sewage-based epidemiology. (abst – 2016) http://www.sciencedirect.com/science/article/pii/S0048969716308233
Secondary Effects of an Alcohol Prevention Program Targeting Students and/or Parents (abst – 2016) http://www.journalofsubstanceabusetreatment.com/article/S0740-5472(16)30152-0/abstract
Assessing the risk of marijuana use disorder among adolescents and adults who use marijuana. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27292878
Basolateral amygdala CB1 cannabinoid receptors are involved in cross state-dependent memory retrieval between morphine and ethanol. (abst – 2016) http://www.sciencedirect.com/science/article/pii/S0091305716301083
Marijuana Use Is Not Associated With Progression to Advanced Liver Fibrosis in HIV/Hepatitis C Virus-coinfected Women. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27225241
Consequences of adolescent use of alcohol and other drugs: Studies using rodent models (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763416304304
A preliminary evaluation of synthetic cannabinoid use among adolescent cannabis users: Characteristics and treatment outcomes (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27454353
Examining the Relationship Between Traumatic Brain Injury and Substance Use Outcomes in the Canadian Population (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27484302
Alcohol use during a trial of N-acetylcysteine for adolescent marijuana cessation. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27521979
Sex differences in alcohol consumption and alterations in nucleus accumbens endocannabinoid mRNA in alcohol-dependent rats (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27578612
The hazards of bad sleep-Sleep duration and quality as predictors of adolescent alcohol and cannabis use (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27659736
FAAH Gene Variation Moderates Stress Response and Symptom Severity in Patients with Posttraumatic Stress Disorder and Comorbid Alcohol Dependence (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27716956
Child maltreatment and cannabis use in young adulthood: A birth cohort study (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27741369
A social network analysis of substance use among immigrant adolescents in six European cities (abst–2016) http://www.sciencedirect.com/science/article/pii/S027795361630538X Oxytocin for the treatment of drug and alcohol use disorders (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27603752
Alcohol, tobacco and cannabis use: Do students with mild-intellectual disability mimic students in the general population? (abst-2016) http://www.sciencedirect.com/science/article/pii/S089142221630230X
Sex-dependent influence of chronic mild stress (CMS) on voluntary alcohol consumption; study of neurobiological consequences. (abst – 2016) http://www.sciencedirect.com/science/article/pii/S0091305716302465
Alcohol and cannabis: Comparing their adverse health effects and regulatory regimes. (abst – 2016) https://www.ncbi.nlm.nih.gov/pubmed/27908654
Persistent cannabis dependence and alcohol dependence represent risks for midlife economic and social problems: A longitudinal cohort study. (abst – 2016) https://www.ncbi.nlm.nih.gov/pubmed/28008372
Independent Versus Co-occurring Substance Use in Relation to Gambling Outcomes in Older Adolescents and Young Adults (abst-2016) https://www.ncbi.nlm.nih.gov/pubmed/28011065
Marijuana Could Help Treat Drug Addiction and Mental Health Problems (news & abst – 2016) http://neurosciencenews.com/addiction-mental-health-marijuana-5536/
Association Between Use of Cannabis in Adolescence and Weight Change into Midlife (link to download – 2017) http://journals.plos.org/plosone/article? id=10.1371/journal.pone.0168897
Beta-caryophyllene protects against alcoholic steatohepatitis by attenuating inflammation and metabolic dysregulation in mice. (abst – 2017) https://www.ncbi.nlm.nih.gov/pubmed/28107775
Developmental Patterns of Adolescent Marijuana and Alcohol Use and Their Joint Association with Sexual Risk Behavior and Outcomes in Young Adulthood. (abst – 2017) https://www.ncbi.nlm.nih.gov/pubmed/28083726
Medicinal versus recreational cannabis use: Patterns of cannabis use, alcohol use, and cued-arousal among veterans who screen positive for PTSD. (abst – 2017) https://www.ncbi.nlm.nih.gov/pubmed/28088054
Modelling possible causality in the associations between unemployment, cannabis use, and alcohol misuse. (abst – 2017) http://www.sciencedirect.com/science/article/pii/S0277953617300011


ALLERGIES AND CANNABIS
Cannabidiol attenuates delayed-type hypersensitivity reactions via suppressing T-cell and macrophage reactivity (full–2010) http://www.nature.com/aps/journal/v31/n12/full/aps2010155a.html
Protective role of palmitoylethanolamide in contact allergic dermatitis (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/19909294
Beneficial effects of cannabinoids (CB) in a murine model of allergen-induced airway inflammation: Role of CB(1)/CB(2) receptors (abst–2010) http://www.unboundmedicine.com/medline/ebm/record/21056512/abstract/Beneficial_effects_of_cannabinoids__CB__in_a_murine_model_of_allergen_induced_airway_inflammation:_Role_of_CB_1_/CB_2__receptors
The cannabinoid receptor agonist WIN 55,212-2 inhibits antigen-induced plasma extravasation in guinea pig airways (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20150748
top
Effects of palmitoylethanolamide on the cutaneous allergic inflammatory response in Ascaris hypersensitive Beagle dogs (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21601500
Cannabinoid 2 (CB2) Receptor Involvement in the Down-regulation but not Up regulation of Serum IgE Levels in Immunized Mice (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419805/
Inhibitory effect of topical adelmidrol on antigen-induced skin wheal and mast cell behavior in a canine model of allergic dermatitis (full–2012) http://www.biomedcentral.com/1746-6148/8/230
Endocannabinoids limit excessive mast cell maturation and activation in human skin (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22226549
The Role of Cannabinoids In Inflammatory Modulation of Allergic Respiratory Disorders, Inflammatory Pain and Ischemic Stroke (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22420307
The cannabinoid receptor-2 is involved in allergic inflammation (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22525379
Cannabinoid 1 Receptors in Keratinocytes Modulate Proinflammatory Chemokine Secretion and Attenuate Contact Allergic Inflammation (full–2013) http://www.jimmunol.org/content/190/10/4929.long
Cannabinoid receptor 1 controls human mucosal-type mast cell degranulation and maturation in situ (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23453134
Effect of endocannabinoids on IgE-mediated allergic response in RBL-2H3 cells (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23731947
Cannabinoid CB2 receptors as novel target for inhibiting house dust mite induced allergic airway inflammation (abst–2013) http://www.jimmunol.org/cgi/content/meeting_abstract/190/1_MeetingAbstracts/120.12?sid=c3422dd2-7ad0-42e4-a862-845dc670f7cf
Anti-inflammatory activity of topical THC in DNFB-mediated mouse allergic contact dermatitis independent of CB1 and CB2 receptors (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23889474
The expression of cannabinoid receptor 1 is significantly increased in atopic patients (full–2014) http://www.jacionline.org/article/S0091-6749%2813%2902936-9/fulltext
Exposure to Allergen Causes Changes in NTS Neural Activities after Intratracheal Capsaicin Application, in Endocannabinoid Levels and in the Glia Morphology of NTS (full–2015) http://www.hindawi.com/journals/bmri/2015/980983/
Life Threatening Idiopathic Recurrent Angioedema Responding to Cannabis (asbst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26257969
top
Adelmidrol increases the endogenous concentrations of palmitoylethanolamide in canine keratinocytes and down-regulates an inflammatory reaction in an in vitro model of contact allergic dermatitis (abst–2015) http://www.sciencedirect.com/science/article/pii/S1090023315004712
The Endogenous Cannabinoid Anandamide Increases Human Airway Epithelial Cell Permeability through an Arachidonic Acid Metabolite (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816000256

Cannabinoid receptor 2 augments eosinophil responsiveness and aggravates allergeninduced pulmonary inflammation in mice (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26850094
Production of endocannabinoids by activated T cells and B cells modulates inflammation associated with delayed type hypersensitivity (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27064137
CB2 receptors regulate natural killer cells that limit allergic airway inflammation in a murine model of asthma (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27992060
The Endocannabinoid System and Its Role in Eczematous Dermatoses (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28098721


ALLERGIES TO CANNABIS
Allergic hypersensitivity to cannabis in patients with allergy and illicit drug users (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21272987
IgE-Mediated Hypersensitivity Reactions to Cannabis in Laboratory Personnel (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21832832
Molecular allergology in practice: an unusual case of LTP allergy (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22360137
World Allergy Organization Study on Aerobiology for Creating First Pollen and Mold Calendar With Clinical Significance in Islamabad, Pakistan;: A Project of World Allergy Organization and Pakistan Allergy, Asthma & Clinical Immunology Centre of Islamabad (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/23283209
Variations and origin of the atmospheric pollen of Cannabis detected in the province of Tetouan (NW Morocco): 2008-2010 (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23208276
Characterization of Cannabis sativa allergens (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3726218/
New Food Allergies in a European Non-Mediterranean Region: Is Cannabis sativa to Blame? (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23549061
Palmitoylethanolamide is a new possible pharmacological treatment for the inflammation associated with trauma (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/22697514
Prevalence of Sensitization to Cannabis sativa. Lipid-Transfer and Thaumatin-Like Proteins Are Relevant Allergens (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23921252
Contact urticaria to Cannabis sativa due to a lipid transfer protein (LTP) (full–2014) http://tinyurl.com/pgbxfa4
Allergy to illicit drugs and narcotics (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24588864
Cannabis Sativa: The Unconventional “Weed” Allergen (full–2015) http://www.west-info.eu/it/oltre-al-polline-ce-allergia-da-cannabis/elsevier-cannabis-sativa-theunconventional-weed-allergen-2015-2/
Chronic Adolescent Marijuana Use as a Risk Factor for Physical and Mental Health Problems in Young Adult Men (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26237286
Marihuana allergy: beyond the joint (link to PDF–2015) http://www.jiaci.org/issues/vol25issue1/vol25issue01-16.htm
Cannabis Allergy: What do We Know Anno 2015 (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26178655
Marihuana allergy: beyond the joint. (link to PDF–2015) http://www.jiaci.org/issues/vol25issue1/vol25issue01-16.htm Cannabis sativa allergy: looking through the fog (full–2016) http://onlinelibrary.wiley.com/doi/10.1111/all.13043/epdf
top


ALS/AMYOTROPHIC LATERAL SCLEROSIS
Cannabis and Amyotrophic Lateral Sclerosis: Hypothetical and Practical Applications, and a Call for Clinical Trials (full-2010) http://safeaccess.ca/research/pdf/Carter-ALS-2010.pdf
The endocannabinoid system in the inflammatory and neurodegenerative processes of multiple sclerosis and of amyotrophic lateral sclerosis (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20353778
Abnormal sensitivity of cannabinoid CB1 receptors in the striatum of mice with experimental amyotrophic lateral sclerosis (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/19452308
The endocannabinoid system in gp120-mediated insults and HIV-associated dementia (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20353779
Tetrahydrocannabinol (THC) for cramps in amyotrophic lateral sclerosis: a randomised, double-blind crossover trial (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20498181
Is lipid signaling through cannabinoid 2 receptors part of a protective system? (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062638/
Cannabinoid receptor signalling in neurodegenerative diseases: a potential role for membrane fluidity disturbance (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165948/
Single-dose Pharmacokinetics and Tolerability of Oral Delta-9-Tetrahydrocannabinol in Patients with Amyotrophic Lateral Sclerosis (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22594565
Medical Cannabis Helps ALS Patient Outlive her Own Doctors (news/anecdotal–2012) http://www.examiner.com/article/medical-cannabis-helps-als-patient-outlive-her-own-doctors
Amyotrophic lateral sclerosis treatment with ultramicronized palmitoylethanolamide: a case report (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22998138
Interplay of cannabinoid 2 (CB2) receptors with nitric oxide synthases, oxidative and nitrative stress and cell death during remote neurodegeneration (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/22371074
Therapeutic Potential of Cannabinoids in Neurodegenerative Disorders: A Selective Review (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23829360
Amyotrophic Lateral Sclerosis Treatment with Ultramicronized Palmitoylethanolamide: A Case Report (2013) http://www.eurekaselect.com/105507/article
The endocannabinoid system: a putative role in neurodegenerative diseases (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4070159/
Cannabinoids: New Promising Agents in the Treatment of Neurological Diseases (link to PDF–2014) http://www.mdpi.com/1420-3049/19/11/18781
top
Changes in Endocannabinoid Receptors and Enzymes in the Spinal Cord of SOD1G93A Transgenic Mice and Evaluation of a Sativex® -like Combination of Phytocannabinoids: Interest for Future Therapies in Amyotrophic Lateral Sclerosis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24703394
Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders (full–2015) http://ascpjournal.biomedcentral.com/articles/10.1186/s13722-015-0032-7
Cannabinoid Signaling and Neuroinflammatory Diseases: A Melting pot for the Regulation of Brain Immune Responses (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25601726
Changes in the endocannabinoid signaling system in CNS structures of TDP-43 transgenic mice: relevance for a neuroprotective therapy in TDP-43-related disorders (full–2015) http://tinyurl.com/oe3oouq
Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26260390
Endocannabinoids in Multiple Sclerosis and Amyotrophic Lateral Sclerosis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26408162
Targeting Cannabinoid CB2 Receptors in the Central Nervous System. Medicinal Chemistry Approaches with Focus on Neurodegenerative Disorders. (full – 2016) http://journal.frontiersin.org/article/10.3389/fnins.2016.00406/full
Acetylcholine receptors from human muscle as pharmacological targets for ALS therapy (full-2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4801305/
Can cannabinoids be a potential therapeutic tool in amyotrophic lateral sclerosis? (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5270417/
Gingival Stromal Cells as an In Vitro Model: Cannabidiol Modulates Genes Linked with Amyotrophic Lateral Sclerosis. (abst – 2016) https://www.ncbi.nlm.nih.gov/pubmed/27714895
Pros and cons of medical cannabis use by people with chronic brain disorders (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27804883
Pain in amyotrophic lateral sclerosis. (abst – 2016) https://www.ncbi.nlm.nih.gov/pubmed/27964824
Up-regulation of CB2 receptors in reactive astrocytes in canine degenerative myelopathy, a disease model of amyotrophic lateral sclerosis (full – 2017) http://dmm.biologists.org/content/early/2017/01/06/dmm.028373.long


ALZHEIMER’S DISEASE/DEMENTIA
Enhancement of endocannabinoid signaling by fatty acid amide hydrolase inhibition: a neuroprotective therapeutic modality (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2848893/?tool=pubmed
Endocannabinoids Prevent β-Amyloid-mediated Lysosomal Destabilization in Cultured Neurons (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2992287/
The Multiplicity of Action of Cannabinoids: Implications for Treating Neurodegeneration (full-2010) http://onlinelibrary.wiley.com/doi/10.1111/j.1755-5949.2010.00195.x/full
Cannabinoids and Dementia: A Review of Clinical and Preclinical Data (link to PDF–2010) http://www.mdpi.com/1424-8247/3/8/2689
The development of cannabinoid CBII receptor agonists for the treatment of central neuropathies (link to PDF–2010) http://www.eurekaselect.com/85808/article
Inhibitory effect of ethanol extract of Magnolia officinalis and 4-O-methylhonokiol on memory impairment and neuronal toxicity induced by beta-amyloid (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20004682
The endocannabinoid system in gp120-mediated insults and HIV-associated dementia (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20353779
Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimers’ disease (full–2011) http://molpharm.aspetjournals.org/content/early/2011/02/24/mol.111.071290.long
Cannabidiol Reduces Aβ-Induced Neuroinflammation and Promotes Hippocampal Neurogenesis through PPARγ Involvement (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3230631/?tool=pubmed
Gadolinium-HU-308-incorporated micelles (full–2011) http://www.ncbi.nlm.nih.gov/books/NBK54067/pdf/CB2R-Gd-Micelles.pdf
top
Cannabinoid receptor signalling in neurodegenerative diseases: a potential role for membrane fluidity disturbance (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165948/
Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3085542/
An amyloid β(42)-dependent deficit in anandamide mobilization is associated with cognitive dysfunction in Alzheimer’s disease (full–2011)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3154439/pdf/nihms284332.pdf
Is lipid signaling through cannabinoid 2 receptors part of a protective system? (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062638/
Endocannabinoid 2-arachidonoylglycerol protects neurons against β-amyloid insults (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3052737/pdf/nihms266962.pdf
Molecular reorganization of endocannabinoid signalling in Alzheimer’s disease (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3069704/pdf/awr046.pdf
Palmitoylethanolamide counteracts reactive astrogliosis induced by beta-amyloid peptide (full–2011) http://onlinelibrary.wiley.com/doi/10.1111/j.1582-4934.2011.01267.x/full
The effects of hempseed meal intake and linoleic acid on Drosophila models of neurodegenerative diseases and hypercholesterolemia (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3933972/
Patent WO 2010012506 A1 – CANNABINOIDS FOR USE IN TREATING OR PREVENTING COGNITIVE IMPAIRMENT AND DEMENTIA (full-2011) http://www.google.it/patents/WO2010012506A1?cl=en
Anandamide and its congeners inhibit human plasma butyrylcholinesterase. Possible new roles for these endocannabinoids? (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21664223
JNK plays a key role in tau hyperphosphorylation in Alzheimer’s disease models (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21628793
The role of phytochemicals in the treatment and prevention of dementia (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/21639405/abstract/The_role_of_phytochemicals_in_the_treatment_and_prevention_of_dementia_
Early onset of aging-like changes is restricted to cognitive abilities and skin structure in Cnr1(-/-) mice (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/20724033
Intact cannabinoid CB1 receptors in the Alzheimer’s disease cortex (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21034788
4-O-Methylhonokiol attenuates memory impairment in presenilin 2 mutant mice through reduction of oxidative damage and inactivation of astrocytes and the ERK pathway (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/20974250
Can the benefits of cannabinoid receptor stimulation on neuroinflammation, neurogenesis and memory during normal aging be useful in AD prevention? (full-2012) http://www.jneuroinflammation.com/content/9/1/10
Prolonged oral Cannabinoid Administration prevents Neuroinflammation, lowers beta-amyloid Levels and improves Cognitive Performance in Tg APP 2576 Mice (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292807/
An amyloid β42-dependent deficit in anandamide mobilization is associated with cognitive dysfunction in Alzheimer’s disease (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3154439/
A Dysregulated Endocannabinoid-Eicosanoid Network Supports Pathogenesis in a Mouse Model of Alzheimer’s Disease (full–2012) http://download.cell.com/cell-reports/mmcs/journals/2211-1247/PIIS2211124712001258.mmc2.pdf
β−Amyloid exacerbates inflammation in astrocytes lacking fatty acid amide hydrolase through a mechanism involving PPAR-α, PPAR-γ and TRPV1, but not CB1 or CB2 receptors (full–2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.01889.x/pdf
Monoacylglycerol lipase is a new therapeutic target for Alzheimer’s disease (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3513645/
Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-α (full–2012) http://www.jneuroinflammation.com/content/9/1/49
The fatty acid amide hydrolase inhibitor URB597 exerts anti-inflammatory effects in hippocampus of aged rats and restores an age-related deficit in long-term potentiation (full–2012) http://www.jneuroinflammation.com/content/9/1/79
Methylhonokiol attenuates neuroinflammation: a role for cannabinoid receptors? (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419612/
Inhibitory effect of 4-O-methylhonokiol on lipopolysaccharide-induced neuro-inflammation, amyloidogenesis and memory impairment via inhibition of nuclear factor-kappaB in vitro and in vivo models (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3323460/
Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-α (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3315437/?tool=pubmed
The endocannabinoid, anandamide, augments Notch-1 signaling in cultured cortical neurons exposed to amyloid-beta and in the cortex of aged rats (full–2012) http://www.jbc.org/content/early/2012/08/13/jbc.M112.350678.long
Review article: The endocannabinoid system in normal and pathological brain ageing (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3326.full?sid=161e7b36-5055-448b-962e-697c782e901d
top
[(125)I]SD-7015 reveals fine modalities of CB(1) cannabinoid receptor density in the prefrontal cortex during progression of Alzheimer’s disease (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4180663/
CB1 cannabinoid receptor activation rescues amyloid β-induced alterations in behaviour and intrinsic electrophysiological properties of rat hippocampal CA1 pyramidal neurones (full–2012) http://www.karger.com/Article/Pdf/338494
Protective effect of cannabinoid CB1 receptor activation against altered intrinsic repetitive firing properties induced by Aβ neurotoxicity (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22172925
4-O-methylhonokiol prevents memory impairment in the Tg2576 transgenic mice model of Alzheimer’s disease via regulation of β-secretase activity (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22330831?dopt=Abstract&holding=f1000,f1000m,isrctn
Contrasting protective effects of cannabinoids against oxidative stress and amyloid-β evoked neurotoxicity in vitro (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22233683
CB1 Agonist ACEA Protects Neurons and Reduces the Cognitive Impairment of AβPP/PS1 Mice (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22451318
The therapeutic potential of the endocannabinoid system for Alzheimer’s disease (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22448595
WIN55212-2 attenuates amyloid-beta-induced neuroinflammation in rats through activation of cannabinoid receptors and PPAR-γ pathway (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22634229
CB(2) receptor and amyloid pathology in frontal cortex of Alzheimer’s disease patients (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22763024
In vivo type 1 cannabinoid receptor availability in Alzheimer’s disease (abst–2012) http://jnumedmtg.snmjournals.org/cgi/content/meeting_abstract/53/1_MeetingAbstracts/1961?maxtoshow=&hits=25&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=130&sortspec=date&resourcetype=HWCIT
Essential fatty acids and lipid mediators. Endocannabinoids (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22730630
How Weed Can Protect Us From Cancer and Alzheimer’s (book excerpt–2012) http://www.alternet.org/story/156269/how_weed_can_protect_us_from_cancer_and_alzheimer%27s
Natural Cannabinoids Improve Dopamine Neurotransmission and Tau and Amyloid Pathology in a Mouse Model of Tauopathy (full–2013) http://iospress.metapress.com/content/4j61942x88175321/fulltext.html
The Influence of Cannabinoids on Generic Traits of Neurodegeneration (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/bph.12492/full
R-flurbiprofen improves tau, but not Aß pathology in a triple transgenic model of Alzheimer’s disease (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3863610/
Δ9-THC-Caused Synaptic and Memory Impairments Are Mediated through COX-2 Signaling (full–2013) http://www.cell.com/cell/abstract/S0092-8674%2813%2901360-3?_returnURL=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0092867413013603%3Fshowall%3Dtrue
top
Neuroglial Roots of Neurodegenerative Diseases: Therapeutic Potential of Palmitoylethanolamide in Models of Alzheimer’s Disease (link to PDF–2013) http://www.eurekaselect.com/107977/article
Effects of magnolol on impairment of learning and memory abilities induced by scopolamine in mice (link to PDF–2013) https://www.jstage.jst.go.jp/article/bpb/36/5/36_b12-00880/_html
Activation of the CB(2) receptor system reverses amyloid-induced memory deficiency (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/22795792
CB(2) receptor and amyloid pathology in frontal cortex of Alzheimer’s disease patients  (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/22763024
CB2 Cannabinoid Receptor Agonist Ameliorates Alzheimer-Like Phenotype in AβPP/PS1 Mice (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23515018
Multitarget Cannabinoids as Novel Strategy for Alzheimer Disease (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23369066
Implication of JNK pathway on tau pathology and cognitive decline in a senescence-accelerated mouse model (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23501261
Glia and Mast Cells as Targets for Palmitoylethanolamide, an Anti-inflammatory and Neuroprotective Lipid Mediator (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23813098
Role of the cannabinoid system in the transit of beta-amyloid across the blood-brain barrier (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23831388
Cannabinoid receptor 1 deficiency in a mouse model of Alzheimer’s disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23838176
Therapeutic Potential of Cannabinoids in Neurodegenerative Disorders: A Selective Review (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23829360
Cannabinoid Effects on β Amyloid Fibril and Aggregate Formation, Neuronal and Microglial-Activated Neurotoxicity In Vitro (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24030360
In vivo type 1 cannabinoid receptor availability in Alzheimer’s disease (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24189376
Cannabidiol Promotes Amyloid Precursor Protein Ubiquitination and Reduction of Beta Amyloid Expression in SHSY5YAPP+ Cells Through PPARγ Involvement (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24288245
Cannabinoid agonists showing BuChE inhibition as potential therapeutic agents for Alzheimer’s disease (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24378710
top
Cannabinoids for treatment of Alzheimer’s disease: moving toward the clinic (full–2014) http://journal.frontiersin.org/Journal/10.3389/fphar.2014.00037/full
The First Dual ChE/FAAH Inhibitors: New Perspectives for Alzheimer’s Disease? (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4025825/
Identification of potential herbal inhibitor of acetylcholinesterase associated Alzheimer’s disorders using molecular docking and molecular dynamics simulation (full–2014) http://www.hindawi.com/journals/bri/2014/705451/
CB2 Receptor Deficiency Increases Amyloid Pathology and Alters Tau Processing in a Transgenic Mouse Model of Alzheimer’s Disease (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3883962/
c-Jun N-terminal kinase has a key role in Alzheimer disease synaptic dysfunction in vivo (full–2014) http://www.nature.com/cddis/journal/v5/n1/full/cddis2013559a.html
The endocannabinoid system: a putative role in neurodegenerative diseases (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4070159/
Synaptic and Cognitive Improvements by Inhibition of 2-AG Metabolism Are through Upregulation of MicroRNA-188-3p in a Mouse Model of Alzheimer’s Disease (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220026/
Palmitoylethanolamide controls reactive gliosis and exerts neuroprotective functions in a rat model of Alzheimer’s disease (full–2014) http://www.nature.com/cddis/journal/v5/n9/full/cddis2014376a.html
β-Amyloid Inhibits E-S Potentiation through Suppression of Cannabinoid Receptor 1-Dependent Synaptic Disinhibition (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4114400/
Endocannabinoid signalling and the deteriorating brain (full–2014)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471876/
Identification of Potential Herbal Inhibitor of Acetylcholinesterase Associated Alzheimer’s Disorders Using Molecular Docking and Molecular Dynamics Simulation (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4099354/
Cannabinoids: New Promising Agents in the Treatment of Neurological Diseases (full–2014) http://www.mdpi.com/1420-3049/19/11/18781/htm
Amyrin Attenuates Scopolamine-Induced Cognitive Impairment in Mice (full–2014) https://www.jstage.jst.go.jp/article/bpb/37/7/37_b14-00113/_html
Medical Cannabis Research, What the Science Says (article–2014) http://www.safeaccessnow.org/medical_cannabis_research_what_does_the_evidence_say
Altered Expression of the CB1 Cannabinoid Receptor in the Triple Transgenic Mouse Model of Alzheimer’s Disease (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24496074
Endocannabinoid signaling in Alzheimer’s disease: current knowledge and future directions (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24813316
Type-1 Cannabinoid Receptor Activity During Alzheimer’s Disease Progression (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24946872
top
Endocannabinoid 2-Arachidonylglycerol Protects Primary Cultured Neurons Against Homocysteine-Induced Impairments in Rat Caudate Nucleus Through CB1 Receptor (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25007951
Cannabis-Based Medicine Reduces Multiple Pathological Processes in AβPP/PS1 Mice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25125475
The Potential Therapeutic Effects of THC on Alzheimer’s Disease (abst–2014) http://iospress.metapress.com/content/8421pvx80144t354/?p=ff122a13e6cf4bf78324e26d253bd883&pi=8
The Role of Endocannabinoid Signaling in the Molecular Mechanisms of Neurodegeneration in Alzheimer’s Disease (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25147120
Reductions in Endocannabinoid Levels and Enhanced Coupling of Cannabinoid Receptors in the Striatum are Accompanied by Cognitive Impairments in the AβPPswe/PS1ΔE9 Mouse Model of Alzheimer’s Disease (abst–2014) http://iospress.metapress.com/content/0617070q2404258h/
Dronabinol for the treatment of agitation and aggressive behavior in acutely hospitalized severely demented patients with noncognitive behavioral symptoms (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/23597932
Type-1 Cannabinoid Receptor Activity During Alzheimer’s Disease Progression (abst-2014) http://iospress.metapress.com/content/8622072156706328/
Altered expression of the CB1 cannabinoid receptor in the triple transgenic mouse model of Alzheimer’s disease (abst–2014) http://iospress.metapress.com/content/j04j4362605u1464/?p=09c91830dc7947dbb9d2c0ee83a7e915&pi=5
β-Caryophyllene Ameliorates the Alzheimer-Like Phenotype in APP/PS1 Mice through CB2 Receptor Activation and the PPARγ Pathway (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25171128
Cannabidiol Normalizes Capase 3, Synatophsin, and Mitochondrial Fission Protein DNM1L Expression Levels in Rats with Brain Iron Overload: Implications for Neuroprotection (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/23893294
Neuroprotection by association of palmitoylethanolamide with luteolin in experimental Alzheimer’s disease models: the control of neuroinflammation (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25106636
Normal aging in rats and pathological aging in human Alzheimer disease decrease FAAH activity: Modulation by cannabinoid agonists (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25456842
Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe/PS1∆E9 mice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24577515
Long-term cannabidiol treatment prevents the development of social recognition memory deficits in Alzheimer’s disease transgenic mice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25024347
top
Monoacylglycerol lipase inhibitor JZL184 reduces neuroinflammatory response in APdE9 mice and in adult mouse glial cells (full–2015) http://www.jneuroinflammation.com/content/12/1/81
WIN 55,212-2, Agonist of Cannabinoid Receptors, Prevents Amyloid β1-42 Effects on Astrocytes in Primary Culture (full-2015)  http://www.plosone.org/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0122843&representation=PDF
Cannabinoids in late-onset Alzheimer’s disease (full–2015) http://onlinelibrary.wiley.com/doi/10.1002/cpt.117/full
Cannabinoid CB2 Receptors in a Mouse Model of Aβ Amyloidosis: Immunohistochemical Analysis and Suitability as a PET Biomarker of Neuroinflammation (full-2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0129618
Cannabinoid Signaling and Neuroinflammatory Diseases: A Melting pot for the Regulation of Brain Immune Responses (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25601726
N-stearoyltyrosine protects primary cortical neurons against Aβ(1-40)-induced injury through inhibiting endocannabinoid degradation (abst–2015) http://www.sciencedirect.com/science/article/pii/S0024320515000521
Analysis of calretinin early expression in the rat hippocampus after beta amyloid (1-42) peptide injection (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25813826
Elevation of Plasma 2-Arachidonoylglycerol Levels in Alzheimer’s Disease Patients as a Potential Protective Mechanism against Neurodegenerative Decline (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25818503
Monoacylglycerol Lipase Inhibitor Protects Primary Cultured Neurons Against Homocysteine-induced Impairments in Rat Caudate Nucleus through COX-2 signaling (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25818189
The role of cannabinoids and leptin in neurological diseases (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25880465
Advancements in the treatment of agitation in Alzheimer’s disease (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26159445
Effect of Homocysteine on Voltage-Gated Sodium Channel Currents in Primary Cultured Rat Caudate Nucleus Neurons and Its Modulation by 2-Arachidonylglycerol (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26179279
Monoacylglycerol lipase inhibitor JZL184 reduces neuroinflammatory response in APdE9 mice and in adult mouse glial cells (full–2015) http://www.jneuroinflammation.com/content/12/1/81
WIN 55,212-2, Agonist of Cannabinoid Receptors, Prevents Amyloid β1-42 Effects on Astrocytes in Primary Culture (full-2015) http://www.plosone.org/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0122843&representation=PDF
Cannabinoid CB2 Receptors in a Mouse Model of Aβ Amyloidosis: Immunohistochemical Analysis and Suitability as a PET Biomarker of Neuroinflammation (full-2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0129618
Potential Therapeutical Contributions of the Endocannabinoid System towards Aging and Alzheimer’s Disease (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567222/
top
Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders (full–2015) http://ascpjournal.biomedcentral.com/articles/10.1186/s13722-015-0032-7
Cannabinoid Signaling and Neuroinflammatory Diseases: A Melting pot for the Regulation of Brain Immune Responses (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25601726
N-stearoyltyrosine protects primary cortical neurons against Aβ(1-40)-induced injury through inhibiting endocannabinoid degradation (abst–2015) http://www.sciencedirect.com/science/article/pii/S0024320515000521
Analysis of calretinin early expression in the rat hippocampus after beta amyloid (1-42) peptide injection (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25813826
Elevation of Plasma 2-Arachidonoylglycerol Levels in Alzheimer’s Disease Patients as a Potential Protective Mechanism against Neurodegenerative Decline (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25818503
Monoacylglycerol Lipase Inhibitor Protects Primary Cultured Neurons Against Homocysteine-induced Impairments in Rat Caudate Nucleus through COX-2 signaling (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25818189
The role of cannabinoids and leptin in neurological diseases (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25880465
Advancements in the treatment of agitation in Alzheimer’s disease (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26159445
Effect of Homocysteine on Voltage-Gated Sodium Channel Currents in Primary Cultured Rat Caudate Nucleus Neurons and Its Modulation by 2-Arachidonylglycerol (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26179279
Cannabinoids for the Treatment of Agitation and Aggression in Alzheimer’s Disease (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26271310
Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26260390
Endocannabinoid regulation of amyloid-induced neuroinflammation (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26362942
Endocannabinoids and Neurodegenerative Disorders: Parkinson’s Disease, Huntington’s Chorea, Alzheimer’s Disease, and Others (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26408163
Pharmacological benefits of selective modulation of cannabinoid receptor type 2 (CB2) in experimental Alzheimer’s disease (abst–2015) http://www.sciencedirect.com/science/article/pii/S0091305715300952
The basolateral amygdala γ-aminobutyric acidergic system in health and disease (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26586374
Characterization of Lignanamides from Hemp (Cannabis sativa L.) Seed and their Antioxidant and Acetylcholinesterase Inhibitory Activities (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26585089
top
Cannabinoid receptor 2 deficiency results in reduced neuroinflammation in an Alzheimer’s disease mouse model (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25443294
Safety, pharmacodynamics, and pharmacokinetics of multiple oral doses of delta-9-tetrahydrocannabinol in older persons with dementia (abst–2015) http://link.springer.com/article/10.1007/s00213-015-3889-y/fulltext.html
Cannabinoid CB2 Receptor Mediates Nicotine-Induced Anti-Inflammation in N9 Microglial Cells Exposed to β Amyloid via Protein Kinase C (full–2016) http://www.hindawi.com/journals/mi/2016/4854378/
Characterization of a novel adult murine immortalized microglial cell line and its activation by amyloid-beta (full–2016) http://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-016-0484-z
Safety and Efficacy of Medical Cannabis Oil for Behavioral and Psychological Symptoms of Dementia: An-Open Label, Add-On, Pilot Study (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26757043
The emerging role of the cannabinoid receptor family in peripheral and neuro-immune interactions (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26758668
Pharmacological benefits of selective modulation of cannabinoid receptor type 2 (CB2) in experimental Alzheimer’s disease (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26577751
Metabolomic-Driven Elucidation of Serum Disturbances Associated with Alzheimer’s Disease and Mild Cognitive Impairment (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26825096
Endocannabinoids in Cerebrovascular Regulation (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26825517
Cannabinoid Receptor 2 Participates in Amyloid-β Processing in a Mouse Model of Alzheimer’s Disease but Plays a Minor Role in the Therapeutic Properties of a CannabisBased Medicine (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26890764
Pharmacological management of agitation and aggression in Alzheimer’s Disease: a review of current and novel treatments (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27137221
Activity of muscarinic, galanin and cannabinoid receptors in the prodromal and advanced stages in the triple transgenic mice model of Alzheimer’s disease (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27223629
Investigational drugs for treating agitation in persons with dementia (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27232589
Fatty acid amide hydrolase (FAAH), acethylcholinesterase (AChE) and butyrylcholinesterase (BuChE): networked targets for the development of carbamates as potential anti Alzheimer’s Disease agents (abst–2016) http://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.6b00609
Endocannabionoid System in Neurological Disorders (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27364363
Agitation in Alzheimer Disease as a Qualifying Condition for Medical Marijuana in the United States (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27389672
Decreased in vivo availability of the cannabinoid type 2 receptor in Alzheimer’s disease (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27488857
Effects of the cannabinoid 1 receptor peptide ligands hemopressin, (m)RVDhemopressin(α) and (m)VD-hemopressin(α) on memory in novel object and object location recognition tasks in normal young and Aβ1-42-treated mice (abst–2016) http://www.sciencedirect.com/science/article/pii/S1074742716301307
Type-2 cannabinoid receptors in neurodegeneration (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816306983
Delineating the Efficacy of a Cannabis-Based Medicine at Advanced Stages of Dementia in a Murine Model (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27567873
Selective modulator of cannabinoid receptor type 2 reduces memory impairment and infarct size during cerebral hypoperfusion and vascular dementia (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27586843
Selective modulator of cannabinoid receptor type 2 (CB2) against biochemical alterations and brain damage in chronic cerebral hypoperfusion induced vascular dementia (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27599483
Gingival Stromal Cells as an In Vitro Model: Cannabidiol Modulates Genes Linked with Amyotrophic Lateral Sclerosis (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27714895
Cannabinoids prevent the amyloid β-induced activation of astroglial hemichannels: A neuroprotective mechanism (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27757991
Pros and cons of medical cannabis use by people with chronic brain disorders (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27804883
A systematic review of the effect of cannabidiol on cognitive function: Relevance to schizophrenia (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763416304390
Cannabinoid Receptors in the Central Nervous System: Their Signaling and Roles in Disease (full–2017) http://journal.frontiersin.org/article/10.3389/fncel.2016.00294/full


AMOTIVATIONAL SYNDROME
Rimonabant eliminates responsiveness to workload changes in a time-constrained food reinforced progressive ratio procedure in rats (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3387812/
Associations of Alcohol, Nicotine, Cannabis, and Drug Use/Dependence with Educational Attainment: Evidence from Cotwin-Control Analyses (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3412907/
So called “soft” drugs: cannabis and the amotivational syndrome (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23888577
Cannabis and Exercise Science: A Commentary on Existing Studies and Suggestions for Future Directions (abst–2015) http://link.springer.com/article/10.1007/s40279-015-0362-3
top
Δ9-Tetrahydrocannabinol decreases willingness to exert cognitive effort in male rats. (link to PDF – 2016) http://jpn.ca/articles-in-press/41-6-150363/


ANGELMAN’S SYNDROME
Investigational new drugs for focal epilepsy. (full – 2016) http://www.tandfonline.com/doi/full/10.1517/13543784.2016.1110144


ANGIOEDEMA
Life Threatening Idiopathic Recurrent Angioedema Responding to Cannabis (asbt–2015) http://www.ncbi.nlm.nih.gov/pubmed/26257969


ANGIOGENESIS
Diabetic retinopathy: Role of inflammation and potential therapies for anti-inflammation (full–2010) http://www.wjgnet.com/1948-9358/full/v1/i1/12.htm
Endocannabinoid-like N-arachidonoyl serine is a novel pro-angiogenic mediator (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2936832/
Angiogenesis: a new physiological role for N-arachidonoyl serine and GPR55? (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2936831/
Genetic and pharmacological inactivation of cannabinoid CB1 receptor inhibits angiogenesis (full–2011) http://bloodjournal.hematologylibrary.org/content/117/20/5541.long
Novel hexahydrocannabinol analogs as potential anti-cancer agents inhibit cell proliferation and tumor angiogenesis (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/20950604
Endocannabinoids inhibit release of nerve growth factor by inflammation-activated mast cells (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21601562
Cannabidiol inhibits angiogenesis by multiple mechanisms (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3504989/
Cannabinoid receptor 2 agonist ameliorates mesenteric angiogenesis and portosystemic collaterals in cirrhotic rats (full–2012) http://onlinelibrary.wiley.com/doi/10.1002/hep.25625/full
Anti-proliferative and Anti-angiogenic Effects of CB2R Agonist (JWH-133) in Non small Lung Cancer Cells (A549) and Human Umbilical Vein Endothelial Cells: an in Vitro Investigation (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22578958
Autophagy triggered by magnolol derivative negatively regulates angiogenesis (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3920944/
Magnolol inhibits angiogenesis by regulating ROS-mediated apoptosis and the PI3K / AKT / mTOR signaling pathway in mES / EB-derived endothelial-like cells (full–2013) http://www.spandidos-publications.com/ijo/43/2/600
Suppression of vascular endothelial growth factor expression by cannabinoids in a canine osteosarcoma cell line (link to PDF–2013) http://www.dovepress.com/suppression-of-vascular-endothelial-growth-factor-expression-by-cannaba13597
Magnolol suppresses vascular endothelial growth factor-induced angiogenesis by inhibiting ras-dependent mitogen-activated protein kinase and phosphatidylinositol 3-kinase/akt signaling pathways (abst + 1st page–2013) http://www.tandfonline.com/doi/abs/10.1080/01635581.2013.828082?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
A new strategy to block tumor angiogenesis by inhibiting endocannabinoid inactivation (abst–2013) http://www.fasebj.org/cgi/content/meeting_abstract/27/1_MeetingAbstracts/1105.6?sid=eea722c0-971c-4daa-8b8c-38c0c63c19ad
top
Blockade of cannabinoid receptors reduces inflammation, leukocyte accumulation and neovascularization in a model of sponge-induced inflammatory angiogenesis (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/23722450
Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23416116
Anandamide inhibits breast tumor-induced angiogenesis (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4140423/
Evaluation of anti-HIF and anti-angiogenic properties of honokiol for the treatment of ocular neovascular diseases (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4244131/
TRPV1 mediates cellular uptake of anandamide and thus promotes endothelial cell proliferation and network-formation (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265754/
Hypoximimetic activity of N-acyl-dopamines. N-arachidonoyl-dopamine stabilizes HIF-1α protein through a SIAH2-dependent pathway (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25090972
Cannabinoids as therapeutic agents in cancer: current status and future implications (link to PDF–2014) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path[]=2233
Cannabinoids inhibit angiogenic capacities of Endothelial cells via release of Tissue inhibitor of matrix metalloproteinases-1 from lung cancer cells (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24976505
The use of cannabinoids as anticancer agents (full–2015) http://www.sciencedirect.com/science/article/pii/S0278584615001190
The G-protein coupled receptor 55-agonist L-α-lysophosphatidylinositol mediates ovarian carcinoma cell induced angiogenesis (full–2015) http://www.actaps.com.cn/qikan/manage/wenzhang/2014-3-10.pdf
New insights into antimetastatic and antiangiogenic effects of cannabinoids (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25619715
Differential role of cannabinoids in the pathogenesis of skin cancer (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25921771
Endocannabinoids and Cancer (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26408171
Human lung-resident macrophages express CB1 and CB2 receptors whose activation inhibits the release of angiogenic and lymphangiogenic factors (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26467187
Endocannabinoids as Guardians of Metastasis (full–2016) http://www.mdpi.com/1422-0067/17/2/230/htm
In vitro and in vivo efficacy of non-psychoactive cannabidiol in neuroblastoma (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791143/
Cannabinoid pharmacology in cancer research: A new hope for cancer patients? (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791144/
Integrating cannabis into clinical cancer care (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791148/
Activation of the orphan receptor GPR55 by lysophosphatidylinositol promotes metastasis in triple-negative breast cancer (full–2016) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path %5B%5D=10206&path%5B%5D=32116 Anticancer mechanisms of cannabinoids (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791144/ Antitumorigenic targets of cannabinoids – current status and implications (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27070944
Cannabinoids: Possible agents for treatment of psoriasis via suppression of angiogenesis and inflammation (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28110689
top


ANOREXIA/ANOREXIA NERVOSA
Activity-based anorexia in C57/BL6 mice: effects of the phytocannabinoid, Delta9-tetrahydrocannabinol (THC) and the anandamide analogue, OMDM-2 (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20471226
Molecular mechanisms underlying anorexia nervosa: focus on human gene association studies and systems controlling food intake (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/19931559
A nonsynonymous polymorphism in cannabinoid CB2 receptor gene is associated with eating disorders in humans and food intake is modified in mice by its ligands (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/19768813
Fish oil promotes survival and protects against cognitive decline in severely undernourished mice by normalizing satiety signals (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3117120/
The Endocannabinoid System as Pharmacological Target Derived from Its CNS Role in Energy Homeostasis and Reward. Applications in Eating Disorders and Addiction (link to PDF-2011) http://www.mdpi.com/1424-8247/4/8/1101
The genetics of eating disorders (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21243475
Brain Type 1 Cannabinoid Receptor Availability in Patients with Anorexia and Bulimia Nervosa (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21718968
Functional polymorphism in the GPR55 gene is associated with anorexia nervosa (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/20506567
The cannabinoid receptor agonist THC attenuates weight loss in a rodent model of activity-based anorexia (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096804/?tool=pubmed
The Therapeutic Potential of Cannabis and Cannabinoids (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442177/
Lower levels of cannabinoid 1 receptor mRNA in female eating disorder patients: Association with wrist cutting as impulsive self-injurious behavior (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22542985
The role of the endocannabinoid system in eating disorders: pharmacological implications (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22785439
Do deficits in brain cannabinoids contribute to eating disorders? (news–2012) http://medicalxpress.com/news/2011-10-deficits-brain-cannabinoids-contribute-disorders.html
Brain Molecules and Appetite: The Case of Oleoylethanolamide (link to PDF–2013) http://www.eurekaselect.com/107948/article
The Role of the Endocannabinoid System in Eating Disorders: Neurochemical and Behavioural Preclinical Evidence (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23829365
top
Small animal PET imaging of the type 1 cannabinoid receptor in a rodent model for anorexia nervosa (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24006151
The endocannabinoid system and its possible role in neurobiology of psychiatric disorders (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24326750
Association of the c.385C>A (p.Pro129Thr) polymorphism of the fatty acid amide hydrolase gene with anorexia nervosa in the Japanese population (full–2014) http://onlinelibrary.wiley.com/doi/10.1002/mgg3.69/full
Dronabinol in severe, enduring anorexia nervosa: A randomized controlled trial (full–2014) http://onlinelibrary.wiley.com/doi/10.1002/eat.22173/full
Effect of dronabinol therapy on physical activity in anorexia nervosa: a randomised, controlled trial (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24890912
The endocannabinoid system and appetite: relevance for food reward (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24933167
Deranged endocannabinoid responses to hedonic eating in underweight and recently weight-restored patients with anorexia nervosa (full–2015) http://ajcn.nutrition.org/content/101/2/262.long
ENP11, a potential CB1R antagonist, induces anorexia in rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26072692
Changes in IGF-I, urinary free cortisol and adipokines during dronabinol therapy in anorexia nervosa: Results from a randomised, controlled trial (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26248813
Endocannabinoids and Metabolic Disorders (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26408168
Association between cerebral cannabinoid 1 receptor availability and body mass index in patients with food intake disorders and healthy subjects: a [(18)F]MK-9470 PET study (full–2016) http://www.nature.com/tp/journal/v6/n7/full/tp2016118a.html
Cannabinoid hyperemesis syndrome masquerading as an eating disorder (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26842268
Association between plasma endocannabinoids and appetite in hemodialysis patients: A pilot study (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27333956
Role of cannabis in digestive disorders (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27792038


ANTI-BACTERIAL PROPERTIES
Antibacterial analysis of crude extracts from the leaves of Tagetes erecta and Cannabis sativa (full–2010) http://www.ipublishing.co.in/ijesarticles/twelve/articles/voltwo/EIJES3150.pdf
Microbial metabolism of cannflavin A and B isolated from Cannabis sativa (abst–2010) http://www.sciencedirect.com/science/article/pii/S0031942210000555
Screening for Antiviral Activities of Isolated Compounds from Essential Oils (full-2011) http://www.hindawi.com/journals/ecam/2011/253643/
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165946/
Effect of extraction conditions on total polyphenol contents, antioxidant and antimicrobial activities of Cannabis sativa L (abst–2012) http://www.cabdirect.org/abstracts/20123212113.html;jsessionid=DDBC2FF41C8322957AD4B468D3785A59?gitCommit=4.13.20-5-ga6ad01a
2-Arachidonoyl-glycerol- and arachidonic acid-stimulated neutrophils release antimicrobial effectors against E. coli, S. aureus, HSV-1, and RSV (full–2013) http://www.jleukbio.org/content/93/2/267.long
top
Palmitoylethanolamide stimulates phagocytosis of Escherichia coli K1 by macrophages and increases the resistance of mice against infections (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4080545/
Effect of the synthetic cannabinoid HU-210 on quorum sensing and on the production of quorum sensing-mediated virulence factors by Vibrio harveyi (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4531395/
Δ9 Tetrahydrocannabinol attenuates Staphylococcal enterotoxin B-induced inflammatory lung injury and prevents mortality in mice by modulation of miR-17-92 cluster and induction of T-regulatory cells (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25425209
The herbal-derived honokiol and magnolol enhances immune response to infection with methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant S. aureus (MRSA) (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25586586
Magnolol inhibits the inflammatory response in mouse mammary epithelial cells and a mouse mastitis model (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25173887
Screening of cannabinoids in industrial-grade hemp using two-dimensional liquid chromatography coupled with acidic potassium permanganate chemiluminescence detection (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25845561
Reducing exposure to pathogens in the horse; A preliminary study into the survival of bacteria on a range of equine bedding types (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27659898
In vitro Antimicrobial and Antioxidant Activity of Extracts from Six Chemotypes of Medicinal Cannabis (abst–2016) https://www.thieme-connect.com/DOI/DOI?10.1055/s-0036-1596302


ANTI-FUNGAL PROPERTIES
Antimicrobial Activity of Cannabis sativa L. (full – 2012) http://file.scirp.org/Html/10-8801078_18123.htm
In vitro binding affinity to human CB1 and CB2 receptors and antimicrobial activity of volatile oil from high potency Cannabis sativa (abst – 2014) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0034-1382491
Synergistic activity of magnolol with azoles and its possible antifungal mechanism against Candida albicans (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25641229
In vitro binding affinity to human CB1 and CB2 receptors and antimicrobial activity of volatile oil from high potency Cannabis sativa (abst–2014) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0034-1382491
In vitro Antimicrobial and Antioxidant Activity of Extracts from Six Chemotypes of Medicinal Cannabis (abst–2016) https://www.thieme-connect.com/DOI/DOI?10.1055/s-0036-1596302


ANTIOXIDANT PROPERTIES
Effect of (-)-Delta(9)-tetrahydrocannabinoid on the hepatic redox state of mice (full–2010) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2010007500015&lng=en&nrm=iso&tlng=en
Acute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusion (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2936031/?tool=pubmed
Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and cell death (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3081988/
Cannabidiol reduces lipopolysaccharide-induced vascular changes and inflammation in the mouse brain: an intravital microscopy study (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3034694/?tool=pmcentrez
Effect of cannabidiol treatment in alimentary induced fatty liver (abst–2011) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0031-1278456
Antioxidant Activities and Oxidative Stabilities of Some Unconventional Oilseeds (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3311859/?tool=pubmed
Review article: The endocannabinoid system in normal and pathological brain ageing (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3326.full?sid=161e7b36-5055-448b-962e-697c782e901d
Δ(8)-Tetrahydrocannabivarin prevents hepatic ischaemia/reperfusion injury by decreasing oxidative stress and inflammatory responses through cannabinoid CB(2) receptors (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423240/
Cannabidiol affects the expression of genes involved in zinc homeostasis in BV-2 microglial cells (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22178458
Cannabidiol treatment ameliorates ischemia/reperfusion renal injury in rats (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22877651
Effect of extraction conditions on total polyphenol contents, antioxidant and antimicrobial activities of Cannabis sativa L (abst–2012) http://www.cabdirect.org/abstracts/20123212113.html;jsessionid=DDBC2FF41C8322957AD4B468D3785A59?gitCommit=4.13.20-5-ga6ad01a
top
The isolation and identification of two compounds with predominant radical scavenging activity in hempseed (seed of Cannabis sativa L.) (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23107724
Neuroprotective effects of Cannabis sativa leaves extracts on α-Motoneurons density after sciatic nerve injury in rats (full–2013) http://www.lifesciencesite.com/lsj/life1005s/113_15973life1005s_644_648.pdf
Understanding the Molecular Aspects of Tetrahydrocannabinol and Cannabidiol as Antioxidants (link to PDF-2013) http://www.mdpi.com/1420-3049/18/10/12663
Anandamide Protects HT22 Cells Exposed to Hydrogen Peroxide by Inhibiting CB1 Receptor-Mediated Type 2 NADPH Oxidase (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4127243/
Cannabidiol protects liver from binge alcohol-induced steatosis by mechanisms including inhibition of oxidative stress and increase in autophagy (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24398069
Diacylglycerol lipase regulates lifespan and oxidative stress response by inversely modulating TOR signaling in Drosophila and C. elegans (full–2014) http://www.ncbi.nlm.nih.gov/pubmed/?term=24889782
Neuroprotective Properties of Cannabigerol in Huntington’s Disease: Studies in R6/2 Mice and 3-Nitropropionate-lesioned Mice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25252936
Increased oxidative stress enhances endocannabinoid tone (abst–2014) http://www.fasebj.org/content/28/1_Supplement/671.13.abstract?sid=db987fd0-3ef0-4796-aff6-4103f0c84daf
Endocannabinoid degradation inhibition improves neurobehavioral function, blood brain barrier integrity, and neuroinflammation following mild traumatic brain injury (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25166905
Oxidative stress and cannabinoid receptor expression in type-2 diabetic rat pancreas following treatment with Δ9 -THC (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25187240
N-Palmitoyl serotonin alleviates scopolamine-induced memory impairment via regulation of cholinergic and antioxidant systems, and expression of BDNF and p-CREB in mice (abst–2015) http://www.sciencedirect.com/science/article/pii/S0009279715300697
Characterization of Lignanamides from Hemp (Cannabis sativa L.) Seed and their Antioxidant and Acetylcholinesterase Inhibitory Activities (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26585089
THC exerts neuroprotective effect in glutamate affected murine primary mesencephalic cultures and neuroblastoma N18TG2 cells (abst–2015) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0035-1565754
Effect of Cannabis sativa extract on gastric acid secretion, oxidative stress and gastric mucosal integrity in rats (abst–2015) http://link.springer.com/article/10.1007/s00580-015-2090-3
top
Correlations between the Memory-Related Behavior and the Level of Oxidative Stress Biomarkers in the Mice Brain, Provoked by an Acute Administration of CB Receptor Ligands (full–2016) http://www.hindawi.com/journals/np/2016/9815092/
Gastric acid inhibitory and gastric protective effects of Cannabis and cannabinoids (full–2016) http://www.sciencedirect.com/science/article/pii/S1995764516300712 CB2 Cannabinoid Receptor As Potential Target against Alzheimer’s Disease (full–2016) http://journal.frontiersin.org/article/10.3389/fnins.2016.00243/full#B36
URB597 inhibits oxidative stress induced by alcohol binging in the prefrontal cortex of adolescent rats (full–2016) http://www.sciencedirect.com/science/article/pii/S0304394016302907
Delta-9-tetrahydrocannabinol protects against MPP+ toxicity in SH-SY5Y cells by restoring proteins involved in mitochondrial biogenesis (full–2016) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path %5B%5D=10314&path%5B%5D=32486
Cannabidiol Prevents Motor and Cognitive Impairments Induced by Reserpine in Rats (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00343/full
Cannabinoid Type 2 (CB2) Receptors Activation Protects against Oxidative Stress and Neuroinflammation Associated Dopaminergic Neurodegeneration in Rotenone Model of Parkinson’s Disease (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969295/ Cannabidiol attenuates OGD/R-induced damage by enhancing mitochondrial bioenergetics and modulating glucose metabolism via pentose-phosphate pathway in hippocampal neurons (full–2016) http://www.sciencedirect.com/science/article/pii/S221323171630338X Cannabidiol Post-Treatment Alleviates Rat Epileptic-Related Behaviors and Activates Hippocampal Cell Autophagy Pathway Along with Antioxidant Defense in Chronic Phase of Pilocarpine-Induced Seizure (abst–2016) http://link.springer.com/article/10.1007/s12031-015-0703-6
β-Caryophyllene, a natural sesquiterpene lactone attenuates hyperglycemia mediated oxidative and inflammatory stress in experimental diabetic rats (abst–2016) http://www.sciencedirect.com/science/article/pii/S000927971530154X
Mn-SOD Upregulation by Electroacupuncture Attenuates Ischemic Oxidative Damage via CB1R-Mediated STAT3 Phosphorylation (abst–2016) http://link.springer.com/article/10.1007/s12035-014-8971-7
Crosstalk between liver antioxidant and the endocannabinoid systems after chronic administration of the FAAH inhibitor, URB597, to hypertensive rats (abst–2016) http://www.sciencedirect.com/science/article/pii/S0041008X1630076X
Anti-inflammatory and antioxidant effects of a combination of cannabidiol and moringin in LPS-stimulated macrophages (abst–2016) http://www.sciencedirect.com/science/article/pii/S0367326X16301150
The role of perivascular adipose tissue in obesity-induced vascular dysfunction (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27761903
Oxyradical Stress Increases the Biosynthesis of 2-Arachidonoylglycerol: Involvement of NADPH Oxidase (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27784678
In vitro Antimicrobial and Antioxidant Activity of Extracts from Six Chemotypes of Medicinal Cannabis (abst–2016) https://www.thieme-connect.com/DOI/DOI?10.1055/s-0036-1596302
URB597 and the Cannabinoid WIN55,212-2 Reduce Behavioral and Neurochemical Deficits Induced by MPTP in Mice: Possible Role of Redox Modulation and NMDA Receptors (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28092019
Beta-caryophyllene protects against alcoholic steatohepatitis by attenuating inflammation and metabolic dysregulation in mice (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28107775


ANTI-PARASITIC PROPERTIES
High prevalence of cannabis use among Aka foragers of the Congo Basin and its possible relationship to helminthiasis (full–2015) http://onlinelibrary.wiley.com/doi/10.1002/ajhb.22740/full
top


ANTI-PROTOZOAL PROPERTIES
Endocannabinoids Inhibit the Growth of Free-Living Amoebae (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2897284/?tool=pubmed
Microbial metabolism of cannflavin A and B isolated from Cannabis sativa (abst–2010) http://www.sciencedirect.com/science/article/pii/S0031942210000555
Trypanocidal Effect of Cannabis sativa on Experimental Camel Trypansomosis (full–2012) http://scialert.net/fulltext/?doi=rjmp.2012.281.285&org=10
Trans-sialidase Stimulates Eat Me Response from Epithelial Cells # (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/tra.12078/full


ANXIETY/ANXIOLYTIC EFFECTS
Cannabis Overdose (case report – undated) http://cannabisclinicians.org/view-all-case-reports/entry/96/?pagenum=3 Mixed mood disorder (case report – undated) http://cannabisclinicians.org/view-all-case-reports/entry/228/?pagenum=2
The use of Cannnabidiol (CBD) and Meditation to reduce Binge Drinking, Anxiety and to improve Emotional Regulation in Long Term Behavior Therapy (case report – undated) http://cannabisclinicians.org/view-all-case-reports/entry/437/?pagenum=2
Anxiety Associated with Dying (case report – undated) http://cannabisclinicians.org/view-all-case-reports/entry/666/
Preservation of Striatal Cannabinoid CB1 Receptor Function Correlates with the Anti-anxiety Effects of Fatty Acid Amide Hydrolase Inhibition (full–2010) http://molpharm.aspetjournals.org/content/78/2/260.long
Pharmacological exploitation of the endocannabinoid system: new perspectives for the treatment of depression and anxiety disorders? (full–2010) http://www.scielo.br/pdf/rbp/v32s1/en_a04v32s1.pdf
A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice (full–2010) http://ijnp.oxfordjournals.org/content/13/7/861.long
Brain CB2 Receptors: Implications for Neuropsychiatric Disorders (link to PDF–2010) http://www.mdpi.com/1424-8247/3/8/2517
Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report (abst-2010) http://www.ncbi.nlm.nih.gov/pubmed/20829306
Cannabinoids and anxiety (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/21309120
Cannabinoids increase conditioned ultrasonic vocalisations and cat odour avoidance in rats: strain differences in drug-induced anxiety (abst–2010)
http://www.ncbi.nlm.nih.gov/pubmed/20875432
top
Intra-dorsal periaqueductal gray administration of cannabidiol blocks panic-like response by activating 5-HT1A receptors (abst–2010) http://www.unboundmedicine.com/medline/ebm/record/20457188/abstract/Intra_dorsal_periaqueductal_gray_administration_of_cannabidiol_blocks_panic_like_response_by_activating_5_HT1A_receptors_
Panic Attack after Spice Abuse in a Patient with ADHD (abst–2010) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0029-1243252
Cannabinoids prevent the development of behavioral and endocrine alterations in a rat model of intense stress (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242307/
Effects of intracisternal administration of cannabidiol on the cardiovascular and behavioral responses to acute restraint stress (full–2011) http://www.sciencedirect.com/science/article/pii/S0091305711002310
Anti-Aversive Effects of Cannabidiol on Innate Fear-Induced Behaviors Evoked by an Ethological Model of Panic Attacks Based on a Prey vs the Wild Snake Epicrates cenchria crassus Confrontation Paradigm (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242302/
Is lipid signaling through cannabinoid 2 receptors part of a protective system? (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062638/
Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3034086/pdf/nihms262924.pdf
Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3079847/
Cannabinoids and emotionality: a neuroanatomical perspective (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21827834
Effect of cannabidiol on sleep disruption induced by the repeated combination tests consisting of open field and elevated plus-maze in rats (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21867717
Anxiolytic-like effect induced by the cannabinoid CB1 receptor agonist, arachydonilcyclopropylamide (ACPA), in the rat amygdala is mediated through the D1 and D2 dopaminergic systems (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/20685770
Behavioral alterations in cystic fibrosis mice are prevented by cannabinoid treatment in infancy (abst–2011) http://www.degruyter.com/abstract/j/jbcpp.2011.22.issue-1-2/jbcpp.2011.005/jbcpp.2011.005.xml?rskey=wRYgJd&result=2&q=cannabinoid
A role for the ventral hippocampal endocannabinoid system in fear-conditioned analgesia and fear responding in the presence of nociceptive tone in rats (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21864979
top
Personalized medicine can pave the way for the safe use of CB₁ receptor antagonists (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21497918
A polymorphism in the gene of the endocannabinoid-degrading enzyme FAAH (FAAH C385A) is associated with emotional–motivational reactivity (full–2012) http://link.springer.com/article/10.1007/s00213-012-2785-y/fulltext.html
Differences in Spontaneously Avoiding or Approaching Mice Reflect Differences in CB1-Mediated Signaling of Dorsal Striatal Transmission (full–2012) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0033260
Cannabidiol, a Cannabis sativa constituent, as an anxiolytic drug (full–2012) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462012000500008&lng=en&nrm=iso&tlng=en
The endocannabinoid system in the rat dorsolateral periaqueductal grey mediates fear-conditioned analgesia and controls fear expression in the presence of nociceptive tone (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423235/
Interleukin-1β causes anxiety by interacting with the endocannabinoid system (full–2012) http://www.jneurosci.org/content/32/40/13896.long
Cannabinoid-related Agents in the Treatment of Anxiety Disorders: Current Knowledge and Future Perspectives (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691841/
Distinct neurobehavioural effects of cannabidiol in transmembrane domain neuregulin 1 mutant mice (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3317922/
Acute Stress Increases Circulating Anandamide and Other N-Acylethanolamines in Healthy Humans (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442338/
Cannabidiol in humans-the quest for therapeutic targets (full–2012) http://www.ncbi.nlm.nih.gov/pubmed/24281562
Comparative Study of Sedation, Pre-Anesthetic and Anti-Anxiety Effects of Hemp Seed Extract and Diazepam in Rats (full–2012) http://docsdrive.com/pdfs/medwelljournals/javaa/2012/2148-2151.pdf
Opposing Roles for Cannabinoid Receptor Type-1 (CB(1)) and Transient Receptor Potential Vanilloid Type-1 Channel (TRPV1) on the Modulation of Panic-Like Responses in Rats (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242309/
Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3481531/
Biphasic Effects of Cannabinoids in Anxiety Responses: CB1 and GABA(B) Receptors in the Balance of GABAergic and Glutamatergic Neurotransmission (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3473327/
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3353.full?sid=1569c370-cd5c-4358-89ff-857201f5e069
top
Nicotine-induced anxiety-like behavior in a rat model of the novelty-seeking phenotype is associated with long-lasting neuropeptidergic and neuroplastic adaptations in the amygdala: Effects of the cannabinoid receptor 1 antagonist AM251 (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3697052/
Bimodal Control of Fear-Coping Strategies by CB1 Cannabinoid Receptors (full–2012) http://www.jneurosci.org/content/32/21/7109.long
Failure to extinguish fear and genetic variability in the human cannabinoid receptor 1 (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3565211/
Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid? (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579248/
Cannabidiol exhibits anxiolytic but not antipsychotic property evaluated in the social interaction test (full–2012) http://www.sciencedirect.com/science/article/pii/S0278584612002801
Bidirectional regulation of endocannabinoid signaling in the amygdala contributes to activation and adaptation of the stress response (full–2012) http://www.ejpt.net/index.php/ejpt/article/view/19555/pdf_1
The biochemical complexity of the endocannabinoid system with some remarks on stress and related disorders: a minireview (link to PDF–2012) http://www.elis.sk/index.php?page=shop.product_details&flypage=flypage.tpl&product_id=2854&category_id=93&keyword=cannabinoid&option=com_virtuemart&Itemid=1
Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23042808
Fear relief-toward a new conceptual frame work and what endocannabinoids gotta do with it (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22173015
Antipsychotic Profile of Cannabidiol and Rimonabant in an Animal Model of Emotional Context Processing in Schizophrenia (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22716146
Cannabinoid CB1 receptor deficiency increases contextual fear memory under highly aversive conditions and long-term potentiation in vivo (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22579951
Expression pattern of the cannabinoid receptor genes in the frontal cortex of mood disorder patients and mice selectively bred for high and low fear (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22534181
Age-related changes of anandamide metabolism in CB1 cannabinoid receptor knockout mice: correlation with behaviour (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/11982628
top
Prevalence of Cannabis Use Disorder Diagnoses Among Veterans in 2002, 2008, and 2009 (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22564034
Cannabidiol blocks long-lasting behavioral consequences of predator threat stress: Possible involvement of 5HT1A receptors (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22979992
Cannabinoid CB(1) receptor in the modulation of stress coping behaviour in mice: the role of serotonin and different forebrain neuronal subpopulations (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23000076
Opposing local effects of endocannabinoids on the activity of noradrenergic neurons and release of noradrenaline: relevance for their role in depression and in the actions of CB(1) receptor antagonists (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22990678
Involvement of serotonin-mediated neurotransmission in the dorsal periaqueductal gray matter on cannabidiol chronic effects in panic-like responses in rats (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23007604
Cannabis Use Vulnerability Among Socially Anxious Users: Cannabis Craving During a Social Interaction (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23002698
CB1 receptor activation in the nucleus accumbens core impairs contextual fear learning (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23018128
Cannabinoid Modulation of Midbrain Urocortin 1 Neurones During Acute and Chronic Stress (abst–2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2826.2012.02355.x/abstract
Cannabinoid type 1 receptor ligands WIN 55,212-2 and AM 251 alter anxiety-like behaviors of marmoset monkeys in an open-field test (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23183218
Anandamide and 2-arachidonoylglycerol: Pharmacological Properties, Functional, Features, and Emerging Specificities of the Two Major Endocannabinoids (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22801993
Inhibition of fatty acid amide hydrolase by URB597 attenuates the anxiolytic-like effect of acetaminophen in the mouse elevated plus-maze test (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22750843
Cannabinoid type 1 receptors and transient receptor potential vanilloid type 1 channels in fear and anxiety-two sides of one coin? (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/21906661
Effect of dietary fat type on anxiety-like and depression-like behavior in mice (full–2013) http://www.springerplus.com/content/2/1/165
Endocannabinoid system and mood disorders: Priming a target for new therapies (full–2013) http://www.sciencedirect.com/science/article/pii/S0278584612002801
top
Translational evidence for the involvement of the endocannabinoid system in stress related psychiatric illnesses (full–2013) http://www.biolmoodanxietydisord.com/content/3/1/19
Rimonabant effects on anxiety induced by simulated public speaking in healthy humans: a preliminary report (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4539121/
Working memory- and anxiety-related behavioral effects of repeated nicotine as a stressor: the role of cannabinoid receptors (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599339/
Voluntary Running in Young Adult Mice Reduces Anxiety-Like Behavior and Increases the Accumulation of Bioactive Lipids in the Cerebral Cortex (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0081459
Cannabinoid facilitation of fear extinction memory recall in humans (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3445738/
Activation of the sympathetic nervous system mediates hypophagic and anxiety-like effects of CB1 receptor blockade (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3607008/
Cannabinoids, Neurogenesis and Antidepressant Drugs: Is there a Link? (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3648779/
Does Cannabidiol Protect Against Adverse Psychological Effects of THC? (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797438/
Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3788575/
Dissociation of the Pharmacological Effects of THC by mTOR Blockade (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3656376/
The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system (full–2013) http://ijnp.oxfordjournals.org/content/16/6/1407.long
The endocannabinoid system as a possible target to treat both the cognitive and emotional features of post-traumatic stress disorder (PTSD) (full-2013) http://journal.frontiersin.org/Journal/10.3389/fnbeh.2013.00100/full#B12
Involvement of prelimbic medial prefrontal cortex in panic-like elaborated defensive behaviour and innate fear-induced antinociception elicited by GABAA receptor blockade in the dorsomedial and ventromedial hypothalamic nuclei: role of the endocannabinoid CB1 receptor (full–2013) http://ijnp.oxfordjournals.org/content/16/8/1781.long
top
The effects of anandamide signaling enhanced by the FAAH inhibitor URB597 on coping styles in rats (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3830591/
Rimonabant precipitates anxiety in rats withdrawn from palatable food: role of the central amygdale (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3799070/
Similar anxiolytic effects of agonists targeting serotonin 5-HT1A or cannabinoid CB receptors on zebrafish behavior in novel environments (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3989442/
CB1 receptor signaling regulates social anxiety and memory (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/gbb.12045/full
Predator threat stress promotes long lasting anxiety-like behaviors and modulates synaptophysin and CB1 receptors expression in brain areas associated with PTSD symptoms (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23178193
Cannabidiol enhances consolidation of explicit fear extinction in humans (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23307069
Monoacylglycerol lipase inhibition-induced changes in plasma corticosterone levels, anxiety and locomotor activity in male CD1 mice (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23578952
Neonatal lipopolysaccharide treatment has long term effects on monoaminergic and cannabinoid receptors in the rat (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23389966
Chronic cannabinoid exposure reduces phencyclidine-induced schizophrenia-like positive symptoms in adult rats (abst–2013) http://link.springer.com/article/10.1007/s00213-012-2839-1
Effect of chronic exposure to rimonabant and phytocannabinoids on anxiety-like behaviorand saccharin palatability (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23103902
Role of TRPV1 receptors on panic-like behaviors mediated by the dorsolateral peri-aqueductal gray in rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23474373
Entopeduncular nucleus endocannabinoid system modulates sleep-waking cycle and mood in rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23584096
Neonatal lipopolysaccharide treatment has long-term effects on monoaminergic and cannabinoid receptors in the rat (abst–2013) http://onlinelibrary.wiley.com/doi/10.1002/syn.21640/abstract
Cannabidiol attenuates the long lasting cognitive deficits and anxiogenic-like behaviors promoted by murine cerebral malaria (abst–2013) http://www.fasebj.org/cgi/content/meeting_abstract/27/1_MeetingAbstracts/1097.9?sid=eea722c0-971c-4daa-8b8c-38c0c63c19ad
top
Effects of compounds that interfere with the endocannabinoid system on behaviors predictive of anxiolytic and panicolytic activity in the elevated T-maze (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23711591
Modulation of anxiety-like behaviour by the endocannabinoid 2-arachidonoylglycerol (2-AG) in the dorsolateral periaqueductal gray (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23714073
Effects of palmitoylethanolamide and luteolin in an animal model of anxiety/depression (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23844686
Complex interaction between anandamide and the nitrergic system in the dorsolateral periaqueductal gray to modulate anxiety-like behavior in rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23899460
Continuous central infusion of cannabinoid receptor agonist WIN 55,212-2 decreases maternal care in lactating rats: Consequences for fear conditioning in adulthood males (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24060654
The role of 5-HT1A receptors in the anti-aversive effects of cannabidiol on panic attack-like behaviors evoked in the presence of the wild snake Epicrates cenchria crassus (Reptilia, Boidae) (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23926240
Effects of intra-prelimbic prefrontal cortex injection of cannabidiol on anxiety-like behavior: Involvement of 5HT1A receptors and previous stressful experience (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24321837
The endocannabinoid system and its possible role in neurobiology of psychiatric disorders (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24326750
Cannabis use motives and personality risk factors (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24368004
The endocannabinoid system: An emotional buffer in the modulation of memory function (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24382324
Cannabis use in a Swiss male prison: Qualitative study exploring detainees’ and staffs’ perspectives (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23773686
Therapeutic benefits of cannabis: a patient survey (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998228/
Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/epi.12631/full
Central anandamide deficiency predicts stress-induced anxiety: behavioral reversal through endocannabinoid augmentation (full–2014) http://www.nature.com/tp/journal/v4/n7/full/tp201453a.html
How Cannabis Causes Paranoia: Using the Intravenous Administration of ∆9-Tetrahydrocannabinol (THC) to Identify Key Cognitive Mechanisms Leading to Paranoia (full–2014) http://schizophreniabulletin.oxfordjournals.org/content/early/2014/07/01/schbul.sbu098.long
top
Genetic Disruption of 2-Arachidonoylglycerol Synthesis Reveals a Key Role for Endocannabinoid Signaling in Anxiety Modulation (full–2014) http://www.cell.com/cell-reports/abstract/S2211-1247%2814%2900955-3?_returnURL=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS2211124714009553%3Fshowall%3Dtrue
Cannabis use and anxiety: is stress the missing piece of the puzzle? (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4241884/
Cannabinoid modulation of predator fear: involvement of the dorsolateral periaqueductal gray (full–2014) http://ijnp.oxfordjournals.org/content/17/8/1193.long
Impaired Fear Memory Specificity Associated with Deficient EndocannabinoidDependent Long-Term Plasticity (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4023141/
Modulation of Fear Memory by Dietary Polyunsaturated Fatty Acids via Cannabinoid Receptors (full–2014) http://www.nature.com/npp/journal/v39/n8/pdf/npp201432a.pdf
Therapeutic Potential of Inhibitors of Endocannabinoid Degradation for the Treatment of Stress-Related Hyperalgesia in an Animal Model of Chronic Pain (full–2014) http://www.nature.com/npp/journal/v40/n2/full/npp2014198a.html
Differential Expression of Brain Cannabinoid Receptors between Repeatedly Stressed Males and Females may Play a Role in Age and Gender-Related Difference in Traumatic Brain Injury: Implications from Animal Studies (full–2014) http://journal.frontiersin.org/article/10.3389/fneur.2014.00161/full
Interaction between Antagonist of Cannabinoid Receptor and Antagonist of Adrenergic Receptor on Anxiety in Male Rat (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4202541/
Translational evidence for a role of endocannabinoids in the etiology and treatment of posttraumatic stress disorder (full–2014) http://www.psyneuen-journal.com/article/S0306-4530%2814%2900396-5/fulltext
Cannabinoid Modulation of Amygdala Subregion Functional Connectivity to Social Signals of Threat (full-2014) http://ijnp.oxfordjournals.org/content/18/3/pyu104.long
Stress regulates endocannabinoid-CB1 receptor signaling (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4247817/
Drug discovery strategies that focus on the endocannabinoid signaling system in psychiatric disease (full-2014) http://ww.ncbi.nlm.nih.gov/pmc/articles/PMC4696509/
top
β-Caryophyllene, a CB2 Receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24930711
Inhibition of FAAH enzyme by pterostilbene: potential mechanism of anxiolytic action (abst–2014) http://www.fasebj.org/content/28/1_Supplement/1144.10.abstract?sid=db987fd0-3ef0-4796-aff6-4103f0c84daf
Inhibition of endocannabinoid neuronal uptake and hydrolysis as strategies for developing anxiolytic drugs (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25083569
Anti-aversive role of the endocannabinoid system in the periaqueductal gray stimulation model of panic attacks in rats (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25388290
Anxiogenic-like effects induced by hemopressin in rats (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25462856
Endocannabinoids and their oxygenation by cyclo-oxygenases, lipoxygenases and other oxygenases (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25543004
Substrate-selective COX-2 inhibition as a novel strategy for therapeutic endocannabinoid augmentation (abst–2014) http://www.cell.com/trends/pharmacological-sciences/abstract/S0165-6147%2814%2900068-6
INVESTIGATING SEDATIVE, PREANAESTHETIC & ANTI-ANXIETY EFFECTS OF HERBAL EXTRACT OF CANNABIS SATIVA IN COMPARISON WITH DIAZEPAM IN RATS (abst–2014) http://en.journals.sid.ir/ViewPaper.aspx?ID=354909
Blockade of 2-arachidonoylglycerol hydrolysis produces antidepressant-like effects and enhances adult hippocampal neurogenesis and synaptic plasticity (full–2015) http://onlinelibrary.wiley.com/doi/10.1002/hipo.22344/full
Increased contextual fear conditioning in iNOS knockout mice: additional evidence for the involvement of nitric oxide in stress-related disorders and contribution of the endocannabinoid system (full–2015) http://ijnp.oxfordjournals.org/content/18/8/pyv005.long
Defects in fatty acid amide hydrolase 2 in a male with neurologic and psychiatric symptoms (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423390/
Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs Through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors (full–2015) http://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.1002194
FAAH genetic variation enhances fronto-amygdala function in mouse and human (full–2015) http://www.nature.com/articles/ncomms7395.epdf?referrer_access_token=PXVrIqmHqcIK8Z6Pdh7gAdRgN0jAjWel9jnR3ZoTv0MFY2u7ZdbRZ8yhzdTOJfaQ9HKMjv_5rGSvPOZGVRItjvxxd3D6Fuj0xbHtGY8oldf7UYS6IrqEzfzB5TJv1Bb-kK5Iw6INd3-c65PpoQpwrtoKFklbGttma8f-Gc9DPI52xj63m2TF7oWmQCbmZBEe79CrwoD9ICraVhXE9mTvCGGdvxQFz8rPtg3fonyQYDECUQWrPFJNuaWEpYy1xb&tracking_referrer=blogs.scientificamerican.com
top
Impaired 2-AG signaling in hippocampal glutamatergic neurons: aggravation of anxiety like behavior and unaltered seizure susceptibility (full–2015) http://ijnp.oxfordjournals.org/content/ijnp/early/2015/07/29/ijnp.pyv091.full.pdf
Cannabis and Cannabinoids–for health professionals (PDQ®) (full–2015) http://www.cancer.gov/about-cancer/treatment/cam/hp/cannabis-pdq#section/all
Cannabis and Cannabinoids (PDQ®): Patient Version (full–2015) http://www.ncbi.nlm.nih.gov/books/NBK65875/
Targeting the endocannabinoid system to treat anxiety-related disorders (full–2015) http://www.degruyter.com/view/j/jbcpp.ahead-of-print/jbcpp-2015-0058/jbcpp-2015-0058.xml
The effect of BLA GABA(A) receptors in anxiolytic-like effect and aversive memory deficit induced by ACPA (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669909/
Cardioprotective effects of fatty acid amide hydrolase inhibitor URB694, in a rodent model of trait anxiety (full–2015) http://www.nature.com/articles/srep18218
Chronic Adolescent Marijuana Use as a Risk Factor for Physical and Mental Health Problems in Young Adult Men (full–2015) http://www.ncbi.nlm.nih.gov/pubmed/26237286
Neural correlates of cannabidiol and Δ9-tetrahydrocannabinol interactions in mice: implications for medical cannabis (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/bph.13333/full
Potential Therapeutic Value of a Novel FAAH Inhibitor for the Treatment of Anxiety (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0137034
Fluoxetine Facilitates Fear Extinction through Amygdala Endocannabinoids (full–2015) http://www.nature.com/npp/journal/vaop/ncurrent/full/npp2015318a.html
Brain transcriptome profiles in mouse model simulating features of post-traumatic stress disorder (full–2015) http://molecularbrain.biomedcentral.com/articles/10.1186/s13041-015-0104-3
Corticotropin-Releasing Hormone Drives Anandamide Hydrolysis in the Amygdala to Promote Anxiety (full-2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4348185/
Cannabinoid type-1 receptor signaling in central serotonergic neurons regulates anxietylike behavior and sociability (full–2015) http://journal.frontiersin.org/article/10.3389/fnbeh.2015.00235/full
top
Developmental regulation of fear learning and anxiety behavior by endocannabinoids (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/gbb.12253/full
Cannabis use, depression and anxiety: A 3-year prospective population-based study (link to PDF–2015) http://www.jad-journal.com/article/S0165-0327%2815%2931030-2/abstract
Cannabinoid CB1 receptors in the dorsal hippocampus and prelimbic medial prefrontal cortex modulate anxiety-like behavior in rats: additional evidence (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25595265
Role of endocannabinoid signalling in the dorsolateral periaqueductal grey in the modulation of distinct panic-like responses (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25601395
Differential proteomic analysis of the anti-depressive effects of oleamide in a rat chronic mild stress model of depression (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25641667
Central administration of GPR55 receptor agonist and antagonist modulates anxiety related behaviors in rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25620584
Chronic Stress Induces Anxiety via an Amygdalar Intracellular Cascade that Impairs Endocannabinoid Signaling (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25754825
Cannabinoids & Stress: Impact of HU-210 on behavioral tests of anxiety in acutely stressed mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25707713
The potential of inhibitors of endocannabinoid metabolism as anxiolytic and anti-depressive drugs-A practical view (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25791296
Effects of intra-infralimbic prefrontal cortex injections of cannabidiol in the modulation of emotional behaviors in rats: Contribution of 5HT1A receptors and stressful experiences (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25701682
2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25814137
Dissociation between the panicolytic effect of cannabidiol microinjected into the substantia nigra, pars reticulata, and fear-induced antinociception elicited by bicuculline administration in deep layers of the superior colliculus: The role of CB1-endoccannabinoid receptor in the ventral mesencephalon (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25841876
CB1 receptors modulate affective behaviour induced by neuropathic pain (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25863168
top
Anxiety, Stress, and Fear Response in Mice with Reduced Endocannabinoid Levels (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25981172
Caffeine protects against memory loss induced by high and non-anxiolytic dose of cannabidiol in adult zebrafish (Danio rerio) (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26099242
Endocannabinoid signaling mechanisms in the substantia nigra pars reticulata modulate GABAergic nigrotectal pathways in mice threatened by urutu-cruzeiro venomous pit viper snake (abst–2015) http://www.sciencedirect.com/science/article/pii/S0306452215005898
The endocannabinoid, endovanilloid and nitrergic systems could interact in the rat dorsolateral periaqueductal gray matter to control anxiety-like behaviors (abst–2015) http://www.sciencedirect.com/science/article/pii/S0166432815300863
Use and effects of cannabinoids in military veterans with posttraumatic stress disorder (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26195653
Influence of single and repeated cannabidiol administration on emotional behavior and markers of cell proliferation and neurogenesis in non-stressed mice (abst–2015) http://www.sciencedirect.com/science/article/pii/S027858461530004X
The Anxiolytic Actions of 2-Arachidonoylglycerol: Converging Evidence from Two Recent Genetic Endocannabinoid Deficiency Models (abst–2015) http://www.biologicalpsychiatryjournal.com/article/S0006 -3223%2815%2900532-6/abstract
Genetic deletion of monoacylglycerol lipase (MAGL) leads to impaired cannabinoid receptor CB1 R signaling and anxiety-like behavior (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26223500
Cannabinoids for the Treatment of Agitation and Aggression in Alzheimer’s Disease (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26271310
Effects of CB1 receptor agonism and antagonism on behavioural fear and physiological stress responses in adult intact, ovariectomized, and estradiol-replaced female rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26311003
Endocannabinoid regulation of amyloid-induced neuroinflammation (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26362942
Endocannabinoid Modulation of Predator Stress-Induced Long-Term Anxiety in Rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26361059
Endocannabinoids and Mental Disorders (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26408164
A runner’s high depends on cannabinoid receptors in mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26438875
Neuromotor tolerability and behavioural characterisation of cannabidiolic acid, a phytocannabinoid with therapeutic potential for anticipatory nausea (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26439367
top
Mechanisms of stress in the brain (abst–2015) http://www.nature.com/neuro/journal/v18/n10/full/nn.4086.html
Chronic ethanol exposure increases voluntary home cage intake in adult male, but not female, Long-Evans rats (abst–2015) http://www.sciencedirect.com/science/article/pii/S0091305715300885
The basolateral amygdala γ-aminobutyric acidergic system in health and disease (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26586374
The endocannabinoid system in guarding against fear, anxiety and stress (abst–2015) http://www.nature.com/nrn/journal/v16/n12/full/nrn4036.html
Role of the endocannabinoid 2-arachidonoylglycerol in aversive responses mediated by the dorsolateral periaqueductal grey (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26628106
Social anxiety and cannabis cravings: The influences of parent injunctive norms and tension reduction expectancies (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26586926
Sex-dependence of anxiety-like behavior in cannabinoid receptor 1 (Cnr1) knockout mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26684509
Modulation of cannabinoid signaling by amygdala α2-adrenergic system in fear conditioning (abst–2015) http://www.sciencedirect.com/science/article/pii/S0166432815303259
Decreased anxiety in juvenile rats following exposure to low levels of chlorpyrifos during development (abst–2015) http://www.sciencedirect.com/science/article/pii/S0161813X15300322
Acute and Chronic Ethanol Exposure Differentially Regulate CB1 Receptor Function at Glutamatergic Synapses in the Rat Basolateral Amygdala (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26707595
Stress and memory: A selective review on recent developments in the understanding of stress hormone effects on memory and their clinical relevance (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26708929
The fatty acid amide hydrolase inhibitor URB597 modulates serotonin-dependent emotional behaviour, and serotonin1A and serotonin2A/C activity in the hippocampus (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26747370
The association between cannabis use and anxiety disorders: Results from a population based representative sample (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26775742
The association between cannabis use and anxiety disorders: Results from a population based representative sample (abst–2015) http://www.sciencedirect.com/science/article/pii/S0924977X15004204
Cannabidiol as a Potential Treatment for Anxiety Disorders (abst–2015) http://link.springer.com/article/10.1007/s13311-015-0387-1
top
Being the Victim of Violence during a Date predicts Next-Day Cannabis Use among Female College Students (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26449928
Mediating processes between stress and problematic marijuana use (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25661989
Runner’s high linked to cannabinoid receptors in mice (news & abstract–2015) http://medicalxpress.com/news/2015-10-runner-high-linked-cannabinoid-receptors.html
Cannabinoid Receptors May Control Aversive Memories (news & abstract-2015) http://neurosciencenews.com/habenula-cb1-receptors-memory-2742/
Exposure to a Highly Caloric Palatable Diet During Pregestational and Gestational Periods Affects Hypothalamic and Hippocampal Endocannabinoid Levels at Birth and Induces Adiposity and Anxiety -Like Behaviors in Male Rat Offspring (full–2016) http://journal.frontiersin.org/article/10.3389/fnbeh.2015.00339/full
Safety and Efficacy of Medical Cannabis Oil for Behavioral and Psychological Symptoms of Dementia: An-Open Label, Add-On, Pilot Study (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26757043
Chronic alcohol exposure disrupts CB1 regulation of GABAergic transmission in the rat basolateral amygdala (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26786379
Facilitatory effect of AM281 on recognition memory in rats (abst–2016) http://www.sciencedirect.com/science/article/pii/S1734114015003254
Interactions between anandamide & corticotropin-releasing hormone signaling modulate human amygdala function & risk for anxiety disorders: An imaging genetics strategy for modeling molecular interactions (abst–2016) http://www.sciencedirect.com/science/article/pii/S0006322315010860
Neuromotor tolerability and behavioural characterisation of cannabidiolic acid, a phytocannabinoid with therapeutic potential for anticipatory nausea (abst–2016) http://link.springer.com/article/10.1007/s00213-015-4100-1
CB2 Cannabinoid Receptor Knockout in Mice Impairs Contextual Long-Term Memory and Enhances Spatial Working Memory (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26819779
Sustained glucocorticoid exposure recruits cortico-limbic CRH signaling to modulate endocannabinoid function (abst–2016) http://www.psyneuen-journal.com/article/S0306-4530%2816%2930003-8/abstract
The effects anandamide signaling in the prelimbic cortex and basolateral amygdala on coping with environmental stimuli in rats (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26809457
top
Interplay between serotonin and cannabinoid function in the amygdala in fear conditioning (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26820636
A systematic review of plant-derived natural compounds for anxiety disorders (abst–2016) http://www.eurekaselect.com/139238/article Concentration, population, and context-dependent effects of AM251 in zebrafish (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26883874
Involvement of M1 and CB1 receptors in the anxiogenic-like effects induced by neostigmine injected into the rat prelimbic medial prefrontal cortex. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/26873081
Cannabidiol, neuroprotection and neuropsychiatric disorders (abst – 2016) http://www.sciencedirect.com/science/article/pii/S1043661816000396
Placebo effect: clinical, biological and therapeutical involvements in depression (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/26879253
Sex and age specific effects of delta-9-tetrahydrocannabinol during the periadolescent period in the rat: The unique susceptibility of the prepubescent animal (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26898326
Cannabis use and symptoms of anxiety in adolescence and the moderating effect of the serotonin transporter gene (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26860734
Genetically reduced FAAH activity may be a risk for the development of anxiety and depression in persons with repetitive childhood trauma (abst–2016) http://www.europeanneuropsychopharmacology.com/article/S0924-977X(16)00077-8/abstract
Interactions Between Anandamide and Corticotropin-Releasing Hormone Signaling Modulate Human Amygdala Function and Risk for Anxiety Disorders: An Imaging Genetics Strategy for Modeling Molecular Interactions (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26923505
Beyond the CB1 Receptor: Is Cannabidiol the Answer for Disorders of Motivation? (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27023732
CB1 cannabinoid receptor-mediated anandamide signalling reduces the defensive behaviour evoked through GABAA receptor blockade in the dorsomedial division of the ventromedial hypothalamus (abst–2016) http://www.sciencedirect.com/science/article/pii/S0028390816301393
Sustained glucocorticoid exposure recruits cortico-limbic
CRH signaling to modulate endocannabinoid function (abst–2016) http://www.psyneuen-journal.com/article/S0306-4530(16)30003-8/abstract
Pharmacological inhibition of FAAH activity in rodents: a promising pharmacological approach for psychological – cardiac comorbidity? (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763416300318
Evidences for the anti-panic actions of Cannabidiol (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27157263
Social Anxiety and Cannabis-Related Impairment: The Synergistic Influences of Peer and Parent Descriptive and Injunctive Normative Perceptions (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27144526
Sevoflurane Prevents Stroke-induced Depressive and Anxiety Behaviors by Promoting Cannabinoid Receptor Subtype I-dependent
Interaction Between β-Arrestin 2 and ERK1/2 in the Rat Hippocampus. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/26991409
Cannabinoid receptor agonism suppresses tremor, cognition disturbances and anxiety-like behaviors in a rat model of essential tremor (abst-2016) http://www.ncbi.nlm.nih.gov/pubmed/27317835
The association between cannabis use and anxiety disorders: Results from a populationbased representative sample (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26775742
New Zealand Health Survey 2012/13: characteristics of medicinal cannabis users (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27349158
Inhibitors of diacylglycerol lipases in neurodegenerative and metabolic disorders (abst–2016) http://www.sciencedirect.com/science/article/pii/S0960894X16306874
The endocannabinoid system and Post Traumatic Stress Disorder (PTSD): From preclinical findings to innovative therapeutic approaches in clinical settings. (abst – 2016) http://www.sciencedirect.com/science/article/pii/S104366181630706X
Deficient adolescent social behavior following early-life inflammation is ameliorated by augmentation of anandamide signaling (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27453335
Anxiety, depression and risk of cannabis use: Examining the internalising pathway to use among Chilean adolescents (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27427415
Magnitude and duration of cue-induced craving for marijuana in volunteers with cannabis use disorder (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27436749
Behavioral evidence for the interaction between cannabinoids and Catha edulis F. (Khat) in mice (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27502029
Acute Stress Suppresses Synaptic Inhibition and Increases Anxiety via Endocannabinoid Release in the Basolateral Amygdala (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27511017 Cannabinoids and post-traumatic stress disorder: clinical and preclinical evidence for treatment and prevention (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27551883
Emotional arousal state influences the ability of amygdalar endocannabinoid signaling to modulate anxiety (abst–2016) http://www.sciencedirect.com/science/article/pii/S0028390816303550
Contribution of health motive to cannabis use among high-school students (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27543835
Seeing through the smoke: human and animal studies of cannabis use and endocannabinoid signalling in corticolimbic networks (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763415303638
Cannabinoid CB1 receptors in distinct circuits of the extended amygdala determine fear responsiveness to unpredictable threat (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27698427
FAAH Gene Variation Moderates Stress Response and Symptom Severity in Patients with Posttraumatic Stress Disorder and Comorbid Alcohol Dependence (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27716956
Chronic stress leads to epigenetic dysregulation of neuropeptide-Y and cannabinoid CB1 receptor in the mouse cingulate cortex (abst–2016) http://www.sciencedirect.com/science/article/pii/S0028390816304580
Effects of alprazolam and cannabinoid-related compounds in an animal model of panic attack (abst–2016) http://www.sciencedirect.com/science/article/pii/S0166432816307999
CB1 cannabinoid receptor-mediated anandamide signalling reduces the defensive behaviour evoked through GABAA receptor blockade in the dorsomedial division of the ventromedial hypothalamus (abst–2016) http://www.sciencedirect.com/science/article/pii/S0028390816301393
Targeting the Endocannabinoid System in Psychiatric Illness (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27811555
Anxiety Sensitivity and Distress Intolerance as Predictors of Cannabis Dependence Symptoms, Problems, and Craving: The Mediating Role of Coping Motives. (abst – 2016) http://www.jsad.com/doi/10.15288/jsad.2016.77.889
Cannabidiol reduces neuroinflammation and promotes neuroplasticity and functional recovery after brain ischemia (abst–2016) http://www.sciencedirect.com/science/article/pii/S0278584616302524
Attitudes to cannabis and patterns of use among Canadians with multiple sclerosis (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27919478
Chapter Eight – The Endocannabinoid System and Anxiety (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28061971 Marijuana Could Help Treat Drug Addiction and Mental Health Problems (news & abst – 2016) http://neurosciencenews.com/addiction-mental-health-marijuana-5536/
Treating Depression in Alcoholics (news & abst–2016) http://neurosciencenews.com/alcoholism-depression-psychology-3541/
Acute and residual effects in adolescent rats resulting from exposure to the novel synthetic cannabinoids AB-PINACA and AB-FUBINACA (full – 2017) http://journals.sagepub.com/doi/abs/10.1177/0269881116684336?url_ver=Z39.88- 2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
Association of cannabis use with the development of elevated anxiety symptoms in the general population: a meta-analysis (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28053188
The involvement of cannabinoids and mTOR in the reconsolidation of an emotional memory in the hippocampal-amygdala-insular circuit (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28131675


APPETITE
The fat-induced satiety factor oleoylethanolamide suppresses feeding through central release of oxytocin (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2900249/?tool=pubmed
The multiple functions of the endocannabinoid system: a focus on the regulation of food intake (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2832623/?tool=pubmed
Expression of cannabinoid CB1 receptors by vagal afferent neurons: kinetics and role in influencing neurochemical phenotype (full–2010) http://ajpgi.physiology.org/content/299/1/G63.full?sid=fc6948f0-78cf-405c-981b-afaa05ee417c
CD36 gene deletion decreases oleoylethanolamide levels in small intestine of free-feeding mice (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2846762/?tool=pubmed
The Peptide Hemopressin Acts through CB1 Cannabinoid Receptors to Reduce Food Intake in Rats and Mice (full–2010) http://www.jneurosci.org/content/30/21/7369.full
Endocannabinoid control of gastric sensorimotor function in man (full-2010) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2036.2010.04259.x/full
Cannabidiol Attenuates the Appetitive Effects of Δ9-Tetrahydrocannabinol in Humans Smoking Their Chosen Cannabis (full-2010) http://www.nature.com/npp/journal/v35/n9/full/npp201058a.html
A novel peripherally restricted cannabinoid receptor antagonist, AM6545, reduces food intake and body weight, but does not cause malaise, in rodents (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2990160/
The novel cannabinoid CB1 antagonist AM6545 suppresses food intake and food reinforced behavior (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3522179/
Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2912197/
Oleamide administered into the nucleus accumbens shell regulates feeding behaviour via CB1 and 5-HT2C receptors (full–2010) http://ijnp.oxfordjournals.org/content/13/9/1247.long
Efficacy and tolerability of high-dose dronabinol maintenance in HIV-positive marijuana smokers: a controlled laboratory study (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3325767/
Modulation of sweet taste sensitivity by orexigenic and anorexigenic factors (full-2010) https://www.jstage.jst.go.jp/article/endocrj/57/6/57_K10E-095/_pdf
Deficiency of CB2 cannabinoid receptor in mice improves insulin sensitivity but increases food intake and obesity with age (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20936991
Cannabis constituents modulate δ9-tetrahydrocannabinol-induced hyperphagia in rats (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20349049
top
A nonsynonymous polymorphism in cannabinoid CB2 receptor gene is associated with eating disorders in humans and food intake is modified in mice by its ligands (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/19768813
Oleoylethanolamide affects food intake and sleep-waking cycle through a hypothalamic modulation (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20100574
PP-014 Control of receptor expression in vagal afferent neurons by activation of cannabinoid 1 receptors (abst-2010) http://gut.bmj.com/cgi/content/meeting_abstract/59/1_MeetingAbstracts/A45-a?sid=0731f0e5-2071-4549-be57-57f444307138
Bimodal control of stimulated food intake by the endocannabinoid system (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20139974
Anandamide and AM251, via water, modulate food intake at central and peripheral level in fish (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/19800340
Analysis of gene expression pattern reveals potential targets of dietary oleoylethanol-amide in reducing body fat gain in C3H mice (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/19954948
AM 251 differentially effects food-maintained responding depending on food palatability (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20331999
A low-Δ9tetrahydrocannabinol cannabis extract induces hyperphagia in rats (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20975531
The endocannabinoid system modulates the valence of the emotion associated to food ingestion (abst–2010) http://onlinelibrary.wiley.com/doi/10.1111/j.1369-1600.2010.00271.x/abstract
Cannabidiol inhibits the hyperphagia induced by cannabinoid-1 or serotonin-1A receptor agonists (full–2011) http://www.sciencedirect.com/science/article/pii/S0091305711000128
Association of genetic variation in cannabinoid mechanisms and gastric motor functions and satiation in overweight and obesity (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3117918/
The neutral cannabinoid CB₁ receptor antagonist AM4113 regulates body weight through changes in energy intake in the rat (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3023913/
Effect of rimonabant on oesophageal motor function in man (full–2011) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2036.2011.04576.x/full
Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial (full–2011) http://annonc.oxfordjournals.org/content/22/9/2086.long
Fish oil promotes survival and protects against cognitive decline in severely under-nourished mice by normalizing satiety signals (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3117120/
top
Gut fat sensing in the negative feedback control of energy balance – recent advances (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3139739/
The Endocannabinoid System as Pharmacological Target Derived from Its CNS Role in Energy Homeostasis and Reward. Applications in Eating Disorders and Addiction (link to PDF-2011) http://www.mdpi.com/1424-8247/4/8/1101
Cannabidiol decreases body weight gain in rats: Involvement of CB2 receptors (abst-2011) http://marijuana.researchtoday.net/archive/8/1/3517.htm
Cannabis sativa and the endogenous cannabinoid system: therapeutic potential for appetite regulation (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21213357
Cannabidiol potentiates Δ(9)-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21667074
Non-Δ9tetrahydrocannabinol phytocannabinoids stimulate feeding in rats (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22157176
Medical cannabis: the opportunity versus the temptation (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22352284
Increment of hypothalamic 2-arachidonoylglycerol induces the preference for a high-fat diet via activation of cannabinoid 1 receptors (abst–2011)
http://www.unboundmedicine.com/medline/ebm/record/20817042/abstract/Increment_of_hypothalamic_2_arachidonoylglycerol_induces_the_preference_for_a_high_fat_diet_via_activation_of_cannabinoid_1_receptors_
Cannabinoids in children (abst–2011) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=295
Plasticity in vagal afferent neurones during feeding and fasting: mechanisms and significance (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21062423
The role of central CB2 cannabinoid receptors on food intake in neonatal chicks (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21927979
Ghrelin-mediated appetite regulation in the central nervous system (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21524673
Homology modelling of CB1 receptor and selection of potential inhibitor against Obesity (full–2012) http://www.ncbi.nlm.nih.gov/pubmed/22829723?dopt=Abstract
Noladin ether, a putative endocannabinoid, enhances motivation to eat after acute systemic administration in rats (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3402806/
Hypothalamic 2-arachidonoylglycerol regulates multistage process of high-fat diet preferences (full–2012) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0038609
top
Cannabinoid facilitation of behavioral and biochemical hedonic taste responses (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705914/
Cannabinoids Facilitate the Swallowing Reflex Elicited by the Superior Laryngeal Nerve Stimulation in Rats (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3507745/
Hypothalamic CB1 Cannabinoid Receptors Regulate Energy Balance in Mice (full–2012) http://press.endocrine.org/doi/full/10.1210/en.2012-1405
G-Protein-Coupled Receptors in Intestinal Chemosensation (full–2012) http://www.sciencedirect.com/science/article/pii/S1550413112000198
Rimonabant eliminates responsiveness to workload changes in a time-constrained food reinforced progressive ratio procedure in rats (full–2012)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3387812/
2-Arachidonoylglycerol Signaling in Forebrain Regulates Systemic Energy Metabolism (full–2012) http://ac.els-cdn.com/S1550413112000526/1-s2.0-S1550413112000526-main.pdf?_tid=186a88ec-7369-11e3-8095-00000aab0f02&acdnat=1388638277_735058a6f79f41a9199132aed604fdab
The Therapeutic Potential of Cannabis and Cannabinoids (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442177/
Pharmacological modulation of the endocannabinoid signalling alters binge-type eating behaviour in female rats (full–2012) http://onlinelibrary.wiley.com/doi/10.1111/bph.12014/full
Cannabinoid Type 1 Receptor Gene Polymorphism and Macronutrient Intake (full–2012) http://www.karger.com/Article/FullText/343563
The thrifty lipids: endocannabinoids and the neural control of energy conservation (full–2012) http://www.ncbi.nlm.nih.gov/pubmed/22622030
Structural analogs of pyrazole and sulfonamide cannabinoids: Effects on acute food intake in mice (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3586205/
GPR119 as a fat sensor (full–2012) http://www.cell.com/trends/pharmacological-sciences/fulltext/S0165-6147%2812%2900054-5
Contrasting effects of different cannabinoid receptor ligands on mouse ingestive behavior (abst–2012) http://www.unboundmedicine.com/medline/ebm/record/22772336/abstract/Contrasting_effects_of_different_cannabinoid_receptor_ligands_on_mouse_ingestive_behaviour_
Effects of the anandamide uptake blocker AM404 on food intake depend on feeding status and route of administration (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22133635
Cannabinol and cannabidiol exert opposing effects on rat feeding patterns (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22543671
The potential use of cannabidiol in the therapy of metabolic syndrome (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22430005
top
Stimulation of acumbens shell cannabinoid CB(1) receptors by noladin ether, a putative endocannabinoid, modulates food intake and dietary selection in rats (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22728691
Photoperiodic Changes in Endocannabinoid Levels and Energetic Responses to Altered Signalling at CB1 Receptors in Siberian Hamsters (abst–2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2826.2012.02312.x/abstract
The role of the endocannabinoid system in eating disorders: pharmacological implications (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22785439
Modulation of sweet responses of taste receptor cells (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22947916
Non-Δ⁹tetrahydrocannabinol phytocannabinoids stimulate feeding in rats (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22157176
Simultaneous postprandial deregulation of the orexigenic endocannabinoid anandamide and the anorexigenic peptide YY in obesity (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/21844878
Ghrelin-Induced Orexigenic Effect in Rats Depends on the Metabolic Status and Is Counteracted by Peripheral CB1 Receptor Antagonism (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0060918
Food for thought: hormonal, experiential, and neural influences on feeding and obesity (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3818543/
AM404 attenuates reinstatement of nicotine seeking induced by nicotine-associated cues and nicotine priming but does not affect nicotine- and food-taking (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058760/
Endocannabinoid signaling in the gut mediates preference for dietary unsaturated fats (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659363/
Obesity-driven synaptic remodeling affects endocannabinoid control of orexinergic neurons (full–2013) http://www.pnas.org/content/110/24/E2229.full
Cannabinoids, eating behaviour, and energy homeostasis (full–2013) http://onlinelibrary.wiley.com/doi/10.1002/dta.1594/full
Fatty Acid Modulation of the Endocannabinoid System and the Effect on Food Intake and Metabolism (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3677644/
Reduced Food Intake is the Major Contributor to the Protective Effect of Rimonabant on Islet in Established Obesity-Associated Type 2 Diabetes (full–2013) http://www.eymj.org/DOIx.php?id=10.3349/ymj.2013.54.5.1127
top
The Gastric CB1 Receptor Modulates Ghrelin Production through the mTOR Pathway to Regulate Food Intake (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0080339
Fasting induces CART down-regulation in the zebrafish nervous system in a cannabinoid receptor 1-dependent manner (full–2013) http://press.endocrine.org/doi/full/10.1210/me.2011-1180
Activation of the sympathetic nervous system mediates hypophagic and anxiety-like effects of CB1 receptor blockade (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3607008/
Long-term CB1 receptor blockade enhances vulnerability to anxiogenic-like effects of cannabinoids (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691020/
Therapeutic potential of cannabinoid medicines (full–2013) http://onlinelibrary.wiley.com/doi/10.1002/dta.1529/full
Orexin neurons use endocannabinoids to break obesity-induced inhibition (full–2013) http://www.pnas.org/content/110/24/9625.full
Developmental Role for Endocannabinoid Signaling in Regulating Glucose Metabolism and Growth (full–2013) http://diabetes.diabetesjournals.org/content/62/7/2359.full?sid=2f5bda2b-a9c7-432a-9588-80c99189164d
Effects of glucagon-like peptide-1 receptor stimulation and blockade on food consumption and body weight in rats treated with a cannabinoid CB1 receptor agonist WIN 55,212-2 (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3638658/
Insulin induces long-term depression of VTA dopamine neurons via endocannabinoids (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072656/
Rimonabant precipitates anxiety in rats withdrawn from palatable food: role of the central amygdale (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3799070/
Brain Molecules and Appetite: The Case of Oleoylethanolamide (link to PDF–2013) http://www.eurekaselect.com/107948/article
Effect of Diet on Tissue Levels of Palmitoylethanolamide (link to PDF–2013) http://www.eurekaselect.com/107972/article
Cannabis and Δ(9)-tetrahydrocannabinol (THC) for weight loss? (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23410498
Taste sensitivity to 6-n-propylthiouracil is associated with endocannabinoid plasma levels in normal-weight individuals (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23398921
Novel antiobesity agents: Synthesis and pharmacological evaluation of analogues of Rimonabant and of LH21 (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23434135
Fat to treat fat: Emerging relationship between dietary PUFA, endocannabinoids, and obesity (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23466458
top
Central functional response to the novel peptide cannabinoid, hemopressin (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23542442
The inverse agonist of CB1 receptor SR141716 blocks compulsive eating of palatable food (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23587012
Cannabinoid receptors and cholecystokinin in feeding inhibition (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23601425
The endocannabinoid system in obesity (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23596738
The Role of the Endocannabinoid System in Eating Disorders: Neurochemical and Behavioural Preclinical Evidence (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23829365
The satiety signal oleoylethanolamide stimulates oxytocin neurosecretion from rat hypothalamic neurons (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23959001
Cannabis withdrawal syndrome: An important diagnostic consideration in adolescents presenting with disordered eating (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24281745
The regulation of food intake by the gut-brain axis: implications for obesity (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/22710925
Concurrent pharmacological modification of cannabinoid-1 and glucagon-like peptide-1
receptor activity affects feeding behavior and body weight in rats fed a free-choice, high carbohydrate diet (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24370558
Oleoylethanolamide: a novel potential pharmacological alternative to cannabinoid antagonists for the control of appetite (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996326/
Effect of intermittent cold exposure on brown fat activation, obesity, and energy homeostasis in mice (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3895006/
Dietary Non-Esterified Oleic Acid Decreases the Jejunal Levels of Anorectic NAcylethanolamines (full–2014) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0100365
Dronabinol in severe, enduring anorexia nervosa: A randomized controlled trial (full–2014) http://onlinelibrary.wiley.com/doi/10.1002/eat.22173/full
Behavioral effects of the cannabinoid CB1 receptor allosteric modulator ORG27569 in rats (full–2014) http://onlinelibrary.wiley.com/doi/10.1002/prp2.69/full
Oleoylethanolamide enhances β-adrenergic-mediated thermogenesis and white-to-brown adipocyte phenotype in epididymal white adipose tissue in rat (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3882055/
The effects of leptin in combination with a cannabinoid receptor 1 antagonist, AM 251, or cannabidiol on food intake and body weight in rats fed a high-fat or a free-choice high sugar diet (full–2014) http://www.jpp.krakow.pl/journal/archive/08_14/pdf/487_08_14_article.pdf
top
Nabilone for Non-chemotherapy Associated Nausea and Weight Loss due to Medical Conditions: A Review of the Clinical Effectiveness and Guidelines [Internet] (full-2014) http://www.ncbi.nlm.nih.gov/books/NBK253668/toc/?report=reader
Behavioral effects of the cannabinoid CB1 receptor allosteric modulator ORG27569 in rats (full–2014) http://onlinelibrary.wiley.com/doi/10.1002/prp2.69/full
Marijuana and Body Weight (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204468/
Involvement of the cannabinoid CB1 receptor in modulation of dopamine output in the prefrontal cortex associated with food restriction in rats (full–2014) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0092224
Rimonabant’s reductive effects on high densities of food reinforcement, but not palatability, in lean and obese Zucker rats (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4036064/
Δ9-THC exposure attenuates aversive effects and reveals appetitive effects of K2/’Spice’ constituent JWH-018 in mice (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4157458/
Is fat taste ready for primetime? (full–2014) http://www.sciencedirect.com/science/article/pii/S003193841400136X
CB1 cannabinoid receptor in SF1-expressing neurons of the ventromedial hypothalamus determines metabolic responses to diet and leptin (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4209357/
Therapeutic Potential of Cannabinoids in Counteracting Chemotherapy-induced Adverse Effects: An Exploratory Review (full–2014) http://onlinelibrary.wiley.com/doi/10.1002/ptr.5265/full
Differential modulation of endogenous cannabinoid CB1 and CB2 receptors in spontaneous and splice variants of ghrelin-induced food intake in conscious rats (full–2014) http://www.nutritionjrnl.com/article/S0899-9007%2814%2900297-4/fulltext
Neural Effects of Cannabinoid CB1 Neutral Antagonist Tetrahydrocannabivarin (THCv) on Food Reward and Aversion in Healthy Volunteers (full–2014) http://ijnp.oxfordjournals.org/content/18/6/pyu094.long
Modulation of plasma N-acylethanolamine levels and physiological parameters by dietary fatty acid composition in humans (full–2014) http://www.jlr.org/content/55/12/2655.long
Oleoylethanolamide and Human Neural Responses to Food Stimuli in Obesity (full–2014) http://archpsyc.jamanetwork.com/article.aspx?articleid=1904805
Vagal afferents are not necessary for the satiety effect of the gut lipid messenger oleoylethanolamide (full–2014) http://ajpregu.physiology.org/content/307/2/R167
Baseline Anandamide Levels and Body Weight Impact the Weight Loss Effect of CB1 Receptor Antagonism in Male Rats (full–2014) http://press.endocrine.org/doi/10.1210/en.2014-1730#sthash.Fbslw7v2.dpuf
top
Cannabinoid type-1 Receptors in The Paraventricular Nucleus of The Hypothalamus Inhibit Stimulated Food Intake (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24434770
The endocannabinoid system controls food intake via olfactory processes (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24509429
Food intake regulation – 2nd part (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24564775
Classical endocannabinoid-like compounds and their regulation by nutrients (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24677570
Role of anorectic N-acylethanolamines in intestinal physiology and satiety control with respect to dietary fat (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24681513
Endocannabinoids and energy homeostasis: An update (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24752980
β-Caryophyllene, a CB2 Receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24930711
The endocannabinoid system and appetite: relevance for food reward (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24933167
A Vapourized Δ9-Tetrahydrocannabinol (Δ9-THC) Delivery System Part II: Comparison of Behavioural Effects of Pulmonary Versus Parenteral Cannabinoid Exposure in Rodents (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24956154
GPR55: From orphan to metabolic regulator? (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24972076
Inhibition of diacylglycerol lipase (DAGL) in the lateral hypothalamus of rats prevents the increase in REMS and food ingestion induced by PAR1 stimulation (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24996194
Haloperidol and rimonabant increase delay discounting in rats fed high-fat and standard-chow diets (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25000488
(Mo1122) Prevalence and Characterization of Cannabinoid Use in Patients With Gastrointestinal Disorders (abst–2014) http://www.gastrojournal.org/article/S0016-5085%2814%2962037-0/pdf
New insights on food intake control by olfactory processes: the emerging role of the endocannabinoid system (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25261796
Oleic acid content of a meal promotes oleoylethanolamide response and reduces subsequent energy intake in humans (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25347552
Truffles contain endocannabinoid metabolic enzymes and anandamide (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25433633
top
The role of gut hormones in appetite regulation (review) (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25532952
Cannabinoid Type 1 (CB1) Receptors on Sim1-Expressing Neurons Regulate Energy Expenditure in Male Mice (abst–2014) http://press.endocrine.org/doi/10.1210/en.2014-1437#sthash.9q1rpqPq.dpuf
Role of oleoylethanolamide as a feeding regulator in goldfish (full–2014) http://jeb.biologists.org/content/217/15/2761
The endocannabinoid system: directing eating behavior and macronutrient metabolism (full–2015) http://journal.frontiersin.org/Journal/10.3389/fpsyg.2014.01506/full
Quantitative analysis of performance on a progressive-ratio schedule: effects of reinforcer type, food deprivation and acute treatment with Δ9-tetrahydrocannabinol (THC) (full–2015) http://www.sciencedirect.com/science/article/pii/S037663571500042X
Lack of hypophagia in CB1 null mice is associated to decreased hypothalamic POMC and CART expression (full–2015) http://ijnp.oxfordjournals.org/content/early/2015/03/09/ijnp.pyv011.long
Negative Regulation of Leptin-induced ROS Formation by CB1 Receptor Activation in Hypothalamic Neurons (full–2015) http://www.jbc.org/content/early/2015/04/13/jbc.M115.646885.full.pdf+html
Effects of mood inductions by meal ambiance and moderate alcohol consumption on endocannabinoids and N-acylethanolamines in humans: a randomized crossover trial (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0126421
The successful use of dronabinol for failure to thrive secondary to intestinal dysmotility (full–2015) http://www.casereports.com/article/S2210-2612%2815%2900219-9/pdf
Deranged endocannabinoid responses to hedonic eating in underweight and recently weight-restored patients with anorexia nervosa (full–2015) http://ajcn.nutrition.org/content/101/2/262.long
Leptin Levels Are Negatively Correlated with 2-Arachidonoylglycerol in the Cerebrospinal Fluid of Patients with Osteoarthritis (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4383333/
Interaction between orexin A and cannabinoid system in the lateral hypothalamus of rats and effects of subchronic intraperitoneal administration of cannabinoid receptor inverse agonist on food intake and the nutritive utilization of protein (full-2015) http://www.jpp.krakow.pl/journal/archive/04_15/pdf/181_04_15_article.pdf
Effects of high-fructose diets on central appetite signaling and cognitive function (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4429636/
top
Diacylglycerol lipase α knockout mice demonstrate metabolic and behavioral phenotypes similar to those of cannabinoid receptor 1 knockout mice (full–2015) http://journal.frontiersin.org/article/10.3389/fendo.2015.00086/full
Hypothalamic POMC neurons promote cannabinoid-induced feeding (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496586/
Cannabis and Cannabinoids–for health professionals (PDQ®) (full–2015) http://www.cancer.gov/about-cancer/treatment/cam/hp/cannabis-pdq#section/all
Cannabis and Cannabinoids (PDQ®): Patient Version (full–2015) http://www.ncbi.nlm.nih.gov/books/NBK65875/
Anticipatory and consummatory effects of (hedonic) chocolate intake are associated with increased circulating levels of the orexigenic peptide ghrelin and endocannabinoids in obese adults (full–2015) http://www.foodandnutritionresearch.net/index.php/fnr/article/view/29678
Prevention of Diet-Induced Obesity Effects on Body Weight and Gut Microbiota in Mice Treated Chronically with Δ9-Tetrahydrocannabinol (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0144270
Anti-Obesity Effect of the CB2 Receptor Agonist JWH-015 in Diet-Induced Obese Mice (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0140592
Intestinal lipid-derived signals that sense dietary fat (full–2015) http://www.jci.org/articles/view/76302/pdf
Anandamide is involved in appetite-related amygdala hyperactivations in schizophrenia patients treated with olanzapine: a functional magnetic resonance imaging study (1st page–2015) http://journals.lww.com/psychopharmacology/Citation/2015/02000/Anandamide_Is_Involved_in_Appetite_Related.14.aspx
Dissecting the cannabinergic control of behavior: The where matters (abst–2015) http://onlinelibrary.wiley.com/doi/10.1002/bies.201500046/abstract;jsessionid=222EC084D6C5E7ECF95BFF9D2752CFE4.f01t01
The role of AMP-activated protein kinase (AMPK) in the androgenic potentiation of cannabinoid-induced changes in energy homeostasis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25550281
Association of G1359A polymorphism of the cannabinoid receptor gene (CNR1) with macro-nutrient intakes in obese females (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25664923
Role of cannabinoidergic system on food intake in neonatal layer-type chicken (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25902906
Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25935511
top
Epigenetic and Proteomic Expression Changes Promoted by Eating Addictive-like Behavior (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25944409
Endocannabinoid and nitric oxide interaction mediates food intake in neonatal chicken (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26053311
ENP11, a potential CB1R antagonist, induces anorexia in rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26072692
A pivotal role for enhanced brainstem orexin receptor 1 signaling in the central cannabinoid receptor 1-mediated pressor response in conscious rats (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26096126
Effects of co-administration of 2-arachidonylglycerol (2-AG) and a selective µ-opioid receptor agonist into the nucleus accumbens on high-fat feeding behaviors in the rat (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26100333
Food Liking Enhances the Plasma Response of 2-Arachidonoylglycerol and of Pancreatic Polypeptide upon Modified Sham Feeding in Humans (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26180248
Changes in IGF-I, urinary free cortisol and adipokines during dronabinol therapy in anorexia nervosa: Results from a randomised, controlled trial (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26248813
Fasting stimulates 2-AG biosynthesis in the small intestine: role of cholinergic pathways (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26290104
Enhanced Glutamatergic Synaptic Plasticity in the Hippocampal CA1 Field of Food Restricted Rats: Involvement of CB1 Receptors (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26354043
New insights on the role of the endocannabinoid system in the regulation of energy balance (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26374449
Endocannabinoids and Metabolic Disorders (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26408168
The Endocannabinoid System: Pivotal Orchestrator of Obesity and Metaboliic Disease (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26412154
Khat (Catha edulis F.) and cannabinoids: Parallel and contrasting behavioral effects in preclinical and clinical studies (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26469212
Sleep Restriction Enhances the Daily Rhythm of Circulating Levels of Endocannabinoid 2-arachidonoylglycerol (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26612385
Endocannabinoid Regulation of Neuroendocrine Systems (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26638767
CB1 receptors into the Prelimbic Cortex modulate food intake in rats (abst–2015) http://www.fasebj.org/content/29/1_Supplement/655.1.abstract?sid=edf921ac-0690-4aa6-ac81-0546314dd384
top
Interaction Between Endocannabinoid and Opioidergic Systems Regulates Food Intake in Neonatal Chicken (abst–2015) http://link.springer.com/article/10.1007/s10989-015-9457-9
Cannabis: a self-medication drug for weight management? The never ending story (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26456495
CB1 receptor blockade counters age-induced insulin resistance and metabolic dysfunction (full–2016) http://onlinelibrary.wiley.com/doi/10.1111/acel.12438/full
Exposure to a Highly Caloric Palatable Diet During Pregestational and Gestational Periods Affects Hypothalamic and Hippocampal Endocannabinoid Levels at Birth and
Induces Adiposity and Anxiety-Like Behaviors in Male Rat Offspring (full–2016) http://journal.frontiersin.org/article/10.3389/fnbeh.2015.00339/full
Responses of peripheral endocannabinoids and endocannabinoid-related compounds to hedonic eating in obesity (abst–2016) http://link.springer.com/article/10.1007/s00394-016-1153-9
Controlled downregulation of the cannabinoid CB1 receptor provides a promising approach for the treatment of obesity and obesity-derived type 2 diabetes (abst–2016) http://link.springer.com/article/10.1007/s12192-015-0653-5
Opioid and Cannabinoid System in Food Intake (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26806346
Efficacy, tolerability, and safety of cannabinoids in gastroenterology : A systematic review (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26809974
Effects of chronic exercise on the endocannabinoid system in Wistar rats with high-fat diet-induced obesity. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/26880264 Pharmacokinetics of Cannabis in Cancer Cachexia-Anorexia Syndrome. (abst – 2016) http://link.springer.com/article/10.1007%2Fs40262-015-0363-2
A role for the endocannabinoid 2-arachidonoyl-sn-glycerol for social and high-fat food reward in male mice. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/26873082 Regulation of Growth Hormone by the Splanchnic Area. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/26940386
Driving the need to feed: Insight into the collaborative interaction between ghrelin and endocannabinoid systems in modulating brain reward systems (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763415301494
Identification of the oleic acid ethanolamide (OEA) isomer cis-vaccenic acid ethanolamide (VEA) as a highly abundant 18:1 fatty acid ethanolamide in blood plasma from rats and humans (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27334716
Association between plasma endocannabinoids and appetite in hemodialysis patients: A pilot study (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27333956
Medical marijuana use in head and neck squamous cell carcinoma patients treated with radiotherapy (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27005465
Inhibitors of diacylglycerol lipases in neurodegenerative and metabolic disorders (abst–2016) http://www.sciencedirect.com/science/article/pii/S0960894X16306874
mGluR1/5 activation in the lateral hypothalamus increases food intake via the endocannabinoid system (abst–2016) http://www.sciencedirect.com/science/article/pii/S0304394016305997
top
Disturbances of sleep and circadian rhythms: novel risk factors for obesity (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27584008
Clinical trials of medicinal cannabis for appetite-related symptoms from advanced cancer: A survey of preferences, attitudes and beliefs among patients willing to consider participation (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27530738
Bisphenol A induces hypothalamic down-regulation of CB1 and anorexigenic effects in male mice (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27641926
Efficacy, tolerability, and safety of cannabinoids in gastroenterology: A systematic review (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/26809974
Hemopressin peptides as modulators of the endocannabinoid system and their potential applications as therapeutic tools (abst–2016) http://www.eurekaselect.com/146167/article
Pros and cons of medical cannabis use by people with chronic brain disorders (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27804883
Got Munchies? Estimating the Relationship between Marijuana Use and Body Mass Index (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27572145
From adolescent to elder rats: Motivation for palatable food and cannabinoids receptors (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27935269
Triazole Ureas Act as Diacylglycerol Lipase Inhibitors and Prevent Fasting-Induced Refeeding (abst–2016) http://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.6b01482
Peripheral endocannabinoid signaling controls hyperphagia in western diet-induced obesity (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28065722
Design, Synthesis and Biological Evaluation of Novel, Non-Brain Penetrant, Hybrid Cannabinoid CB1R Inverse Agonist/Inducible Nitric Oxide Synthase (iNOS) Inhibitors for the Treatment of Liver Fibrosis (abst–2017) http://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.6b01504
N-Oleoylglycine-induced hyperphagia was associated with the activation of AgRP neuron by CB1R (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28102080
A cannabigerol-rich Cannabis sativa extract, devoid of [INCREMENT]9- tetrahydrocannabinol, elicits hyperphagia in rats (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28125508


ARTHRITIS
Tissue Engineering of Cartilage; Can Cannabinoids Help? (full–2010) http://www.tara.tcd.ie/bitstream/2262/40674/1/Tissue%20Engineering%20of%20Cartilage%20-%20Can%20Cannabinoids%20Help.pdf
Cannabinoid-induced apoptosis in immune cells as a pathway to immuno-suppression (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005548/?tool=pubmed
Paradoxical effects of the cannabinoid CB2 receptor agonist GW405833 on rat osteo-arthritic knee joint pain (full–2010) http://www.oarsijournal.com/article/S1063-4584%2810%2900315-8/fulltext
Tonic modulation of spinal hyperexcitability by the endocannabinoid receptor system in a rat model of osteoarthritis pain (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3132591/?tool=pubmed
top
Honokiol inhibits the progression of collagen-induced arthritis by reducing levels of proinflammatory cytokines and matrix metalloproteinases and blocking oxidative tissue damage (full–2010) https://www.jstage.jst.go.jp/article/jphs/114/1/114_10070FP/_pdf
Local application of the endocannabinoid hydrolysis inhibitor URB597 reduces nociception in spontaneous and chemically induced models of osteoarthritis (abst–2010) http://www.unboundmedicine.com/medline/ebm/record/21185649/abstract/Local_application_of_the_endocannabinoid_hydrolysis_inhibitor_URB597_reduces_nociception_in_spontaneous_and_chemically_induced_models_of_osteoarthritis_
Is lipid signaling through cannabinoid 2 receptors part of a protective system? (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062638/

Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3085542/
Cannabinoids for Treatment of Chronic Non-Cancer Pain; a Systematic Review of Randomized Trials (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3243008/
Fatty acid amide hydrolase blockade attenuates the development of collagen-induced arthritis and related thermal hyperalgesia in mice (full-2011)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3164582/
The abnormal cannabidiol analogue O-1602 reduces nociception in a rat model of acute arthritis via the putative cannabinoid receptor GPR55 (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21683763
Medical cannabis: the opportunity versus the temptation (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22352284
Expression of cannabinoid receptors by human articular chondrocytes (abst–2011) http://www.thebonejournal.com/article/S8756-3282%2811%2900386-3/abstract
The effects of peptide and lipid endocannabinoids on arthritic pain at the spinal level (full-2012) http://journals.lww.com/anesthesiaanalgesia/Fulltext/2012/06000/The_Effects_of_Peptide_and_Lipid_Endocannabinoids.30.aspx
Dynamic changes to the endocannabinoid system in models of chronic pain (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3300.full?sid=1569c370-cd5c-4358-89ff-857201f5e069
Clinical implications for cannabinoid use in the rheumatic diseases: potential for help or harm? (full-2012) http://onlinelibrary.wiley.com/doi/10.1002/art.34522/full
Cortisol-mediated adhesion of synovial fibroblasts is dependent on the degradation of anandamide and activation of the endocannabinoid system (full-2012) http://onlinelibrary.wiley.com/doi/10.1002/art.37684/pdf
Lack of effect of chronic pre-treatment with the FAAH inhibitor URB597 on inflammatory pain inflammatory pain behaviour: evidence for plastic changes in the endocannabinoid system (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3449266/
Peripheral FAAH inhibition causes profound antinociception and protects against indomethacin-induced gastric lesions (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738192/
Platelet-rich plasma loaded hydrogel scaffold enhances chondrogenic differentiation and maturation with up-regulation of CB1 and CB2 (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22366523
top
Cannabinoids: novel therapies for arthritis? (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22530636
Role of CB1 and CB2 cannabinoid receptors in the development of joint pain induced by monosodium iodoacetate (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23199705
Neuromodulators for pain management in rheumatoid arthritis (abst–2012) http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD008921.pub2/abstract
Palmitoylethanolamide versus a nonsteroidal anti-inflammatory drug in the treatment of temporomandibular joint inflammatory pain (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22558609
Role of type 2 cannabinoid receptors in osteoarthritis (abst–2012) http://www.thebonejournal.com/article/S8756-3282%2812%2900234-7/abstract
Electroacupuncture inhibition of hyperalgesia in rats with adjuvant arthritis: involvement of cannabinoid receptor 1 and dopamine receptor subtypes in striatum (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3677619/
Cannabinoid CB2 Receptors Regulate Central Sensitization and Pain Responses Associated with Osteoarthritis of the Knee Joint (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0080440
Palmitoylethanolamide and luteolin ameliorate development of arthritis caused by injection of collagen type II in mice (full–2013) http://arthritis-research.com/content/15/6/R192
Osteoarthritis pain mechanisms: basic studies in animal models (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3771690/
Cannabinoid WIN-55,212-2 Mesylate Inhibits Interleukin-1β Induced Matrix Metalloproteinase and Tissue Inhibitor of Matrix Metalloproteinase Expression in Human Chondrocytes (full–2013) http://www.oarsijournal.com/article/S1063-4584%2813%2900999-0/fulltext
Honokiol, a low molecular weight natural product, prevents inflammatory response and cartilage matrix degradation in human osteoarthritis chondrocytes (full-2013) http://onlinelibrary.wiley.com/doi/10.1002/jor.22577/full
CB1 and CB2 contribute to antinociceptive and anti-inflammatory effects of electro-acupuncture on experimental arthritis of the rat temporomandibular joint (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23181276
Selective Cannabinoid Receptor Type 2 (CB2) Agonists: Optimization of a Series of Purines Leading to the Identification of a Clinical Candidate for the Treatment of Osteoarthritic Pain (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23795771
Rheumatologists lack confidence in their knowledge of cannabinoids pertaining to the management of rheumatic complaints (full–2014) http://www.biomedcentral.com/content/pdf/1471-2474-15-258.pdf

Cannabinoid receptor 2 as a potential therapeutic target in rheumatoid arthritis (full–2014) http://www.biomedcentral.com/1471-2474/15/275
High hopes for cannabinoid agonists in the treatment of rheumatic diseases (full–2014) http://www.biomedcentral.com/content/pdf/1471-2474-15-410.pdf
Expression of cannabinoid receptor 2 and its inhibitory effects on synovial fibroblasts in rheumatoid arthritis (full–2014) http://rheumatology.oxfordjournals.org/content/53/5/802.long
top
Tapping into the endocannabinoid system to ameliorate acute inflammatory flares and associated pain in mouse knee joints (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4201700/
CB1 augments mGluR5 function in medial prefrontal cortical neurons to inhibit amygdala hyperactivity in an arthritis pain model (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288820/
Medical Cannabis Research, What the Science Says (article–2014)
http://www.safeaccessnow.org/medical_cannabis_research_what_does_the_evidence_say
Involvement of the endocannabinoid system in osteoarthritis pain (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24494687
Hempseed oil induces reactive oxygen species- and C/EBP homologous protein-mediated apoptosis in MH7A human rheumatoid arthritis fibroblast-like synovial cells (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24814038
Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24836296
Discriminating the effects of Cannabis sativa and Cannabis indica: a web survey of medical cannabis users (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25191852
Cannabinoid Receptor CB2 Is Involved in Tetrahydrocannabinol-Induced Anti-Inflammation against Lipopolysaccharide in MG-63 Cells (full–2015) http://www.hindawi.com/journals/mi/2015/362126/
Leptin Levels Are Negatively Correlated with 2-Arachidonoylglycerol in the Cerebro-spinal Fluid of Patients with Osteoarthritis (full–2015)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4383333/
Cannabinoid-based drugs targeting CB1 and TRPV1, the sympathetic nervous system, and arthritis. (full–2015) http://www.arthritis-research.com/content/17/1/226
Cannabis – the Israeli perspective (full–2015) http://www.degruyter.com/view/j/jbcpp.ahead-of-print/jbcpp-2015-0091/jbcpp-2015-0091.xml

Anti-inflammatory effects of N-acylethanolamines in rheumatoid arthritis synovial cells are mediated by TRPV1 and TRPA1 in a COX-2 dependent manner (full–2015) http://www.arthritis-research.com/content/17/1/321
Cannabinoid-based drugs targeting CB1 and TRPV1, the sympathetic nervous system, and arthritis (full–2015) http://link.springer.com/article/10.1186/s13075-015-0743-x
Endocannabinoids and acute pain after total knee arthroplasty (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4299927/
Activation of cannabinoid receptor 2 attenuates synovitis and joint distruction in collagen-induced arthritis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25601571
Deficiency of G-protein coupled receptor 40, a lipid-activated receptor, heightens in vitro- and in vivo-induced murine osteoarthritis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25585625
top
The endocannabinoid system and its therapeutic implications in rheumatoid arthritis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25791728
A multi-target approach for pain treatment – dual inhibition of fatty acid amide hydrolase and TRPV1 in a rat model of osteoarthritis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25719612
The type 2 cannabinoid receptor regulates susceptibility to osteoarthritis in mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25937028
Association between cannabinoid receptor type 2 Q63R variant and oligo/polyarticular juvenile idiopathic arthritis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25974389
Role of the endocannabinoid system in the emotional manifestations of osteo-arthritis pain (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26067584
The Potential of Inhibitors of Endocannabinoid Metabolism for Drug Development: A Critical Review (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26408159
Efficacy, tolerability and safety of cannabinoid treatments in the rheumatic diseases: A systematic review of randomized controlled trials (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26548380
INF/IR-15: ADELMIDROL, A PALMITOYLETHANOLAMIDE ANALOGUE, AS A NEW PHARMACOLOGICAL TREATMENT FOR THE MANAGEMENT OF INFLAMMATORY PAIN (abst–2015) http://www.medscape.com/medline/abstract/26375095
Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26517407
Rescue of Impaired mGluR5-Driven Endocannabinoid Signaling Restores Prefrontal Cortical Output to Inhibit Pain in Arthritic Rats (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26791214
Cannabinoid WIN-55,212-2 mesylate inhibits ADAMTS-4 activity in human osteoarthritic articular chondrocytes by inhibiting expression of syndecan-1. (link to PDF- 2016) https://www.spandidos-publications.com/10.3892/mmr.2016.5137
Cannabinoids and autoimmune diseases: A systematic review (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26876387
MEDICAL CANNABIS (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27215115
Robust anti-nociceptive effects of MAG lipase inhibition in a model of osteoarthritis pain (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27501482
Endocannabinoids inhibit neurogenic inflammation in murine joints by a non-canonical cannabinoid receptor mechanism (abst–2016) http://www.neuropeptidesjournal.com/article/S0143-4179(16)30047-6/abstract
Cannabinoids in the Management of Musculoskeletal or Rheumatic Diseases (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27832442
Survey of herbal cannabis (marijuana) use in rheumatology clinic attenders with a rheumatologist confirmed diagnosis (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27842047
Medical Cannabis – another piece in the mosaic of autoimmunity? (abst – 2016) https://www.ncbi.nlm.nih.gov/pubmed/27859024
top


ASTHMA
Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005548/?tool=pubmed
Anti-inflammatory effects of the neurotransmitter agonist Honokiol in a mouse model of allergic asthma (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3197781/
Beneficial effects of cannabinoids (CB) in a murine model of allergen-induced airway inflammation: Role of CB(1)/CB(2) receptors (abst-2010) http://www.unboundmedicine.com/medline/ebm/record/21056512/abstract/Beneficial_effects_of_cannabinoids__CB__in_a_murine_model_of_allergen_induced_airway_inflammation:_Role_of_CB_1_/CB_2__receptors
The cannabinoid receptor agonist WIN 55,212-2 inhibits antigen-induced plasma extravasation in guinea pig airways (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20150748
Is lipid signaling through cannabinoid 2 receptors part of a protective system? (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062638/
The role of CB2 receptor ligands in human eosinophil function (full–2012) http://www.biomedcentral.com/content/pdf/2050-6511-13-S1-A13.pdf
The Role of Cannabinoids In Inflammatory Modulation of Allergic Respiratory Disorders, Inflammatory Pain and Ischemic Stroke (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22420307
The effects of cannabidiol on the antigen-induced contraction of airways smooth muscle in the guinea-pig (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23428645
Cannabinoid CB2 receptors as novel target for inhibiting house dust mite induced allergic airway inflammation (abst–2013) http://www.jimmunol.org/cgi/content/meeting_abstract/190/1_MeetingAbstracts/120.12?sid=c3422dd2-7ad0-42e4-a862-845dc670f7cf
top
The expression of cannabinoid receptor 1 is significantly increased in atopic patients (full–2014) http://www.jacionline.org/article/S0091-6749%2813%2902936-9/fulltext
Cannabinoids inhibit cholinergic contraction in human airways through prejunctional CB1 receptors (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24467410
Cannabidiol improves lung function and inflammation in mice submitted to LPS-induced acute lung injury (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25356537
Exposure to Allergen Causes Changes in NTS Neural Activities after Intratracheal Capsaicin Application, in Endocannabinoid Levels and in the Glia Morphology of NTS (full–2015) http://www.hindawi.com/journals/bmri/2015/980983/
Implications of Marijuana Decriminalization on the Practice of Pulmonary, Critical Care, and Sleep Medicine. A Report of the American Thoracic Society Marijuana Workgroup (full–2015) http://www.atsjournals.org/doi/full/10.1513/AnnalsATS.201504-195AR#.Vo20QFJwtSE
How beneficial is vaping cannabis to respiratory health compared to smoking? (article–2015) http://onlinelibrary.wiley.com/doi/10.1111/add.13075/full

The effect of phytocannabinoids on airway hyper-responsiveness, airway inflammation, and cough (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25655949
The Endogenous Cannabinoid Anandamide Increases Human Airway Epithelial Cell Permeability through an Arachidonic Acid Metabolite (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816000256
The Endogenous Cannabinoid Anandamide Increases Human Airway Epithelial Cell Permeability through an Arachidonic Acid Metabolite (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26808080
Cannabinoid receptor 2 augments eosinophil responsiveness and aggravates allergen induced pulmonary inflammation in mice (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/26850094
Stimulation of cannabinoid CB1 receptors prevents nerve-mediated airway hyperreactivity in NGF-induced inflammation in mouse airways. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/26896777
The effect of cannabinoids on dinitrofluorobenzene-induced experimental asthma in mice (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27216000
Δ9-Tetrahydrocannabinol Reverses TNFα-induced Increase in Airway Epithelial Cell Permeability through CB2 Receptors (abst–2016) http://www.sciencedirect.com/science/article/pii/S0006295216302878
CB2 receptors regulate natural killer cells that limit allergic airway inflammation in a murine model of asthma (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27992060
top


ATAXIA
The du2J mouse model of ataxia and absence epilepsy has deficient cannabinoid CB1 receptor-mediated signalling (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3764637/
Changes in CB1 and CB2 receptors in the post-mortem cerebellum of humans affected by spinocerebellar ataxias (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3954486/
Endocannabinoid-Hydrolysing Enzymes in the Post-Mortem Cerebellum of Humans Affected by Hereditary Autosomal Dominant Ataxias (full–2014) http://www.karger.com/Article/FullText/358127 Does modulation of the endocannabinoid system have potential therapeutic utility in cerebellar ataxia? (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4983615/ Targeting Cannabinoid CB2 Receptors in the Central Nervous System. Medicinal Chemistry Approaches with Focus on Neurodegenerative Disorders (full–2016) http://journal.frontiersin.org/article/10.3389/fnins.2016.00406/full Buzz Juice: Neurological sequelae of synthetic cannabinoids (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27865819


ATHEROSCLEROSIS
US Patent Application 20100158973 – THERAPEUTIC USES OF CANNABIDIOL COMPOUNDS (full–2010) http://www.google.com/patents/US20100158973
WIN55212-2 ameliorates atherosclerosis associated with suppression of pro inflammatory responses in ApoE-knockout mice (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20868672
The activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaques (full–2011) http://eurheartj.oxfordjournals.org/content/33/7/846.full
Cannabinoid receptor 2 signaling does not modulate atherogenesis in mice (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3082575/?tool=pubmed
Is lipid signaling through cannabinoid 2 receptors part of a protective system? (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062638/
top
Cannabinoid Receptor 2 Deficiency in Haematopoietic cells Aggravates Early Atherosclerosis in LDL Receptor Deficient Mice (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3109635/?tool=pubmed
Atheroprotection via cannabinoid receptor-2 is mediated by circulating and vascular cells in vivo (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21884703
The effect of dietary hempseed on atherogenesis and contractile function in aortae from hypercholesterolemic rabbits (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21893466
Cannabinoids and atherosclerotic coronary heart disease (full–2012) http://onlinelibrary.wiley.com/doi/10.1002/clc.21962/pdf
Antihyperglycemic and hypolipidemic effects of α, β-amyrin, a triterpenoid mixture from Protium heptaphyllum in mice (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3484111/
Targeting cannabinoid receptor CB(2 ) in cardiovascular disorders: promises and controversies (full–2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02042.x/full
The potential use of cannabidiol in the therapy of metabolic syndrome (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22430005
Update on the endocannabinoid-mediated regulation of gelatinase release in arterial wall physiology and atherosclerotic pathophysiology (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23253273
Endogenous cannabinoid receptor CB1 activation promotes vascular smooth muscle cell proliferation and neointima formation (full–2013) http://www.jlr.org/content/early/2013/03/11/jlr.M035147.long ;
Fatty acid amide hydrolase deficiency enhances intraplaque neutrophil recruitment in atherosclerotic mice (full–2013) http://atvb.ahajournals.org/content/33/2/215.long
Therapeutic Opportunities through the Modulation of Endocannabinoid Transport (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4255948/
top
Endocannabinoid system as a potential mechanism for n-3 long-chain polyunsaturated fatty acid mediated cardiovascular protection (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24020800
Magnolol inhibits migration of vascular smooth muscle cells via cytoskeletal remodeling pathway to attenuate neointima formation (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23906924
A new face of endocannabinoids in pharmacotherapy. Part II. Role of endocannabinoids in inflammation-derived cardiovascular diseases (full–2014) http://www.jpp.krakow.pl/journal/archive/04_14/pdf/183_04_14_article.pdf
Detailed characterization of the endocannabinoid system in human macrophages and foam cells, and anti-inflammatory role of type-2 cannabinoid receptor (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24529123
Role of endocannabinoid 2-arachidonoylglycerol in the physiology and pathophysiology of the cardiovascular system (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24934539
Anti-atherosclerosis role of N-oleoylethanolamine in CB2 (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24961101

Increased oxidative stress enhances endocannabinoid tone (abst–2014) http://www.fasebj.org/content/28/1_Supplement/671.13.abstract?sid=db987fd0-3ef0-4796-aff6-4103f0c84daf
Cannabinoid receptor type 2 activation in atherosclerosis and acute cardiovascular diseases (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25245379
The Activated Endocannabinoid System in Atherosclerosis: Driving Force or Protective Mechanism? (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25469884
Fatty Acid-Binding Protein 4 (FABP4): Pathophysiological Insights and Potent Clinical Biomarker of Metabolic and Cardiovascular Diseases (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315049/
Activation of GPR55 Receptors Exacerbates oxLDL-Induced Lipid Accumulation and Inflammatory Responses, while Reducing Cholesterol Efflux from Human Macrophages (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0126839
top
Monoglyceride lipase deficiency modulates endocannabinoid signaling and improves plaque and improves plaque stability in ApoE-knockout mice (full–2015) http://www.ncbi.nlm.nih.gov/pubmed/26584135
Oxyradical Stress, Endocannabinoids, and Atherosclerosis (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4686160/
Elevation of Plasma 2-Arachidonoylglycerol Levels in Alzheimer’s Disease Patients as a Potential Protective Mechanism against Neurodegenerative Decline (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25818503
The effect of endocannabinoid system in ischemia-reperfusion injury: a friend or a foe? (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25936364
Endocannabinoids and the Cardiovascular System in Health and Disease (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26408169
Cannabinoid Receptor Type 2 (CB2) Dependent and Independent Effects of WIN55,212-2 on Atherosclerosis in Ldlr-null Mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26413498
Beyond Lipoprotein Receptors: Learning from Receptor Knockouts Mouse Models about New Targets for Reduction of the Atherosclerotic Plaque (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26592248
Myeloid-Specific Deletion of Diacylglycerol Lipase α Inhibits Atherogenesis in ApoEDeficient Mice (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0146267
Monoglyceride lipase deficiency modulates endocannabinoid signaling and improves plaque stability in ApoE-knockout mice (full–2016) http://www.sciencedirect.com/science/article/pii/S0021915015301933
The CB2 receptor and its role as a regulator of inflammation (full–2016) http://link.springer.com/article/10.1007%2Fs00018-016-2300-4
N-Oleoylethanolamine reduces inflammatory cytokines and adhesion molecules in TNF- α-induced human umbilical vein endothelial cells by activating CB2 and PPAR-α (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27281236
Optimized extraction of 2-arachidonyl glycerol and anandamide from aortic tissue and plasma for quantification by LC-MS/MS (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27274705
Selective activation of CB2 receptor improves efferocytosis in cultured macrophages (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27474129
Treatment with the GPR55 antagonist CID16020046 increases neutrophil activation in mouse atherogenesis (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27465665
Overlapping molecular pathways between cannabinoid receptors type 1 and 2 and estrogens/androgens on the periphery and their involvement in the pathogenesis of common diseases (Review) (abst–2016) https://www.spandidos-publications.com/10.3892/ijmm.2016.2779
Oxyradical Stress Increases the Biosynthesis of 2-Arachidonoylglycerol: Involvement of NADPH Oxidase (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27784678
Cannabinoid receptor type 2 (CB2) as one of the candidate genes in human carotid plaque imaging: Evalulation of the novel radiotracer [11C]RS-016 targeting CB2 in atherosclerosis (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28104528
top


AUTISM
Use of dronabinol (delta-9-THC) in autism: A prospective single-case-study with an early infantile autistic child (full–2010) http://www.cannabis-med.org/data/pdf/en_2010_04_1.pdf
Can autism be triggered by acetaminophen activation of the endocannabinoid system? (link to PDF–2010) http://www.ncbi.nlm.nih.gov/pubmed/20628445
Variation in the human Cannabinoid Receptor (CNR1) gene modulates gaze duration for happy faces (full–2011) http://www.molecularautism.com/content/pdf/2040-2392-2-10.pdf
Consequences of cannabinoid and monoaminergic system disruption in a mouse model of autism spectrum disorders (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3137184/
Moderation of antipsychotic-induced weight gain by energy balance gene variants in the RUPP autism network risperidone studies (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693401/
Autism-Associated Neuroligin-3 Mutations Commonly Disrupt Tonic Endocannabinoid Signaling (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663050/
Evidence for a Common Endocannabinoid-Related Pathomechanism in Autism Spectrum Disorders (link to full–2013) http://www.sciencedirect.com/science/article/pii/S0896627313003619
Cannabinoid Receptor Type 2, but not Type 1, is Up-Regulated in Peripheral Blood Mononuclear Cells of Children Affected by Autistic Disorders (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23585028
Alterations in the endocannabinoid system in the rat valproic acid model of autism (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23643692
The in vitro GcMAF effects on endocannabinoid system transcriptionomics, receptor formation, and cell activity of autism-derived macrophages (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996516/
top
Defects in fatty acid amide hydrolase 2 in a male with neurologic and psychiatric symptoms (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423390/
Increased Cortical Inhibition in Autism-Linked Neuroligin-3R451C Mice Is Due in Part to Loss of Endocannabinoid Signaling (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0140638
Endocannabinoid signaling mediates oxytocin-driven social reward (full–2015) http://www.pnas.org/content/112/45/14084.full
Medical marijuana: review of the science and implications for developmental-behavioral pediatric practice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25650954
Endocannabinoid Signaling in Autism (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26216231

Endocannabinoids and Mental Disorders (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26408164
The basolateral amygdala γ-aminobutyric acidergic system in health and disease (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26586374
β-Neurexins Control Neural Circuits by Regulating Synaptic Endocannabinoid Signaling (abst–2015) http://www.cell.com/cell/abstract/S0092-8674%2815%2900826-0?_returnURL=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0092867415008260%3Fshowall%3Dtrue
Oxytocin Enhances Pleasure of Social Interactions by Stimulating Production of “Bliss Molecule” (news/abstract–2015) http://neurosciencenews.com/oxytocin-anandamide-2926/
p21-activated kinase 1 restricts tonic endocannabinoid signaling in the hippocampus (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4907698/
Endocannabinoid signaling in social functioning: an RDoC perspective (full–2016) http://www.nature.com/tp/journal/v6/n9/full/tp2016169a.html
Targeting anandamide metabolism rescues core and associated autistic-like symptoms in rats prenatally exposed to valproic acid (full–2016) http://www.nature.com/tp/journal/v6/n9/full/tp2016182a.html
Acetaminophen Use for Fever in Children Associated with Autism Spectrum Disorder (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5044872/
top
Involvement of TRPV1 in the Olfactory Bulb in Rimonabant-Induced Olfactory Discrimination Deficit. (click “Full Text Links” for PDF–2016) http://www.ncbi.nlm.nih.gov/pubmed/26875559
Deficient adolescent social behavior following early-life inflammation is ameliorated by augmentation of anandamide signaling (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27453335
Pharmacological inhibition of fatty acid amide hydrolase attenuates social behavioural deficits in male rats prenatally exposed to valproic acid (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816308660
Functions of synapse adhesion molecules neurexin/neurexins and neurodevelopmental disorders (abst–2016) http://www.sciencedirect.com/science/article/pii/S0168010216301419

Advertisements